Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,solute:sodium symporter activity (GO:0015370),0.8470300389401237,2.028588376534828,0.0,0.0,0.0,4/27,2.82%,SLC4A10;SLC4A4;SLC5A6;SLC34A2
prerank,cAMP binding (GO:0030552),-0.8209962047793012,-2.0002502580928345,0.0,0.04616777308388654,0.045,6/11,7.74%,RAPGEF4;PDE4B;RAPGEF2;PDE4D;HCN1;PDE2A
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.7687863270486452,-1.9873496317126924,0.0,0.028968014484007244,0.056,5/14,5.34%,SLC7A11;SLC1A3;SLC1A1;SLC1A2;SLC25A13
prerank,gap junction channel activity (GO:0005243),-0.6827664713333738,-1.9765744858274794,0.0,0.024140012070006035,0.071,5/22,4.94%,GJB6;GJB2;GJA1;GJC1;GJD3
prerank,wide pore channel activity (GO:0022829),-0.673638640327057,-1.9758245279465783,0.0,0.018105009052504527,0.071,5/23,4.94%,GJB6;GJB2;GJA1;GJC1;GJD3
prerank,sulfate transmembrane transporter activity (GO:0015116),0.9221869306202531,1.9469288872488755,0.0,0.003104373427038321,0.006,3/14,2.44%,SLC26A7;SLC26A2;SLC26A6
prerank,outward rectifier potassium channel activity (GO:0015271),-0.7931099158522406,-1.9274338281310295,0.0,0.02715751357875679,0.129,6/11,13.10%,KCNK2;KCNT2;KCND2;KCND3;KCNQ1;KCNT1
prerank,anion:anion antiporter activity (GO:0015301),0.8855189846985076,1.926311967122367,0.0,0.007588468377204784,0.018,4/17,4.18%,SLC26A7;SLC26A2;SLC26A6;SLC4A2
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.8868190368176211,1.8990174778589823,0.0,0.016297960491951185,0.049,3/15,2.44%,SLC26A7;SLC26A2;SLC26A6
prerank,chloride transmembrane transporter activity (GO:0015108),0.8633418379399124,1.8890080556498579,0.0,0.017591449419883817,0.066,3/16,2.44%,SLC26A7;SLC26A2;SLC26A6
prerank,glutamate receptor activity (GO:0008066),-0.6707596488032286,-1.8650253780191401,0.0,0.05220277610138806,0.277,8/19,5.80%,GRM7;GRID2;GRIK2;GRIA4;GRM5;GRM3;GRM1;GRIA1
prerank,adenylate cyclase binding (GO:0008179),-0.7730695246617028,-1.8538214162373972,0.0,0.05250452625226312,0.317,4/10,8.41%,ADCY5;AKAP6;CAP2;CALM1
prerank,symporter activity (GO:0015293),0.904197497846706,1.8276739028241142,0.0,0.0629497944927215,0.261,2/10,0.41%,SLC4A4;SLC5A6
prerank,carbohydrate:cation symporter activity (GO:0005402),0.8880006228309809,1.7998830078591679,0.0015432098765432098,0.09239206628090241,0.402,2/11,0.14%,SLC23A1;SLC23A2
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.73022949988158,1.7769306304230572,0.002680965147453083,0.12404558818873958,0.544,3/29,2.44%,SLC26A7;SLC26A2;SLC26A6
prerank,organic anion transmembrane transporter activity (GO:0008514),0.6067865376350969,1.7690388362433764,0.0,0.1238300067007508,0.584,18/134,5.89%,SLC26A7;SLC38A2;SLC26A2;SLC23A1;SLC23A2;SLC38A1;SLC5A6;SLCO3A1;SLCO2A1;SLCO4A1;ABCG2;SLC16A1;SLC26A6;SFXN3;SLC38A6;SLC7A9;SLC6A7;SLC25A25
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.7484288207464569,1.7662195013961106,0.0026595744680851063,0.11631052439970241,0.604,4/27,3.32%,SLC26A7;SLC26A2;SLC26A6;SLC39A14
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.7241936311765923,1.740123602950059,0.0013422818791946308,0.15992226745348925,0.759,3/27,0.21%,SLC23A1;SLC9A2;SLC9B2
prerank,metalloendopeptidase activity (GO:0004222),0.6257916557859002,1.7348836502729283,0.0,0.159788998897278,0.782,16/76,10.88%,ADAMTSL3;ADAMTS17;ADAMTSL1;THSD4;ADAMTS2;TRABD2B;ADAM9;MMP28;ADAMTS3;ECE1;PHEX;ADAMTS6;ADAMTSL5;MMP16;IDE;MMEL1
prerank,solute:anion antiporter activity (GO:0140323),0.813859676795369,1.7300527536489254,0.0046875,0.1588006406908064,0.805,4/14,4.18%,SLC26A7;SLC26A2;SLC26A6;SLC4A2
prerank,cell adhesion mediator activity (GO:0098631),-0.5925918403995695,-1.7249517784322024,0.0,0.18116324683162344,0.779,11/24,13.46%,LRRC4C;BSG;ESAM;CNTN4;DSCAML1;BCAM;SIRPA;JAM3;ROBO4;NEXN;PALLD
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.6875938029354731,1.7163512287047975,0.007863695937090432,0.1793884358910001,0.855,6/32,5.58%,SLC38A2;SLC38A1;SFXN3;SLC38A6;SLC7A9;SLC6A7
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.8031243376701684,1.705622842345555,0.003048780487804878,0.1942647904564425,0.89,3/14,4.24%,CAPN5;CAPN2;CAPN12
prerank,chemoattractant activity (GO:0042056),0.7130436598007696,1.7020374192063903,0.006811989100817439,0.1906602679772702,0.898,6/26,4.13%,BMP4;PGF;DEFB130A;FGF2;VEGFA;CCL3
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.6441085139605206,-1.6906060277300254,0.017391304347826087,0.21866827600080468,0.865,6/15,14.90%,SLC1A3;SLC1A1;SLC1A2;SLC25A13;SLC1A5;SLC1A6
prerank,retinoid binding (GO:0005501),-0.5860193043825013,-1.6851395695267875,0.009433962264150943,0.20648762824381414,0.88,6/22,2.78%,ALDH1A2;PTGDS;NR2F2;CYP26B1;RBP4;ABCA4
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.6832249839294449,1.68282766010569,0.011780104712041885,0.2271670907785689,0.939,3/31,0.50%,KCNK5;SLC12A7;SLC12A2
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.6216198184275067,-1.6780560800758135,0.017142857142857144,0.19816755362923136,0.897,5/16,14.90%,SLC13A3;SLC1A1;SLC25A13;SLC1A5;SLC1A6
prerank,metal ion:proton antiporter activity (GO:0051139),0.794725369422624,1.667773342545339,0.01337295690936107,0.25651322650824054,0.963,2/13,0.21%,SLC9A2;SLC9B2
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.6654696256512282,-1.6573535680661702,0.02040816326530612,0.21673204586602293,0.934,6/12,8.54%,PDE8B;PDE4B;PDE7B;PDE4D;PDE2A;PDE8A
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.6256413082376613,-1.6528238952386265,0.023529411764705882,0.20737198830137876,0.937,10/15,26.76%,ALDH1A2;ALDH1A1;ALDH1L1;ALDH4A1;ALDH3B1;ALDH7A1;ALDH1A3;ALDH1L2;ALDH2;ALDH9A1
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.8067544223964395,1.6453292631764291,0.008116883116883116,0.3157202237989674,0.986,5/12,11.92%,AOX1;FDX1;CISD2;XDH;FXN
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.6872785513473396,-1.6422212781332455,0.029891304347826088,0.2101474265022847,0.945,7/11,17.33%,ITPR1;TRPC3;TRPC4;TRPC6;TRPC1;RPH3A;TRPC7
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.7971006526309339,1.640566690939287,0.018461538461538463,0.31716348512908177,0.991,2/12,0.21%,SLC9A2;SLC9B2
prerank,sodium:proton antiporter activity (GO:0015385),0.8077311351029367,1.6373506753829397,0.0140625,0.31265475229457373,0.991,2/11,0.21%,SLC9A2;SLC9B2
prerank,ligand-gated ion channel activity (GO:0015276),-0.5178184555672869,-1.627465605530883,0.0036900369003690036,0.22311406155703079,0.958,8/30,5.95%,GRID2;GRIK2;GRIA4;GRIN2A;GABRB1;GRIN2B;GRIA1;GRIN1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.6051453584625707,1.6267487446931026,0.009603841536614645,0.33306163995239924,0.994,7/55,4.01%,SLC38A2;SLC23A1;SLC23A2;SLC38A1;SLC16A9;SLC16A1;SLC38A6
prerank,gated channel activity (GO:0022836),0.75431356341529,1.6155175094733771,0.025449101796407185,0.35794775341328816,0.997,2/14,2.42%,PIEZO2;TMC6
prerank,cation:chloride symporter activity (GO:0015377),0.8092329547777404,1.6099092912884672,0.021875,0.3638153191298521,0.997,2/10,0.50%,SLC12A7;SLC12A2
prerank,cyclic nucleotide binding (GO:0030551),-0.5538555142283825,-1.6095362306028798,0.021660649819494584,0.24085319855159928,0.977,6/21,7.74%,RAPGEF4;PDE4B;RAPGEF2;PDE4D;HCN1;PDE2A
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.6454757063868075,-1.6092110379912252,0.04477611940298507,0.22705811352905675,0.977,3/11,10.97%,ITPR1;RYR2;RASA3
prerank,aspartic-type peptidase activity (GO:0070001),0.799282995192253,1.6078102954804872,0.012924071082390954,0.35679598588093775,0.997,5/10,13.93%,PGC;ASPRV1;BACE2;DDI2;CTSE
prerank,metal ion transmembrane transporter activity (GO:0046873),0.6615591650415921,1.606016824994744,0.02403204272363151,0.3492420105418111,0.997,5/27,5.90%,SLC23A1;SLC9B2;SLC12A2;CNNM2;ATP2B4
prerank,ligand-gated channel activity (GO:0022834),-0.5208672884499204,-1.6052740020256493,0.007575757575757576,0.2194729430698049,0.978,8/29,5.95%,GRID2;GRIK2;GRIA4;GRIN2A;GABRB1;GRIN2B;GRIA1;GRIN1
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.7749031001342037,1.5927150236471053,0.02702702702702703,0.38498063055061643,0.999,5/11,12.73%,UBE4B;UBR5;UBE4A;ANAPC11;UBE2K
prerank,mechanosensitive ion channel activity (GO:0008381),0.7666712604494225,1.5875690873425907,0.03697996918335902,0.3895619082667969,1.0,2/12,2.42%,PIEZO2;TMC6
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.5983210135593768,1.5838345908714553,0.013398294762484775,0.38990216594537624,1.0,6/53,5.58%,SLC47A1;SLC38A2;SLC38A1;SLC38A6;SLC7A9;SLC6A7
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.5735962376073507,-1.5807865206914542,0.05120481927710843,0.2502302830098783,0.989,10/18,29.79%,ALDH1A2;ALDH1A1;FAR2;ALDH3B1;ALDH1A3;HSD17B12;ALDH2;ALDH9A1;FAR1;ALDH8A1
prerank,transmitter-gated ion channel activity (GO:0022824),-0.5044288678867219,-1.5773888017252369,0.033707865168539325,0.2442365721182861,0.99,14/29,14.49%,GRID2;GRIK2;GRIA4;GABRG3;GABRB3;GABRB1;GABRA2;GABRB2;GLRA3;GABRG1;GABRA5;GABRA1;GABRG2;GRIK1
prerank,amino acid transmembrane transporter activity (GO:0015171),0.5962563444979649,1.5728330265007893,0.016129032258064516,0.4191593987263298,1.0,3/47,0.16%,SLC47A1;SLC38A2;SLC38A1
prerank,aspartic-type endopeptidase activity (GO:0004190),0.7481721706949156,1.5693020909297535,0.030534351145038167,0.41949097696333953,1.0,6/12,13.93%,PGC;ASPRV1;BACE2;SPPL2A;DDI2;CTSE
prerank,cation transmembrane transporter activity (GO:0008324),0.5938004472896272,1.5674845439401286,0.01987577639751553,0.41281699134970007,1.0,5/48,5.58%,SLC38A2;SLC38A1;SFXN3;SLC38A6;SLC6A7
prerank,metallopeptidase activity (GO:0008237),0.5487537165098006,1.5637631422341827,0.001098901098901099,0.4145122457779754,1.0,28/113,16.30%,ADAMTSL3;ADAMTS17;ADAMTSL1;THSD4;ADAMTS2;TRABD2B;BMP1;ADAM9;MMP28;ADAMTS3;ECE1;MYSM1;PHEX;ADAMTS6;ADAMTSL5;MMP16;IDE;ADAM12;MMEL1;ECE2;DPEP1;COPS5;ADAMTS5;BRCC3;ADAM15;NLN;PRPF8;ADAMTS1
prerank,secondary active transmembrane transporter activity (GO:0015291),0.5878065769807991,1.5552041207492404,0.020987654320987655,0.4342166243485855,1.0,5/51,1.29%,SLC4A4;SLC5A6;SLCO3A1;SLCO2A1;SLCO4A1
prerank,anion channel activity (GO:0005253),0.5801122083655647,1.553769812836771,0.009615384615384616,0.42713221809926305,1.0,8/61,4.12%,SLC26A7;CLIC4;LRRC8D;ANO9;GABRA3;ANO6;CLIC1;GLRB
prerank,R-SMAD binding (GO:0070412),0.6824719184047525,1.5399854261254107,0.04072398190045249,0.4678118289356359,1.0,9/18,18.27%,DDX5;SMAD6;PMEPA1;SMAD2;RANBP3;LDLRAD4;PAX6;SMAD4;SMURF1
prerank,insulin-like growth factor I binding (GO:0031994),-0.604436810915674,-1.531781865506108,0.045576407506702415,0.3196396241055263,0.998,6/13,4.29%,IGF1R;IGFBP2;ITGA6;IGFBP3;INSR;IGFBP4
prerank,CoA hydrolase activity (GO:0016289),0.6862818136221934,1.5288144583826213,0.05606060606060606,0.5005872069419721,1.0,7/16,13.07%,ACOT12;ABCD1;HIBCH;ACOT9;ACOT11;ACOT8;ACOT13
prerank,endopeptidase activity (GO:0004175),0.5014572366437419,1.527953499981904,0.0010204081632653062,0.49138963588514467,1.0,53/257,16.53%,ADAMTSL3;F3;ADAMTS17;HTRA3;PCSK5;ADAMTSL1;THSD4;ADAMTS2;TRABD2B;ADAM9;USP2;CASP6;USP46;HTRA4;PGC;ASPRV1;PRSS12;MMP28;PSMB2;ADAMTS3;USP24;USP15;USP25;USP13;ECE1;BACE2;CASP2;PHEX;ADAMTS6;ADAMTSL5;MMP16;USP1;USP34;TASP1;IDE;MMEL1;DDI2;PCSK7;ECE2;CTRC;USP40;CPNE1;CLPP;TYSND1;CTSE;ADAMTS5;PIDD1;ATG4B;USP28;NLN;GZMM;ADAMTS1;USP47
prerank,histone deacetylase activity (GO:0004407),0.6696159610007857,1.5210284063543524,0.04512372634643377,0.5056679382264643,1.0,5/19,6.80%,HDAC4;HDAC9;HDAC8;SIRT6;MIER1
prerank,cytokine activity (GO:0005125),0.5140045842784966,1.515627793974036,0.014008620689655173,0.5150672911027747,1.0,21/131,7.67%,BMP4;WNT9A;TNFRSF11B;BMP5;WNT11;FGF2;SLURP1;FAM3C;VEGFA;TGFB3;CXCL2;CLCF1;GDF10;CCL3;CCL1;TIMP1;IL33;BMP6;CTF1;INHBA;KITLG
prerank,5'-nucleotidase activity (GO:0008253),0.7097449935483546,1.507887488530329,0.06666666666666667,0.5333464980501935,1.0,4/13,9.76%,NT5C1A;NT5E;ACP3;NT5DC1
prerank,nucleotidase activity (GO:0008252),0.6908061303563457,1.5059520501185368,0.06606606606606606,0.5276202931748066,1.0,4/15,9.76%,NT5C1A;NT5E;ACP3;NT5DC1
prerank,ligand-gated calcium channel activity (GO:0099604),-0.5258370517146584,-1.5031716421919399,0.046052631578947366,0.3631288747462555,1.0,5/19,5.95%,ITPR1;RYR2;GRIN2A;GRIN2B;GRIN1
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.5773699878622037,1.5030497562712413,0.038461538461538464,0.5254813810295254,1.0,10/48,11.37%,PIEZO2;SLC12A7;SLC12A2;TRPM7;TRPM6;CALHM5;TRPM4;TRPM8;NALCN;RHCG
prerank,I-SMAD binding (GO:0070411),0.7186992286356716,1.5012557164624356,0.06259780907668232,0.5205940165221232,1.0,8/13,18.27%,SMAD6;SMAD9;TGFBR1;SMAD2;TGFB1I1;SMAD4;SMAD7;SMURF1
prerank,phospholipase inhibitor activity (GO:0004859),0.7342082553712587,1.4840615503541066,0.05442176870748299,0.5756888055252175,1.0,4/10,11.46%,ANXA2;ANXA4;ANXA1;ANGPTL3
prerank,glucose transmembrane transporter activity (GO:0005355),-0.545088614362648,-1.482015100700518,0.05642633228840126,0.39555508908189235,1.0,4/17,11.72%,SLC2A1;SLC5A3;MFSD4A;SLC5A11
prerank,chloride channel activity (GO:0005254),0.5504032656645739,1.4787658441659834,0.03260869565217391,0.5856692911082804,1.0,7/59,4.12%,SLC26A7;CLIC4;ANO9;GABRA3;ANO6;CLIC1;GLRB
prerank,leucine zipper domain binding (GO:0043522),0.7289156137186772,1.4717288981777563,0.060221870047543584,0.6032612191549644,1.0,4/10,13.77%,ERC1;PAWR;MRTFA;AATF
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.6096805525136411,-1.4711256618637336,0.0708215297450425,0.4059293904646953,1.0,3/11,17.73%,PPP1R1A;PPP1R2;PPP1R14A
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.5673208786708197,-1.469198866586671,0.06853582554517133,0.39414604707302353,1.0,9/14,32.24%,ALDH1L1;ALDH4A1;AASS;ALDH1L2;QDPR;PYCR1;BLVRB;NOXRED1;CRYM
prerank,Notch binding (GO:0005112),0.6401753055848363,1.4675147316577586,0.06232294617563739,0.6095350991394547,1.0,8/22,12.02%,CCN3;TCIM;SNED1;NCOR2;CUL3;AAK1;GALNT11;JAG1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.6887373459046704,1.4587134345939181,0.07716535433070866,0.6337145428473874,1.0,3/13,6.10%,BMP4;BMP5;BMP6
prerank,potassium ion antiporter activity (GO:0022821),0.669137636357976,1.458047773927957,0.09985315712187959,0.6240618421260903,1.0,2/15,0.76%,SLC9A2;SLC24A3
prerank,nucleotidyltransferase activity (GO:0016779),0.6368202891016922,1.4560304680031568,0.06896551724137931,0.62095584549726,1.0,7/19,17.28%,PAPSS2;NUDT5;TUT7;TUT4;CGAS;TENT2;TENT4B
prerank,sodium channel regulator activity (GO:0017080),0.5810611824633997,1.4514913281520416,0.060411311053984576,0.6272426308990248,1.0,9/37,5.90%,FXYD5;NEDD4;PTPN3;CAMK2D;FGF13;SNTA1;RANGRF;PRSS41;ATP2B4
prerank,translation initiation factor activity (GO:0003743),0.5776012766933977,1.449555453225253,0.06072874493927125,0.6226514022747113,1.0,14/36,19.43%,EIF4G3;MTIF3;EIF4E3;AGO2;EIF4G2;EIF3E;EIF3A;EIF2S1;EIF5B;COPS5;EIF3L;EIF2S2;EIF2D;EIF4G1
prerank,BMP receptor binding (GO:0070700),0.6887411651188825,1.4493559905507818,0.0873015873015873,0.6118490071105342,1.0,3/12,6.10%,BMP4;BMP5;BMP6
prerank,MAP kinase kinase kinase activity (GO:0004709),0.700760474627191,1.4471009271872908,0.09472049689440994,0.6104138876777654,1.0,2/11,0.92%,EGFR;MAP3K5
prerank,calcium channel inhibitor activity (GO:0019855),-0.5963416766418943,-1.4466390841952648,0.08333333333333333,0.4319089178775359,1.0,3/11,11.27%,ITPR1;CALM1;SLC30A1
prerank,androgen receptor binding (GO:0050681),0.593057997935666,1.4450181235904689,0.08548168249660787,0.6077919688222884,1.0,5/25,10.43%,FOXP1;DDX5;KDM1A;NSD1;TGFB1I1
prerank,potassium:proton antiporter activity (GO:0015386),0.7132086957515585,1.4419772992727518,0.09813084112149532,0.6085661170829156,1.0,3/10,11.17%,SLC9A2;SLC9A1;SLC9A8
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.5066531278534758,-1.4352940922393067,0.08766233766233766,0.4427009991282773,1.0,3/21,5.80%,GRM5;GRM1;GRIA1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.6104536247012612,-1.435267710436163,0.09192200557103064,0.42692257953271834,1.0,5/11,19.87%,KCNJ3;KCND3;KCNQ1;KCNJ8;KCNH2
prerank,manganese ion binding (GO:0030145),0.5330766781703316,1.4315564168730974,0.0688360450563204,0.6415169845748098,1.0,17/48,22.23%,ME1;MPPED2;ABL1;LARGE1;XPNPEP3;XPNPEP1;B4GALT1;WRN;ARG1;PRIMPOL;MGAT1;MGAT5;NEK4;MPPE1;SOD2;LARGE2;TDP2
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.6403200033941177,1.4304816519713148,0.07703488372093023,0.6350636012408507,1.0,5/18,8.31%,BAIAP2L1;ANXA2;KRT18;ANXA1;STXBP6
prerank,death receptor activity (GO:0005035),-0.5968746559804771,-1.4278689640891622,0.09116809116809117,0.4294320854056979,1.0,3/11,9.96%,TNFRSF19;TNFRSF11A;FAS
prerank,calcium-activated potassium channel activity (GO:0015269),0.6854793045000231,1.4277648052664682,0.10828025477707007,0.6354307474766661,1.0,2/11,1.57%,KCNMB3;KCNMB2
prerank,nucleoside-diphosphatase activity (GO:0017110),0.6965035127973481,1.4270153503293381,0.09649122807017543,0.6282030423501809,1.0,6/12,11.57%,ENTPD6;NUDT5;ENTPD2;ENTPD5;NUDT15;ENTPD7
prerank,thiol-dependent deubiquitinase (GO:0004843),0.5039101784780023,1.42635658150546,0.04919908466819222,0.6206076425322201,1.0,38/83,24.18%,TANK;USP2;USP46;OTUD1;USP24;USP15;USP25;USP13;MYSM1;ZC3H12A;USP1;USP34;DESI2;USP40;COPS5;ZRANB1;USP4;BRCC3;USP28;MINDY3;USP47;OTUD5;OTUD4;OTUD3;USP49;PSMD14;VCPIP1;USP21;USP16;USP19;USP10;USP32;USP30;USP36;USP9X;USP7;USP33;USP42
prerank,transcription corepressor binding (GO:0001222),0.5968868620176551,1.424505252560302,0.07244318181818182,0.6183123454361404,1.0,14/27,20.09%,ESR1;ZBTB16;PER1;LCOR;EHMT1;RORA;EED;PER3;NR1D1;FAM89B;THAP7;SUZ12;ZBTB7A;NEK6
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.7044886511642761,1.4239854428354548,0.08914100486223663,0.6102842448102158,1.0,3/10,1.29%,SLCO3A1;SLCO2A1;SLCO4A1
prerank,sequence-specific DNA binding (GO:0043565),0.4612192621945751,1.418971338449242,0.0,0.6203015703134417,1.0,118/590,15.35%,FOXP2;TBX15;FOXP1;KLF12;VSX1;SIX1;NR3C2;TCF7L1;KLF5;TCF7L2;TFCP2L1;PRRX2;NFIB;SLTM;FOXD1;HES1;HDAC4;ZIC4;CUX1;RARB;HOXA5;KLF3;MEOX2;NFAT5;HOXB6;PBX1;FOXL1;DMRT3;DMBX1;SOX14;SP8;GRHL2;PITX2;JDP2;ZNF423;ESR1;NFE2L2;GRHL1;ZNF148;TELO2;FOXC2;ZIC1;GLIS1;HOXC4;RARA;ELF1;KLF4;GLI3;ABL1;ATOH7;HOXA6;SMG6;FOXO3;KLF10;NFIX;MEF2A;NFATC4;BHLHE40;GLI2;HOXB4;GLIS2;NR4A2;MBD1;RORA;TEN1;E2F3;POU3F4;NFATC3;MLX;EGR1;NFIC;GATA4;KDM1A;RUNX2;RXRA;HOXA2;STN1;FOXC1;ELF3;ARNT;SIX4;ATF7;ATF6;POU4F1;ERF;CREB3L1;MECP2;RFX2;HOXB5;TEAD1;RXRB;ZBTB32;NR2F1;ETV3;HSF2;NR1D1;CEBPD;BATF3;LMX1A;SREBF1;NR4A1;MBD3;E2F1;PRMT5;HOXA7;NFATC1;SIRT3;PRDM2;RFX7;SP3;SOX9;NR3C1;BCL11B;POU2F1;FOSB;GMEB1;E2F2;MEF2D
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.6181453806816103,1.4147548667686525,0.08753709198813056,0.6268168951493184,1.0,6/20,13.65%,DLG2;MAGI3;DLG1;AK4;AK3;AK1
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.555646562517404,-1.4147269565765945,0.09887005649717515,0.4469221484610742,1.0,6/13,16.20%,ALDH1A2;ALDH1A1;ALDH1L1;ALDH4A1;ALDH7A1;ALDH1A3
prerank,double-stranded DNA binding (GO:0003690),0.46027987581172275,1.4130066228492666,0.0,0.6244578427960865,1.0,112/531,16.03%,TBX15;FOXP1;KLF12;VSX1;SIX1;EGFR;NR3C2;TCF7L1;KLF5;TFCP2L1;PRRX2;NFIB;HES1;ZIC4;CUX1;RARB;HOXA5;KLF3;MEOX2;NFAT5;HOXB6;PBX1;DMRT3;DMBX1;SOX14;SP8;PITX2;JDP2;ESR1;GRHL1;FOXC2;ZIC1;GLIS1;HOXC4;RARA;ELF1;KLF4;GLI3;ABL1;ATOH7;ERCC5;HOXA6;FOXO3;KLF10;RAD51;NFIX;NFATC4;BHLHE40;GLI2;HOXB4;GLIS2;NR4A2;MBD1;APEX1;E2F3;POU3F4;NFATC3;SMAD2;MLX;EGR1;NFIC;GATA4;RUNX2;RXRA;HOXA2;ELF3;TOP1;ARNT;NEIL3;SIX4;ATF7;ATF6;HDGFL3;POU4F1;KIN;CREB3L1;CGAS;WDR48;MECP2;RFX2;HOXB5;TEAD1;POLR3F;RAD50;RXRB;ZBTB32;NR2F1;ETV3;HSF2;NR1D1;CEBPD;BATF3;LMX1A;SREBF1;NR4A1;E2F1;HOXA7;NFATC1;DDX11;RFX7;SP3;SOX9;NR3C1;BCL11B;FOSB;GMEB1;E2F2;MEF2D;PRKDC;HOXD3;KDM5B;PAX6
prerank,pre-mRNA binding (GO:0036002),0.5943180835872884,1.4130051680305693,0.08641975308641975,0.6153050742591543,1.0,9/28,16.81%,DDX5;CELF3;U2AF2;SRSF6;CELF4;CELF1;ERI1;PRPF8;RNPC3
prerank,water transmembrane transporter activity (GO:0005372),-0.5918077288804546,-1.4130046116598542,0.103125,0.4368563474604318,1.0,3/11,13.88%,AQP11;PDPN;AQP4
prerank,GTPase inhibitor activity (GO:0005095),0.6688640329132515,1.4045641005150489,0.11496062992125984,0.6400108230545284,1.0,2/13,5.07%,SLIT2;PDE6D
prerank,hexose transmembrane transporter activity (GO:0015149),-0.5705083441445785,-1.4022875686682845,0.09641873278236915,0.4481272631261316,1.0,3/12,9.57%,SLC2A1;SLC5A3;MFSD4A
prerank,omega peptidase activity (GO:0008242),0.4915820490646032,1.4004866195631998,0.06278538812785388,0.6469957703866009,1.0,41/89,24.18%,TANK;USP2;USP46;OTUD1;USP24;USP15;USP25;USP13;MYSM1;ZC3H12A;USP1;USP34;DESI2;USP40;COPS5;ZRANB1;USP4;BRCC3;USP28;MINDY3;ASRGL1;USP47;OTUD5;APEH;OTUD4;OTUD3;USP49;PSMD14;VCPIP1;USP21;USP16;USP19;USP10;USP32;USP30;USP36;GGH;USP9X;USP7;USP33;USP42
prerank,MHC class I protein binding (GO:0042288),-0.5553639280017971,-1.4003868593946223,0.12244897959183673,0.4389093103637461,1.0,7/13,20.56%,TAP2;ATP5F1A;ABCB9;ATP5F1B;TUBB4B;DERL1;TAPBP
prerank,GABA-A receptor activity (GO:0004890),-0.5093510434352161,-1.3994711088188216,0.10256410256410256,0.42813021406510704,1.0,9/18,14.14%,GABRG3;GABRB3;GABRB1;GABRA2;GABRB2;GABRG1;GABRA5;GABRA1;GABRG2
prerank,calcium activated cation channel activity (GO:0005227),0.6298582798540275,1.3985922556582815,0.1240768094534712,0.6453890333150748,1.0,4/17,8.50%,KCNMB3;KCNMB2;ANO6;TRPM4
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.452998505951439,1.3972120108255088,0.0,0.6415273919569886,1.0,131/597,16.76%,BNC2;TBX15;FOXP1;KLF12;VSX1;SIX1;NR3C2;TCF7L1;KLF5;TCF7L2;TFCP2L1;PRRX2;NFIB;HES1;HDAC4;ZIC4;CUX1;RARB;HOXA5;KLF3;MEOX2;SMAD6;NFAT5;HOXB6;PBX1;DMRT3;DMBX1;SOX14;SP8;PITX2;JDP2;ESR1;NFE2L2;GRHL1;FOXC2;ZIC1;GLIS1;HOXC4;RARA;ELF1;KLF4;GLI3;ABL1;ATOH7;HOXA6;ARID4B;STAT3;FOXO3;CDC45;KLF10;MCM2;NFIX;PER1;NFATC4;BHLHE40;GLI2;HOXB4;GLIS2;NR4A2;CRY2;NCOR1;E2F3;POU3F4;NFATC3;IRF1;CHD3;MLX;EGR1;NFIC;GATA4;PER3;RUNX2;RXRA;HOXA2;GABPB1;GABPB2;FOXC1;ELF3;MLH3;ARNT;SIX4;ATF7;ATF6;TBL1X;POU4F1;DHX36;BCOR;ARID4A;CREB3L1;RFX2;HOXB5;TEAD1;RXRB;ZBTB32;ZW10;ORC3;NR2F1;ETV3;HSF2;BRCA1;NR1D1;CEBPD;BATF3;LMX1A;SREBF1;NR4A1;E2F1;HOXA7;NFYA;NFATC1;DDX11;RFX7;HINFP;SP3;SOX9;NR3C1;BCL11B;MCM7;FOSB;GMEB1;E2F2;MEF2D;HOXD3;KDM5B;PAX6;MZF1;PRDM5;SMAD4;FOXK1;ZFP1;MBNL2
prerank,insulin-like growth factor binding (GO:0005520),-0.5255309336551675,-1.3935826791595407,0.10285714285714286,0.42991637210104316,1.0,6/15,4.29%,IGF1R;IGFBP2;ITGA6;IGFBP3;INSR;IGFBP4
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.4471430472837807,1.3841791041804776,0.0,0.6833307096977593,1.0,163/730,16.48%,FOXP2;TBX15;FOXP1;KLF12;ZBTB7C;SIX1;PBX3;NR3C2;PLAGL1;ZFHX3;TCF7L1;KLF5;TCF7L2;TFCP2L1;ZFHX4;PRRX2;NFIB;MKX;FOXD1;HES1;HDAC4;FOXP4;ZIC4;RARB;HOXA5;KLF3;MEOX2;NFAT5;HOXA3;NFIA;SKIL;HOXB6;PBX1;FOXL1;SMAD9;EHF;PRRX1;DMRT3;SOX14;SP8;GRHL2;PITX2;JDP2;ZNF423;ESR1;HOXC6;NFE2L2;GRHL1;ZNF148;FOXC2;ZIC1;GLIS1;MLXIP;HOXC4;RARA;ELF1;KLF4;GLI3;ATOH7;HOXA6;KLF7;HOXB3;NR4A3;TWIST1;STAT3;FOXO3;KLF10;CC2D1B;SKI;NFIX;ZBTB16;PER1;MEF2A;NFIL3;NFATC4;BHLHE40;KLF9;GLI2;HOXB4;GLIS2;REL;NR4A2;NFE2L1;NRF1;RORA;ZNF691;E2F3;POU3F4;NFATC3;IRF1;SMAD2;FOXO6;MLX;MLXIPL;EGR1;NFIC;GATA4;THRAP3;DNMT3A;RUNX2;RXRA;HOXA2;HIF3A;MXD4;FOXC1;TOP1;MTA1;ARNT;HES3;SIX4;ATF7;ATF6;NSD1;POU4F1;DHX36;CREB3L1;RFX2;ATOH8;HOXB5;TEAD1;ZBTB1;RXRB;ZBTB32;MYNN;NR2F1;HSF2;NR1D1;CEBPD;BATF3;GTF2IRD1;SREBF1;NR4A1;ZBTB24;E2F1;PRMT5;HOXA7;NFYA;NFATC1;PATZ1;RBMX;RFX7;HINFP;SP3;ZBTB34;SOX9;NR3C1;BCL11B;POU2F1;FOSB;GMEB1;E2F2;MEF2D;ZNF394;ZNF219;HOXD3;HIVEP3;PAX6;ZBTB3;MZF1;ATF1;PRDM5;SMAD4;FOXK1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.4458950689503742,1.3818668675631132,0.0,0.6828363009716588,1.0,161/731,16.48%,FOXP2;TBX15;FOXP1;KLF12;ZBTB7C;SIX1;PBX3;NR3C2;PLAGL1;ZFHX3;TCF7L1;KLF5;TCF7L2;TFCP2L1;ZFHX4;PRRX2;NFIB;MKX;FOXD1;HES1;HDAC4;FOXP4;ZIC4;RARB;HOXA5;KLF3;MEOX2;NFAT5;FOXN3;HOXA3;NFIA;SKIL;HOXB6;PBX1;FOXL1;SMAD9;EHF;PRRX1;DMRT3;SOX14;SP8;GRHL2;PITX2;JDP2;ZNF423;ESR1;HOXC6;NFE2L2;GRHL1;ZNF148;FOXC2;ZIC1;GLIS1;MLXIP;HOXC4;RARA;ELF1;KLF4;GLI3;ATOH7;HOXA6;KLF7;HOXB3;NR4A3;STAT3;FOXO3;KLF10;CC2D1B;SKI;NFIX;ZBTB16;PER1;MEF2A;NFIL3;NFATC4;BHLHE40;KLF9;GLI2;HOXB4;GLIS2;REL;NR4A2;NFE2L1;NRF1;RORA;ZNF691;E2F3;POU3F4;NFATC3;IRF1;SMAD2;FOXO6;MLX;MLXIPL;EGR1;NFIC;GATA4;THRAP3;DNMT3A;RUNX2;RXRA;HOXA2;HIF3A;MXD4;FOXC1;TOP1;MTA1;ARNT;HES3;SIX4;ATF7;ATF6;NSD1;POU4F1;DHX36;RFX2;ATOH8;HOXB5;TEAD1;ZBTB1;RXRB;ZBTB32;MYNN;NR2F1;HSF2;NR1D1;CEBPD;BATF3;GTF2IRD1;SREBF1;NR4A1;ZBTB24;E2F1;HOXA7;NFYA;NFATC1;PATZ1;RBMX;RFX7;HINFP;SP3;ZBTB34;SOX9;NR3C1;BCL11B;POU2F1;FOSB;GMEB1;E2F2;MEF2D;ZNF394;ZNF219;HOXD3;HIVEP3;PAX6;ZBTB3;MZF1;ATF1;PRDM5;SMAD4;FOXK1
prerank,ATPase binding (GO:0051117),0.5066128800840752,1.37716111183276,0.06839622641509434,0.6925650157494025,1.0,13/71,9.01%,EGFR;SLC2A13;PPP3CA;PTPN3;ANK2;ATP1B1;EZR;ESR1;SNTA1;TCIRG1;USP25;ATP6V0A4;RDX
prerank,protein phosphorylated amino acid binding (GO:0045309),0.5297387814370526,1.3757655326185334,0.10886075949367088,0.6890075127273999,1.0,9/42,6.73%,NEDD4;PTPN3;VAV2;CBLC;IRS1;PLCG2;ABL1;SHC1;NCK2
prerank,single-stranded DNA helicase activity (GO:0017116),0.6195808140342605,1.3747503089404338,0.11257309941520467,0.6839969450907767,1.0,8/19,18.46%,CHTF18;MCM2;RAD51;CHTF8;DSCC1;HELB;MCM7;DHX9
prerank,deubiquitinase activity (GO:0101005),0.4811097446844807,1.370840858746603,0.07403189066059225,0.6904842895601003,1.0,38/88,24.18%,TANK;USP2;USP46;OTUD1;USP24;USP15;USP25;USP13;MYSM1;ZC3H12A;USP1;USP34;DESI2;USP40;COPS5;ZRANB1;USP4;BRCC3;USP28;MINDY3;USP47;OTUD5;OTUD4;OTUD3;USP49;PSMD14;VCPIP1;USP21;USP16;USP19;USP10;USP32;USP30;USP36;USP9X;USP7;USP33;USP42
prerank,RNA polymerase II complex binding (GO:0000993),0.5506386935903027,1.368846070999354,0.11196911196911197,0.6899175222596431,1.0,19/32,29.60%,ELOF1;ERCC5;AGO2;WAC;UVSSA;SCAF8;WDR43;SCAF1;URI1;RECQL5;DHX9;BRD4;ELP4;GTF2B;SMYD2;SUPT4H1;CTR9;AGO1;RTRAF
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.5798874818310283,1.3656334612898227,0.13304093567251463,0.6939826796144166,1.0,6/23,4.45%,PLCE1;PLCZ1;EDNRA;CASR;PLCB3;PLCG2
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.6403581104176813,1.3645599893367772,0.14937106918238993,0.689503055984001,1.0,2/13,6.36%,EXO1;SLX4
prerank,mannose binding (GO:0005537),0.6488820796268837,1.3637222378512674,0.1288244766505636,0.68446386304525,1.0,2/12,6.51%,COLEC11;LMAN2L
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.6799131487134813,1.3606479854652254,0.13398692810457516,0.6878493603074628,1.0,3/10,12.95%,DPYSL3;DPYSL2;DPEP1
prerank,flavin adenine dinucleotide binding (GO:0050660),0.5054381379360845,1.360279238919534,0.08862275449101796,0.680978804258934,1.0,17/53,17.42%,MICAL2;AOX1;MMACHC;GSR;AGPS;ACOX3;CRY2;KDM1A;MTO1;ETFDH;XDH;ETFA;GFER;ACOX1;ACADL;SQLE;PPOX
prerank,telomeric DNA binding (GO:0042162),0.554168881865114,1.3575429472746994,0.12037037037037036,0.6835830286338382,1.0,12/32,20.29%,TELO2;SMG6;TEN1;APEX1;WRN;KDM1A;STN1;RAD50;UPF2;HNRNPA2B1;XRCC5;ZBTB48
prerank,phosphotyrosine residue binding (GO:0001784),0.5359015309747037,1.3574446529660003,0.1167979002624672,0.6759833299651661,1.0,10/37,12.16%,PTPN3;VAV2;CBLC;IRS1;PLCG2;ABL1;SHC1;NCK2;PIK3R3;BCAR3
prerank,UDP-glycosyltransferase activity (GO:0008194),0.48928071694757047,1.3560918612591282,0.09132947976878612,0.6735181980056397,1.0,13/70,11.61%,EXT1;GXYLT2;B3GNT2;MGAT4C;HEXA;LARGE1;HAS1;B4GALNT3;B4GALT1;B4GAT1;B3GALT6;POGLUT3;B3GNT9
prerank,acylglycerol lipase activity (GO:0047372),0.666905502963421,1.3540720297142552,0.14378029079159935,0.6730022892033494,1.0,2/11,9.43%,MGLL;ABHD6
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.6757004781142442,1.3531895859228058,0.14710743801652892,0.6686029734900324,1.0,4/10,13.17%,DSE;RENBP;GLCE;RPE
prerank,serine-type peptidase activity (GO:0008236),0.4707056663476318,1.350646675715905,0.06002265005662514,0.6701307437833388,1.0,5/96,3.68%,F3;HTRA3;PCSK5;PRSS12;HTRA1
prerank,RNA polymerase core enzyme binding (GO:0043175),0.5381861259604513,1.3458370651265148,0.12276214833759591,0.6800738358148491,1.0,18/33,29.60%,ELOF1;ERCC5;AGO2;ERBB2;WAC;UVSSA;SCAF8;WDR43;URI1;RECQL5;DHX9;ELP4;GTF2B;SMYD2;SUPT4H1;CTR9;AGO1;RTRAF
prerank,calcium channel regulator activity (GO:0005246),-0.4112508871936194,-1.345747583709416,0.07468879668049792,0.5314323073828204,1.0,9/37,11.27%,ITPR1;PRKG1;NRXN1;SGK1;CACNG7;REM1;CALM1;CACNG4;SLC30A1
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.5549027876886437,1.3450805585590766,0.11956521739130435,0.6754374227068051,1.0,10/27,18.58%,POLR1A;PRIM1;POLR1D;POLR3F;POLR3A;PRIMPOL;POLR3K;POLR1F;MED20;POLR2C
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.5246142722977846,-1.3443223983440402,0.11444141689373297,0.521032801056941,1.0,5/14,3.22%,COL4A3;SPOCK3;SPOCK2;SPOCK1;TIMP3
prerank,protein kinase C binding (GO:0005080),0.5179421322022085,1.3433907252416395,0.1,0.6753625587847489,1.0,8/43,5.88%,ADAM9;GRK5;HDAC9;IRS1;NELL1;DSP;ABL1;DACT1
prerank,O-acyltransferase activity (GO:0008374),0.5460065228213665,1.342516286181281,0.1278600269179004,0.6712602073067931,1.0,9/30,16.45%,SOAT1;MBOAT4;PLA2G15;MBOAT1;LPCAT1;SOAT2;MOGAT1;LPCAT2;LCAT
prerank,fibroblast growth factor binding (GO:0017134),0.5838220961567262,1.3384845946518,0.15259259259259259,0.6790408401458559,1.0,7/21,16.78%,THBS1;FGFR1;FGFBP3;ITGAV;FGFRL1;ITGB3;FGFR3
prerank,nuclear receptor binding (GO:0016922),0.46588287341860135,1.3382490437280832,0.0664488017429194,0.6727328123433634,1.0,27/111,13.28%,FOXP1;TCF7L2;DDX5;TACC2;JMJD1C;ESR1;BCAS3;MED13;NR4A3;DNAAF4;LCOR;NR4A2;STRN;NCOR1;MED24;NCOR2;THRAP3;KDM1A;RXRA;TADA3;NSD1;TGFB1I1;GAS2L1;JUP;NCOA6;NR4A1;TRIP12
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.37457056558667107,-1.3357935862321781,0.061224489795918366,0.5293809357430995,1.0,25/60,10.33%,FLT1;IGF1R;TEK;PDGFRB;KIT;MERTK;EPHB1;EPHA6;TIE1;KDR;EPHA7;ERBB4;INSR;ROR2;EPHA5;RYK;EPHA8;EPHA4;AXL;LMTK2;FGFR4;BMPR1B;NTRK2;ALK;FLT3
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.6408970571502296,1.334102120338452,0.17050691244239632,0.6805725331661056,1.0,5/12,19.55%,CYFIP2;EIF4E3;AGO2;CYFIP1;GEMIN5
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.6232566322714899,1.3297202481681223,0.15337423312883436,0.6902373692247211,1.0,6/14,20.01%,RSAD1;ETFDH;ACO2;NUBPL;NFU1;IREB2
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.5387183378688742,-1.3283305818439566,0.158311345646438,0.5352815561023165,1.0,3/11,7.11%,SASH1;ROR2;DAB2IP
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.43393461601473027,1.3259690360624423,0.03248730964467005,0.6968847984090872,1.0,62/254,16.42%,SIX1;PLAGL1;KLF5;TFCP2L1;NFIB;HOXA5;MEOX2;NFAT5;NFIA;EHF;PRRX1;GRHL2;ESR1;GRHL1;FOXC2;MLXIP;HOXC4;ELF1;KLF4;KLF7;HOXB3;NR4A3;STAT3;FOXO3;KLF10;ZBTB16;MEF2A;GLIS2;REL;NR4A2;NRF1;E2F3;NFATC3;IRF1;SMAD2;EGR1;NFIC;GATA4;FOXC1;ELF3;ATF6;POU4F1;CREB3L1;TFDP1;RXRB;MDM4;HSF2;NR4A1;HOXA7;NFATC1;PRDM2;RFXANK;HINFP;SOX9;NR3C1;PLSCR1;GMEB1;E2F2;HOXD3;MZF1;ATF1;SMAD4
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.5464481233134219,-1.325382696761191,0.13157894736842105,0.5290057332528667,1.0,9/12,14.14%,GABRG3;GABRB3;GABRB1;GABRA2;GABRB2;GABRG1;GABRA5;GABRA1;GABRG2
prerank,amino acid:sodium symporter activity (GO:0005283),0.6588970401836705,1.3252766574675627,0.16293929712460065,0.692596059483673,1.0,2/11,0.16%,SLC38A2;SLC38A1
prerank,transforming growth factor beta binding (GO:0050431),0.5677585773119916,1.3222831695462902,0.1392757660167131,0.6969779389259501,1.0,9/23,9.87%,THBS1;TGFB3;CD109;TGFBR1;LTBP3;TSKU;TGFBR2;LTBP4;ITGAV
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.42587004760371394,1.320022363466114,0.0,0.6975811150868693,1.0,174/830,16.48%,FOXP2;TBX15;FOXP1;KLF12;ZBTB7C;SIX1;PBX3;NR3C2;PLAGL1;ZFHX3;TCF7L1;KLF5;TCF7L2;TFCP2L1;ZFHX4;PRRX2;NFIB;MKX;FOXD1;HES1;HDAC4;FOXP4;ZIC4;CUX1;RARB;TWIST2;HOXA5;KLF3;MEOX2;NFAT5;HOXA3;NFIA;SKIL;HOXB6;PBX1;PURG;FOXL1;SMAD9;EHF;PRRX1;DMRT3;DMBX1;SOX14;SP8;GRHL2;PITX2;JDP2;ZNF423;ESR1;HOXC6;NFE2L2;GRHL1;ZNF148;FOXC2;ZIC1;GLIS1;MLXIP;HOXC4;RARA;ELF1;KLF4;GLI3;ATOH7;HOXA6;KLF7;HOXB3;NR4A3;TWIST1;STAT3;FOXO3;KLF10;CC2D1B;SKI;NFIX;ZBTB16;PER1;MEF2A;NFIL3;NFATC4;BHLHE40;KLF9;GLI2;HOXB4;GLIS2;REL;NR4A2;NFE2L1;NRF1;RORA;ZNF691;E2F3;POU3F4;NFATC3;IRF1;SMAD2;FOXO6;MLX;MLXIPL;EGR1;NFIC;GATA4;THRAP3;DNMT3A;RUNX2;RXRA;HOXA2;HIF3A;MXD4;FOXC1;TOP1;MTA1;ARNT;HES3;SIX4;ATF7;ATF6;NSD1;POU4F1;DHX36;ZNF25;RFX2;ATOH8;HOXB5;TEAD1;ZBTB1;TFDP1;RXRB;ZBTB32;MYNN;ZBTB8B;NFXL1;NR2F1;HSF2;NR1D1;CEBPD;ZBTB8A;ZFP3;BATF3;GTF2IRD1;LMX1A;SREBF1;NR4A1;ZBTB24;E2F1;HOXA7;NFYA;NFATC1;PATZ1;RBMX;PRDM2;RFX7;RFXANK;HINFP;SP3;ZBTB34;SOX9;NR3C1;BCL11B;POU2F1;FOSB;GMEB1;E2F2;MEF2D;ZNF394;ZNF219;HOXD3;HIVEP3;PAX6;ZBTB3;MZF1;ATF1;PRDM5;SMAD4;FOXK1
prerank,H4 histone acetyltransferase activity (GO:0010485),0.6747957860038418,1.3187119397275806,0.15485996705107083,0.6955906244914312,1.0,8/10,29.23%,MSL3;NAA40;ATF2;BRCA2;NAA60;KAT8;HAT1;NAA50
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.498556343819768,-1.317618530729655,0.11711711711711711,0.5361732193061218,1.0,8/16,29.14%,SLC44A1;SLC22A4;SLC22A2;SLC44A2;SLC22A3;SLC5A7;SLC29A4;SLC25A17
prerank,phospholipase C activity (GO:0004629),0.5469478525755143,1.3138708948395013,0.15602836879432624,0.7057574088245356,1.0,6/25,4.45%,PLCE1;PLCZ1;EDNRA;CASR;PLCB3;PLCG2
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.5107352785635463,1.3119368279856243,0.13231552162849872,0.7057571245412549,1.0,13/42,19.87%,CCNA2;CCNL1;CCNL2;CCND1;CDKN2C;CCNB1;CCNYL1;CDKN1B;CCNG1;CCNT2;CDKN1A;HEXIM1;CCNT1
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.5509750866763679,1.3115302418447816,0.15244755244755245,0.7005731277294908,1.0,2/25,1.17%,MICAL2;FMO1
prerank,inward rectifier potassium channel activity (GO:0005242),0.5575114936943801,1.3102346604430872,0.15730337078651685,0.6988031622770561,1.0,2/24,1.49%,KCNJ2;KCNJ15
prerank,transforming growth factor beta receptor binding (GO:0005160),0.5730557832305903,1.3099499024274308,0.1567489114658926,0.6934921119617489,1.0,6/18,7.92%,SMAD6;TGFB3;TGFBR1;USP15;TGFBR2;SMAD2
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.5597769203991538,-1.306690877541955,0.15691489361702127,0.5504569359427537,1.0,4/10,13.97%,PRKAR2B;PRKAR1B;PRKAR1A;PRKAG2
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.5551630136916892,1.305253524858282,0.16358463726884778,0.7037624052592591,1.0,10/21,30.88%,REV3L;POLE2;POLI;PRIMPOL;POLB;POLM;POLK;POLQ;POLA1;POLD1
prerank,diacylglycerol kinase activity (GO:0004143),-0.5387838291600139,-1.3048370620403824,0.15718157181571815,0.5422871257947257,1.0,4/11,7.53%,DGKB;DGKI;DGKD;DGKG
prerank,ligand-gated anion channel activity (GO:0099095),-0.48596774229123263,-1.3043313242821897,0.14473684210526316,0.5309911120864651,1.0,11/17,14.14%,GABRG3;GABRB3;GABRB1;GABRA2;GABRB2;GLRA3;GLRA1;GABRG1;GABRA5;GABRA1;GABRG2
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.5241233351832926,1.3036721819698829,0.13938618925831203,0.702905401419101,1.0,18/33,29.60%,ELOF1;ERCC5;AGO2;WAC;UVSSA;SCAF8;WDR43;URI1;RECQL5;DHX9;ELP4;TBP;GTF2B;SMYD2;SUPT4H1;CTR9;AGO1;RTRAF
prerank,cysteine-type endopeptidase activity (GO:0004197),0.46250396569430047,1.3018528832216278,0.11945392491467577,0.7028562467211026,1.0,30/78,24.18%,CAPN5;USP2;CASP6;USP46;CAPN2;CAPN12;USP24;USP15;USP25;USP13;CASP2;USP1;USP34;USP40;USP28;USP47;PIGK;USP49;USP16;USP10;CAPN1;USP30;GPAA1;USP36;USP9X;CTSK;CTSO;USP7;USP33;USP42
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.548203325299707,1.3017251155069716,0.1597315436241611,0.6971258577092929,1.0,5/26,2.44%,SLC5A6;SLC16A9;ABCG2;SLC16A1;SLC26A6
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.4325710973544385,1.2894080515722008,0.06889352818371608,0.7349214897154378,1.0,34/188,10.84%,BNC2;VSX1;SIX1;TCF7L2;HDAC4;SMAD6;PBX1;PITX2;NFE2L2;GRHL1;FOXC2;KLF4;ARID4B;STAT3;FOXO3;PER1;GLIS2;CRY2;NCOR1;IRF1;CHD3;EGR1;GATA4;PER3;RXRA;GABPB1;GABPB2;FOXC1;ATF6;TBL1X;DHX36;BCOR;ARID4A;CREB3L1
prerank,acyl-CoA hydrolase activity (GO:0047617),0.5819872890496314,1.2892247329216626,0.19319938176197837,0.7290466682439672,1.0,6/17,13.07%,ACOT12;ABCD1;ACOT9;ACOT11;ACOT8;ACOT13
prerank,histone deacetylase binding (GO:0042826),0.45501998047059844,1.287450656995107,0.12008978675645342,0.7292218171032249,1.0,22/88,15.75%,HES1;HDAC4;HDAC9;GLI3;NIPBL;MEF2A;DACT1;LCOR;MIER1;NCOR1;CCND1;NCOR2;MTA1;BRMS1L;BRMS1;ANKRA2;DHX36;BCOR;KPNA2;THAP7;MEF2D;TRAF6
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.6022082218852911,1.2827418689952725,0.2027439024390244,0.7394831597924386,1.0,1/14,0.23%,KCNJ2
prerank,transferrin receptor binding (GO:1990459),0.6299093787228822,1.2823222904117324,0.22006472491909385,0.73455135679719,1.0,4/10,19.76%,SNX2;IKBKG;IKBKB;CHUK
prerank,glucuronosyltransferase activity (GO:0015020),0.5591909655543298,1.281440261175237,0.18398876404494383,0.7312640998131964,1.0,3/19,10.81%,EXT1;LARGE1;B4GAT1
prerank,ephrin receptor activity (GO:0005003),-0.4792470173522305,-1.2813311791417887,0.1436950146627566,0.5629477053868962,1.0,6/17,5.71%,EPHB1;EPHA6;EPHA7;EPHA5;EPHA8;EPHA4
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.4792470173522305,-1.2813311791417887,0.1436950146627566,0.5629477053868962,1.0,6/17,5.71%,EPHB1;EPHA6;EPHA7;EPHA5;EPHA8;EPHA4
prerank,NF-kappaB binding (GO:0051059),0.53858579547267,1.2812416889389382,0.19318181818181818,0.7258929427699662,1.0,9/24,19.99%,ANXA4;GSK3B;BRMS1;CPNE1;MTDH;PSMA6;COMMD7;HDAC2;HIF1AN
prerank,kinase activator activity (GO:0019209),0.5167643092631669,1.2794860315455157,0.19452054794520549,0.7256127955321293,1.0,7/30,12.67%,WNK1;WNT11;FGF13;STRADA;DUSP19;CAB39;MARK2
prerank,NAD binding (GO:0051287),0.5413379760645675,1.2779970857831995,0.18106995884773663,0.7242768317060673,1.0,6/26,13.62%,ME1;BDH2;SIRT6;CRYL1;SORD;SIRT3
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.4508724572041822,1.2771098946672808,0.11818181818181818,0.721325763266721,1.0,28/91,15.65%,KCNJ2;MARK1;VILL;ANXA2;PLCZ1;GSN;PLEKHA4;FZD7;GBF1;KIF16B;RLBP1;FLII;FCHO2;STXBP6;KRIT1;WDR45B;SLC9A1;RAB35;CGAS;SNX14;SNX18;TTPAL;PARD3;TIRAP;WIPI2;COMMD1;ANXA8;GSDME
prerank,protein kinase regulator activity (GO:0019887),0.4504005366069028,1.2752529299812227,0.12652608213096558,0.7218130929350511,1.0,30/95,19.87%,CCNA2;WNK1;WNT11;FGF13;ELP3;KIDINS220;PARVA;CCNL1;CCNL2;STRADA;CCND1;CCNB1;DUSP19;QARS1;DNAJC3;CCNYL1;CAB39;CDKN1C;CDKN1B;MARK2;CCNG1;CCNT2;NCK1;CDKN1A;SOCS3;NCKAP1L;ELP4;HEXIM1;ANKRD54;CCNT1
prerank,voltage-gated ion channel activity (GO:0005244),-0.48897841897110994,-1.2750011996371906,0.14647887323943662,0.5662823097368995,1.0,3/14,6.28%,KCND2;CACNA1E;HCN1
prerank,phosphatase binding (GO:0019902),0.4432492637802779,1.2724308091412213,0.11221122112211221,0.7250881675497463,1.0,25/105,13.51%,EGFR;MET;MAP3K5;WNK1;FCRL6;SHOC2;STAT3;ANAPC5;PPP1R3C;VRK3;ERBB2;STYXL1;CRY2;AP3B1;IKBKE;SMAD2;MAST2;VCP;PPP6R3;TRPC4AP;JUP;CDKN1B;TRAF2;DLG1;PDLIM4
prerank,protease binding (GO:0002020),0.44617776090958144,1.271631033716786,0.1282633371169126,0.7220772591291135,1.0,22/99,13.74%,F3;SLC2A13;ANXA2;CRADD;COL3A1;LDLR;GSK3B;TIMP1;SERPINB9;LCOR;FN1;ITGB1;ADRM1;TIMP2;VCP;LONP2;ITGAV;RIPK2;COL1A2;CARD16;ITGB3;TYSND1
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.5271845146333389,-1.267479021181205,0.17391304347826086,0.5724766143633072,1.0,4/10,9.48%,DPP10;DPP4;PRCP;DPP6
prerank,triglyceride lipase activity (GO:0004806),0.5616027559036815,1.265474532047281,0.18394160583941604,0.7369683964251608,1.0,6/20,17.98%,PLA2G15;PNPLA3;PNPLA2;LCAT;CEL;DAGLB
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.6045779291644456,1.264588105082433,0.21638330757341576,0.7341802415136875,1.0,1/13,1.39%,EHHADH
prerank,glycerophospholipid flippase activity (GO:0140333),-0.5266413548143764,-1.2637691707596075,0.18579234972677597,0.569698126685798,1.0,6/11,14.65%,ABCA4;ATP11C;ATP8A1;ATP8A2;ATP10B;ABCB4
prerank,retinoic acid binding (GO:0001972),-0.5161728629348546,-1.262924280632716,0.1863013698630137,0.5603138201569101,1.0,2/12,2.27%,NR2F2;CYP26B1
prerank,phospholipase activity (GO:0004620),0.45929912368933123,1.2625358508282545,0.14883720930232558,0.7352918653891053,1.0,11/67,10.48%,PLCE1;MGLL;PLCB3;PLA2G4F;PLA2G15;LYPLA2;SMPDL3A;PNPLA3;ABHD6;LYPLAL1;SEC23IP
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.5765336289991416,1.2578545475048983,0.20926756352765322,0.7456191586993255,1.0,2/15,5.85%,PLA2G4F;PLA2G2C
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.44169024387680933,-1.2564306199222455,0.18085106382978725,0.5647342823671412,1.0,8/21,10.44%,PDE8B;PDE4B;PDE7B;PDE1A;PDE4D;PDE2A;PDE8A;PDE1C
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.519618306233913,-1.2523034115794816,0.18571428571428572,0.5635009980966529,1.0,12/12,48.08%,OPN3;GPR88;ELOVL4;GPR52;RRH;OPN1MW3;OPN1MW;RHO;OPN5;OPN1SW;GNAT2;OPN4
prerank,N-methyltransferase activity (GO:0008170),0.546279125687163,1.2514906015080174,0.218705035971223,0.7616540403579198,1.0,4/20,15.93%,RNMT;NNMT;METTL15;TRMT11
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.42881666421448966,-1.249367863943083,0.15985130111524162,0.5599401054417509,1.0,8/23,10.44%,PDE8B;PDE4B;PDE7B;PDE1A;PDE4D;PDE2A;PDE8A;PDE1C
prerank,peptidoglycan binding (GO:0042834),-0.5373397194849903,-1.2474625363742515,0.22105263157894736,0.5540970964929927,1.0,6/10,30.56%,NOD1;PGLYRP1;NOD2;JCHAIN;NLRP3;TLR2
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.4780087041120549,1.24518755940937,0.19023136246786632,0.7773888204797693,1.0,9/46,15.47%,EXT1;B3GNT2;MGAT4C;HEXA;LARGE1;B4GAT1;B3GNT9;MGAT1;MGAT5
prerank,mRNA methyltransferase activity (GO:0008174),0.6120183490806487,1.243310723968308,0.23823975720789076,0.7778258479903265,1.0,1/12,0.87%,RNMT
prerank,phospholipid transfer activity (GO:0120014),0.5366807577242728,1.2427736200887445,0.21757925072046108,0.7739459706295988,1.0,3/21,3.78%,TNFAIP8L3;PITPNC1;PITPNA
prerank,miRNA binding (GO:0035198),0.5093560736428728,1.2425041506603876,0.2130257801899593,0.7689656535925246,1.0,15/30,29.21%,ZC3H7A;AGO2;TUT7;TUT4;ZC3H12A;DDX21;HNRNPA2B1;PUM2;PUM1;FMR1;TRIM71;RBM4;ZC3H10;AGO1;ELAVL1
prerank,histone acetyltransferase activity (GO:0004402),0.5041959488764826,1.2419728080071792,0.19230769230769232,0.7652088869660139,1.0,17/30,29.23%,SRCAP;CREBBP;TADA3;NAA40;KAT6B;ATF2;BRCA2;NAA60;EPC1;BAZ1A;KAT6A;EPC2;TADA2A;KAT8;HAT1;KAT2B;NAA50
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.41594307960270266,1.2416246309894279,0.1119324181626188,0.7605714896243885,1.0,37/181,13.58%,ZFPM2;TCF7L2;HES1;HDAC4;ANXA4;TACC2;PRRX1;PITX2;NFE2L2;ID2;WWP2;GSK3B;BCAS3;KLF4;MDFIC;STAT3;MEF2A;DACT1;BHLHE40;MIER1;CREBBP;NCOR1;NCOR2;GATA4;KDM1A;RXRA;MTA1;TADA3;ARNT;BRMS1;ZFPM1;JUP;CPNE1;MTDH;HIRA;NFATC1;DMAP1
prerank,FAD binding (GO:0071949),0.5279588943446352,1.2371087689757654,0.22002820874471085,0.7698468438054179,1.0,4/24,7.13%,MICAL2;MMACHC;AGPS;CRY2
prerank,receptor ligand activity (GO:0048018),0.4054307796290878,1.236577872846186,0.07959183673469387,0.7659853969053588,1.0,28/245,6.78%,BMP4;WNT9A;OSGIN2;PGF;SEMA3E;DEFB130A;TNFRSF11B;BMP5;WNT11;FGF2;EDA;SLURP1;NGF;FAM3C;VEGFA;TGFB3;CLCF1;GDF10;CCL3;TIMP1;SEMA3C;PTHLH;IL33;SEMA3D;NBL1;BMP6;CTF1;INHBA
prerank,nuclear export signal receptor activity (GO:0005049),0.6004321576856275,1.2361072525247616,0.23162939297124602,0.7621497322299812,1.0,5/11,16.18%,NUP214;XPO1;XPO4;XPO7;CSE1L
prerank,transcription cis-regulatory region binding (GO:0000976),0.4029737283960671,1.2360564285997906,0.045180722891566265,0.75686841560785,1.0,93/406,17.32%,BNC2;FOXP1;VSX1;SIX1;PLAGL1;TCF7L2;HDAC4;CUX1;TWIST2;SMAD6;FOXN3;PBX1;PURG;DMBX1;GRHL2;PITX2;NFE2L2;GRHL1;FOXC2;MLXIP;RARA;KLF4;GLI3;TWIST1;ARID4B;STAT3;FOXO3;KLF10;PER1;MEF2A;NFIL3;PRDX5;AGO2;GLIS2;RORA;CRY2;NCOR1;E2F3;IRF1;SMAD2;CHD3;MLX;EGR1;GATA4;PER3;RXRA;HIF3A;GABPB1;GABPB2;FOXC1;ARNT;ATF6;TBL1X;DHX36;BCOR;ARID4A;ZNF25;CREB3L1;TEAD1;TFDP1;RXRB;ZBTB8B;NFXL1;HSF2;BRCA1;NR1D1;ZBTB8A;ZFP3;LMX1A;SREBF1;E2F1;NFYA;PRDM2;RFXANK;HINFP;SP3;TAF4;SOX9;NR3C1;E2F2;MEF2D;HOXD3;PAX6;MZF1;ATF1;PRDM5;SMAD4;FOXK1;YAP1;E4F1;KMT2D;RB1;ZBTB7B
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.5314023498372099,-1.2355698320525563,0.23160762942779292,0.572118286059143,1.0,3/10,3.02%,SLC6A13;SLC6A12;SLC6A1
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.41122349714085477,1.2355201539769705,0.11030176899063475,0.753298595850878,1.0,35/173,16.48%,FOXP2;FOXP1;KLF12;PLAGL1;ZFHX3;HES1;FOXP4;SKIL;JDP2;ZNF148;FOXO3;SKI;ZBTB16;NFIL3;NFATC4;BHLHE40;NFATC3;MLX;ERF;ZNF25;CREB3L1;ZBTB1;ZBTB32;NR2F1;NR1D1;BATF3;GTF2IRD1;PATZ1;PRDM2;ZBTB34;NR3C1;ZNF219;MZF1;PRDM5;FOXK1
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.4641256646043708,-1.2306563262417984,0.2085889570552147,0.5632087158148842,1.0,6/16,7.45%,PTPRG;PTPRB;PTPRM;PTPRT;PTPRN2;PTPRO
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.4641256646043708,-1.2306563262417984,0.2085889570552147,0.5632087158148842,1.0,6/16,7.45%,PTPRG;PTPRB;PTPRM;PTPRT;PTPRN2;PTPRO
prerank,cation channel activity (GO:0005261),0.4420577948796301,1.2303422751211945,0.17318435754189945,0.7651333153645905,1.0,14/94,11.52%,PIEZO2;KCNK5;SLC24A3;PKD1;ANXA2;ANO6;TRPM7;TRPM6;CALHM5;SEC61A1;TRPM4;TRPM8;NALCN;MCU
prerank,cysteine-type peptidase activity (GO:0008234),0.4374243976480698,1.230287526726016,0.18475750577367206,0.7600070580921998,1.0,31/73,24.18%,USP2;CASP6;USP46;CAPN2;USP24;USP15;USP25;USP13;CASP2;TINAGL1;USP1;USP34;USP40;ATG4C;ATG4B;USP28;ATG4A;USP47;USP49;USP21;USP16;USP10;USP30;USP36;GGH;USP9X;CTSK;CTSO;USP7;USP33;USP42
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.4456556662869944,1.2291577917254062,0.17801672640382318,0.7583797444965028,1.0,21/72,15.65%,KCNJ2;MARK1;VILL;ANXA2;PLCZ1;GSN;PLEKHA4;FZD7;FLII;FCHO2;STXBP6;KRIT1;SLC9A1;RAB35;CGAS;SNX18;PARD3;TIRAP;COMMD1;ANXA8;GSDME
prerank,BMP binding (GO:0036122),-0.5061736599855957,-1.2268654498423899,0.21081081081081082,0.5619888456495953,1.0,2/11,1.89%,ENG;GREM2
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.5249131355260772,1.2268147151753461,0.21810089020771514,0.7606571275120312,1.0,13/20,27.40%,USP25;SENP5;DESI2;COPS5;USP47;OTUD5;USP21;COPS2;USP9X;SENP1;USP7;SENP2;SENP3
prerank,RNA cap binding (GO:0000339),0.5535862993373096,1.2261426291209492,0.24495677233429394,0.7576017807980665,1.0,8/16,28.66%,CYFIP2;EIF4E3;AGO2;CYFIP1;GEMIN5;LSM1;SNUPN;NCBP3
prerank,enoyl-CoA hydratase activity (GO:0004300),0.6135765628842171,1.2255722950335457,0.25728987993138935,0.754320506397155,1.0,7/10,26.31%,EHHADH;AUH;ECHDC1;ECHDC2;ECI1;HADHA;HSD17B4
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.42662766951634107,-1.2254384054156409,0.17064846416382254,0.5559311805079632,1.0,7/24,14.62%,OSBPL8;CERT1;PLEKHA5;GSDMD;DAB2IP;JPH2;SNX3
prerank,death receptor binding (GO:0005123),0.563956355629557,1.2226578423657213,0.24383164005805516,0.7585158910037821,1.0,5/15,14.67%,EDA;NGF;FEM1B;MYD88;PIDD1
prerank,protein tyrosine kinase activity (GO:0004713),-0.30632814611896636,-1.2224994680984653,0.08,0.5535908267954134,1.0,31/108,10.33%,FLT1;IGF1R;LYN;TEK;PEAK1;PDGFRB;KIT;MERTK;EPHB1;EPHA6;TEC;TIE1;KDR;EPHA7;ERBB4;INSR;ROR2;EPHA5;RYK;EPHA8;EPHA4;AXL;DYRK1A;LMTK2;FGFR4;NTRK2;BMX;ALK;AATK;TNK2;FLT3
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.439725950950079,1.2206431799936246,0.1838150289017341,0.7599672827157703,1.0,11/75,13.95%,ME1;EHHADH;ADH7;BDH2;RDH12;CBR3;CRYL1;SORD;DHRS3;KDSR;ADH5
prerank,GTPase regulator activity (GO:0030695),-0.2765013277886162,-1.218580180725143,0.030303030303030304,0.5535829120373577,1.0,46/212,10.25%,PLCB1;RANBP3L;PREX2;ARHGAP28;ASAP1;ARHGAP29;TBC1D4;CHN2;ERRFI1;ARHGAP24;RASGRP3;RGS3;ADGRB3;ALDH1A1;CPEB2;ARHGAP32;RGS7;RIMS1;RAPGEF2;ARHGAP26;RALGAPA2;RGS5;ARAP3;RALGAPA1;USP6NL;RGS12;SIRPA;ARHGAP22;SIPA1;VAV3;IQGAP2;HACD3;TBC1D8;ELMOD1;OPHN1;ARHGAP25;ARHGAP39;TBC1D30;ABR;EVI5L;TBC1D9;STXBP5L;ARHGEF10L;RHOH;SYDE2;TNK2
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.5235552571022557,1.2184447188789889,0.21448863636363635,0.7622754457054518,1.0,9/22,15.80%,TAB3;IKBKG;IKBKE;UIMC1;WDR81;TAB2;ZBTB1;ZRANB1;PRPF8
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.448999760251489,-1.2170876958147199,0.1942675159235669,0.5480999474370705,1.0,7/17,9.79%,GRIK2;GRIA4;GRIN2A;GRIN2B;GRIA1;GRIN1;GRIA3
prerank,DNA polymerase activity (GO:0034061),0.5158743361776577,1.2149076951253999,0.2233285917496444,0.7688361129202125,1.0,8/22,25.86%,REV3L;POLE2;POLI;PRIMPOL;POLB;POLM;POLK;POLQ
prerank,protein phosphatase 2A binding (GO:0051721),-0.40681543654223523,-1.2148444208614586,0.18900343642611683,0.544630284219904,1.0,8/23,11.75%,MFHAS1;CTTNBP2NL;FOXO1;DAB2IP;MAPT;SPHK1;ANKLE2;SMG7
prerank,protein tyrosine phosphatase activity (GO:0004725),0.43656093404979934,1.211002912698608,0.19186046511627908,0.7762975918534643,1.0,13/71,8.48%,EYA2;UBASH3B;PTP4A2;PTPN3;PTPRU;PTPRF;EYA4;PTPDC1;PTPN2;ACP4;CDC14A;PTPRA;DUSP11
prerank,SUMO transferase activity (GO:0019789),0.5593469905380068,1.2107456490944082,0.2319277108433735,0.7720556423021905,1.0,8/16,29.30%,HDAC4;RANBP2;PIAS2;PIAS1;TOPORS;PIAS3;UBE2I;PIAS4
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.520365503220811,1.2090794555782423,0.24217687074829933,0.7726530121824295,1.0,6/24,13.65%,IP6K1;IP6K2;PPIP5K1;AK4;AK3;AK1
prerank,monocarboxylic acid binding (GO:0033293),-0.43291465910061105,-1.2083625332801664,0.24242424242424243,0.5508166113458057,1.0,2/18,2.27%,NR2F2;CYP26B1
prerank,vitamin D receptor binding (GO:0042809),0.5722569822352773,1.2081702899306677,0.2581120943952802,0.7706056256692029,1.0,4/14,8.75%,MED13;MED24;THRAP3;RXRA
prerank,DNA-binding transcription factor binding (GO:0140297),0.40021124101461736,1.2071626621302856,0.1325678496868476,0.769015650676995,1.0,53/189,20.09%,ZFPM2;TCF7L2;HES1;HDAC4;HDAC9;PRRX1;PITX2;NFE2L2;ID2;WWP2;GSK3B;TXLNG;KLF4;TLE2;TWIST1;STAT3;SKI;MEF2A;DACT1;BHLHE40;MIER1;CREBBP;NCOR1;SMAD2;CBX5;GATA4;KDM1A;MTA1;CRTC2;ZFPM1;CRTC1;MTDH;HIRA;NFATC1;DMAP1;MEF2D;ZMYND8;MAP3K10;PRDM5;SIK1;YAP1;HCFC1;RB1;TLE6;ATF2;DHX9;MKKS;PIAS2;PPARG;HDAC2;ZBTB7A;TCF12;NEK6
prerank,frizzled binding (GO:0005109),0.4880964127789668,1.2062410337868037,0.23243243243243245,0.7670570595866089,1.0,6/34,6.16%,WNT9A;LRP6;WNT11;FZD1;FZD7;MYOC
prerank,5'-3' RNA polymerase activity (GO:0034062),0.5000527814403052,1.2029347359176241,0.24279835390946503,0.7732575050846697,1.0,9/27,18.58%,POLR1A;POLR1D;POLR3F;POLR3A;TENT2;POLR3K;POLR1F;MED20;POLR2C
prerank,potassium ion leak channel activity (GO:0022841),0.5569161513198274,1.2022037983641927,0.2606707317073171,0.7706655843525573,1.0,1/15,0.18%,KCNK5
prerank,delayed rectifier potassium channel activity (GO:0005251),0.4855754090338978,1.2006998615200333,0.2570332480818414,0.7707253777086598,1.0,3/32,3.07%,KCNB2;KCNB1;KCNS3
prerank,histone methyltransferase activity (GO:0042054),0.48584705567417813,1.2001447805857108,0.23404255319148937,0.7676157821213534,1.0,21/32,32.86%,KMT2C;PRMT8;SETD2;EHMT1;EED;KMT5B;PRMT5;KMT5A;SMYD3;KMT2E;PRMT6;SUZ12;SMYD2;SETD7;CARM1;DOT1L;NTMT1;SETDB1;MEN1;EHMT2;PRDM9
prerank,endodeoxyribonuclease activity (GO:0004520),0.5252993310730224,1.1958468662968236,0.26606875934230195,0.7763871863432094,1.0,8/20,23.71%,EXO1;ERCC5;APEX1;RAD50;APLF;ERCC4;EXOG;RBBP8
prerank,ion channel inhibitor activity (GO:0008200),0.48352136616791713,1.1950919451710096,0.25725593667546176,0.7740174260629717,1.0,4/35,1.67%,NEDD4;KCNMB2;WNK1;CAMK2D
prerank,low-density lipoprotein particle binding (GO:0030169),0.5391330699915533,1.1950831481094986,0.2600297176820208,0.7693356658238932,1.0,2/16,3.45%,THBS1;LDLR
prerank,single-stranded RNA binding (GO:0003727),0.46460804724258126,1.1933896166381066,0.24539877300613497,0.7702608975936295,1.0,11/43,18.46%,STRBP;U2AF2;AGO2;ZFR;IFIH1;TLR8;ZFR2;DDX11;SRA1;EIF4B;DHX9
prerank,endonuclease activity (GO:0004519),0.4522801956317204,1.1912096654083781,0.2266500622665006,0.7725027561692709,1.0,15/49,20.59%,N4BP2;ERCC5;SMG6;AGO2;APEX1;ZC3H12C;ZC3H12A;ZC3H12B;CPSF3;ERN2;APLF;DIS3;ERCC4;EXOG;YBEY
prerank,protein phosphatase binding (GO:0019903),0.40991985516989915,1.1906916354235546,0.16429353778751368,0.7695809885523601,1.0,26/117,13.51%,EGFR;MET;MAP3K5;PPP1R3B;FCRL6;SHOC2;STAT3;ANAPC5;PPP1R3C;ATP2B4;VRK3;ERBB2;STRN;STYXL1;AP3B1;IKBKE;VCP;PTPA;SLC9A1;PPP6R3;IGBP1;JUP;CDKN1B;TRAF2;STRN3;PDLIM4
prerank,sialyltransferase activity (GO:0008373),-0.4220110065996406,-1.1905841547281797,0.19090909090909092,0.5833433916716958,1.0,8/20,7.52%,ST6GALNAC3;ST6GAL1;ST8SIA4;ST3GAL1;ST3GAL6;ST3GAL3;ST8SIA1;ST8SIA6
prerank,ADP binding (GO:0043531),0.5015156126812438,1.18995297095641,0.260748959778086,0.7672052399833574,1.0,4/25,10.01%,ME1;GCLC;ABCD1;MIEF1
prerank,chemorepellent activity (GO:0045499),-0.4043006316294661,-1.1828016234679448,0.20306513409961685,0.5928293191419323,1.0,15/25,20.81%,SEMA6A;NRG3;SEMA7A;DPP4;EPHA7;SEMA6D;SEMA3B;SEMA5A;SEMA3G;SEMA5B;SEMA6B;SEMA4G;SEMA3A;SEMA3F;SEMA4D
prerank,3'-5' exonuclease activity (GO:0008408),0.45821937027963244,1.1804185191578636,0.2623152709359606,0.7926561380616288,1.0,20/45,28.21%,REV3L;ERI3;CNOT8;APEX1;WRN;ANGEL2;RAD50;EXOSC3;REXO2;ERI1;APLF;DIS3;EXOSC2;EXOSC7;TATDN1;RAD9A;ANGEL1;PARN;ERI2;EXD1
prerank,iron ion binding (GO:0005506),0.4582633353101218,1.1794107539786953,0.2475609756097561,0.7909273921354476,1.0,18/48,25.32%,AOX1;EGLN3;FDX1;ALKBH8;TYW5;ACO2;FXN;AGMO;ALOX5;FTO;SCD;NFU1;HIF1AN;PHF8;JMJD6;ALKBH1;KDM3A;HEPH
prerank,thyroid hormone receptor binding (GO:0046966),0.4873950350787277,1.1787818137648296,0.2742155525238745,0.7883111539314913,1.0,9/28,13.28%,JMJD1C;MED13;NCOR1;MED24;THRAP3;NSD1;GAS2L1;NCOA6;TRIP12
prerank,DNA binding (GO:0003677),0.37979417981717895,1.178322918064733,0.052,0.7852681038065442,1.0,159/694,19.89%,FOXP2;KLF12;SIX1;EGFR;PLAGL1;TCF7L1;TCF7L2;NFIB;SLTM;FOXD1;HES1;HDAC4;ZIC4;CUX1;RARB;HOXA5;MEOX2;PBX1;FOXL1;EHF;DMBX1;SOX14;GRHL2;ZNF423;NFE2L2;GRHL1;ZNF148;EXO1;MPG;COLEC11;FOXC2;ABL1;CHTF18;ERCC5;NR4A3;CCDC25;C1D;STAT3;FOXO3;NABP1;CDC45;MCM2;RAD51;ZBTB16;MEF2A;GLI2;NR4A2;MBD1;CREBBP;RORA;CRY2;APEX1;E2F3;WRN;ZMYM4;IRF1;SMAD2;CHD3;ZC3H12A;MLX;MLXIPL;EGR1;GATA4;THRAP3;DNMT3A;RXRA;STN1;FOXC1;TOP1;SMC6;ILF2;ARNT;NEIL3;CLSPN;ATF6;HDGFL3;POU4F1;DHX36;RAD23B;ARID4A;ERF;KIN;CGAS;DENND4A;WDR48;MECP2;RFX2;TLR8;TEAD1;POLR3F;RAD50;ZBTB32;RNF138;NR2F1;BRCA1;EZH1;SREBF1;NR4A1;MBD3;E2F1;HOXA7;NFYA;PATZ1;SIRT3;DDX11;MAP1S;PRDM2;DNTTIP1;HINFP;TAF4;BRIP1;KHDRBS1;MSL3;RTF2;SOX9;MCM7;POU2F1;FOSB;DNASE2;E2F2;PRKDC;ZNF219;SMC1A;FAM111A;KDM5B;PAX6;SMARCA5;PRDM5;SMAD4;RNF11;TSHZ2;CHD8;ESR2;POLG2;KMT2D;CAMTA2;PCID2;POU6F1;NUP35;MCM9;BRCA2;MTERF2;DHX9;BCLAF3;RBM6;PPARG;RFC1;MBD5;AIFM1;HDAC2;PARP4;CARF;DEDD;MAFF;CEBPG;XRCC5;LIN9;CCNT1;ZBTB7A
prerank,small GTPase binding (GO:0031267),0.3932136315699018,1.178159712737104,0.19517313746065057,0.7813151640848297,1.0,50/170,18.27%,PLCE1;CDC42EP5;EXOC4;UNC13B;SGSM2;SRGAP2;AKAP13;ERC1;YBX3;ARHGDIB;NDRG1;HPS4;MLPH;PDE6D;RANGRF;DOCK7;SIKE1;RAB11FIP3;ARFIP2;RGP1;CIB1;TNPO3;KIF3B;FGD1;RAF1;AP3M1;OCRL;STRN3;RANBP2;EHD1;FGD3;NUTF2;SORL1;PARD6A;ANKRD27;PIH1D2;EVI5;BICD1;CYFIP1;RNF41;FGD6;RABGAP1;AFDN;CDC42EP2;IQGAP1;ANKFY1;GOLGA4;LRRK2;MTSS2;MYCBP2
prerank,protein kinase inhibitor activity (GO:0004860),0.45667017700190565,1.177438473405276,0.2549019607843137,0.7790133708451662,1.0,14/42,17.39%,CIT;SPRED2;PARVA;IBTK;CEP43;CIB1;DUSP19;QARS1;DNAJC3;CDKN1C;CDKN1B;NCK1;CDKN1A;SOCS3
prerank,CARD domain binding (GO:0050700),0.5451026552781224,1.1772871981652853,0.2962962962962963,0.775094044170686,1.0,4/14,13.46%,CARD14;MAVS;RIPK2;CARD16
prerank,CoA-ligase activity (GO:0016405),-0.44692424692098887,-1.1772278760466566,0.25892857142857145,0.5976004107405039,1.0,5/14,11.53%,ACSS3;ACSL1;ACSS2;ACSS1;ACSBG1
prerank,carboxypeptidase activity (GO:0004180),-0.3672999585511818,-1.1759896170592992,0.21120689655172414,0.5917941708970854,1.0,9/35,17.80%,AEBP1;AGBL4;CTSA;ACE2;MINDY1;PEPD;FOLH1;CTSZ;CPXM1
prerank,clathrin adaptor activity (GO:0035615),0.5451836522478333,1.174243121577955,0.30654761904761907,0.7803795087071388,1.0,7/15,23.60%,STON2;AP2A2;STON1;AP2B1;AP2A1;AP1M1;DAB2
prerank,Wnt-activated receptor activity (GO:0042813),0.5520183822964412,1.1738036138586816,0.29012345679012347,0.7772509197323743,1.0,4/15,7.12%,PKD1;FZD1;FZD7;ROR1
prerank,receptor antagonist activity (GO:0048019),0.5262006207023638,1.1726210316929706,0.3031674208144796,0.7766572597978252,1.0,4/17,16.97%,ADH7;DKK3;WFIKKN1;ESR2
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.5495367807959916,1.1690256099081204,0.294478527607362,0.7836143806489226,1.0,3/14,11.77%,ADH7;RDH12;DHRS3
prerank,lysine N-methyltransferase activity (GO:0016278),0.505139231135304,1.1689937653681695,0.2942028985507246,0.7793586976976502,1.0,9/20,26.83%,SETD2;EHMT1;ETFBKMT;EEF1AKMT4;EEF2KMT;KMT5A;SETD6;SMYD2;SETD7
prerank,FMN binding (GO:0010181),0.5661679873853706,1.167079793058426,0.3004769475357711,0.7808213803768191,1.0,2/11,4.72%,IYD;PNPO
prerank,GTPase activator activity (GO:0005096),-0.2642066982121476,-1.16620214543008,0.1,0.6057043898087167,1.0,62/313,9.23%,PLCB1;RANBP3L;PREX2;ARHGAP28;ASAP1;ARHGAP29;RAPGEF5;TBC1D4;DOCK10;RAPGEF4;CHN2;ERRFI1;ARHGAP24;DENND2A;RASGRP3;DOCK11;ELMO1;RGS3;ADGRB3;SBF2;ALDH1A1;FGD5;RAPGEF3;RASGRF1;RASGRF2;ARHGAP32;RGS7;RAPGEF2;ARHGAP26;RALGAPA2;RGS5;RASGRP2;RALGPS1;ARAP3;RALGAPA1;USP6NL;ARHGAP22;DOCK2;SIPA1;VAV3;IQGAP2;HACD3;EPS8L2;TBC1D8;ELMOD1;NGEF;OPHN1;ARHGEF15;ARHGAP25;ARHGAP39;TBC1D30;SPATA13;ABR;CYTH1;DENND5A;RGL1;EEF1B2;EVI5L;TBC1D9;STXBP5L;ARHGEF10L;DENND4C
prerank,nuclease activity (GO:0004518),0.4408281603328386,1.166018604726714,0.2512135922330097,0.779584355448594,1.0,15/52,20.85%,N4BP2;EXO1;STK31;ERCC5;APEX1;WRN;ZC3H12A;RNASE3;RNASEH2A;MAP1S;PLSCR1;ERN2;DIS3;EXOG;REXO1
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.5762898156358084,1.1656024842900805,0.30474732006125577,0.7767210169606754,1.0,6/11,30.27%,SLC25A25;SLC19A1;SLC35B3;LRRC8A;SLC17A9;SLC25A24
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.5433175201025465,1.1639717976120092,0.3035439137134052,0.7773362309033763,1.0,7/14,23.82%,USP15;USP13;DESI2;MINDY3;OTUD5;USP9X;USP7
prerank,SUMO binding (GO:0032183),0.5504141712927701,1.1629068169833081,0.2872503840245776,0.7763394692474896,1.0,6/13,24.99%,HERC2;USP25;RNF111;SERBP1;PML;TDG
prerank,transition metal ion binding (GO:0046914),0.3767405080626972,1.1622871418129117,0.13004032258064516,0.7740849718005107,1.0,90/397,16.08%,AOX1;ME1;ZFPM2;ACER3;HDAC4;ADH7;MPPED2;TES;CBLC;TNP2;FDX1;ADAMTS3;KLF4;ADA;LIMS1;TIMP1;S100B;ABL1;PLA2G15;LARGE1;KLF7;CLIP1;SKI;EEA1;TAB3;ECE1;XPNPEP3;XPNPEP1;GLI2;MNAT1;SIRT6;PLSCR3;MBD1;NPEPPS;B4GALT1;ZFYVE1;SEC24B;SMPDL3A;WRN;ZMYM2;ZDHHC20;TIMP2;CHD3;PHEX;AOC3;ARG1;SEC23A;EGR1;MMP16;RXRA;NUDT12;ARIH1;EPRS1;ALKBH8;IFIH1;CUTC;TYW5;SEC24D;NSD1;SORD;CDADC1;TAB2;IDE;TK1;ACO2;CHORDC1;ESCO1;ZBTB32;AGMO;SCO2;UBA5;MDM4;ZDHHC15;DPEP1;SIRT3;PRDM2;ADH5;RNF8;COMMD1;PRIMPOL;MGAT1;TIMM9;PLSCR1;MGAT5;ZMYND8;CCS;ALOX5;KDM5B;DPP3;HHIP
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.4407910083498718,1.161398954912149,0.25539568345323743,0.772524157364857,1.0,7/54,6.80%,ACER3;HDAC4;HDAC9;VNN1;HDAC8;SIRT6;MIER1
prerank,actin monomer binding (GO:0003785),0.49781609131611115,1.1602699152200673,0.29929078014184396,0.7716184354897537,1.0,5/22,6.03%,COBL;PRKCE;ABL1;MRTFA;LIMA1
prerank,MAP kinase activity (GO:0004707),-0.4596251735772503,-1.1581693013973973,0.26843657817109146,0.6162815759979309,1.0,4/14,12.82%,MAPK4;MAPK6;MAPK1;MAPK10
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.5662497175671835,1.1557751876785376,0.31164901664145234,0.7812070865318091,1.0,7/12,31.96%,SLC25A25;SLC19A1;SLC35B3;LRRC8A;SLC17A9;SLC25A24;SLC25A5
prerank,kinase inhibitor activity (GO:0019210),0.4561973445634194,1.1543577586748703,0.2882882882882883,0.7812836512788215,1.0,11/33,19.69%,LRP6;PARVA;DUSP19;QARS1;DNAJC3;CDKN1C;CDKN1B;NCK1;CDKN1A;SOCS3;HEXIM1
prerank,potassium channel activity (GO:0005267),0.4105815039343626,1.1542961608610653,0.2595936794582393,0.7774261244088847,1.0,7/89,3.63%,KCNK5;KCNB2;KCNMB3;KCNMB2;KCNB1;KCNS3;GRIK4
prerank,copper ion binding (GO:0005507),-0.3367649964448177,-1.1536052000740757,0.20168067226890757,0.6189108094554047,1.0,16/42,25.68%,PAM;MOXD1;SOD3;LOXL3;LACC1;ATOX1;RNF7;ATP13A2;MT3;SOD1;PRNP;SNCA;S100A13;ACR;GPC1;TYR
prerank,calcium ion binding (GO:0005509),0.37581175431499836,1.151275521822526,0.1708542713567839,0.7823344408368552,1.0,38/323,10.24%,SLIT3;SLIT2;SMOC2;THBS1;CDH11;ACER3;ESYT3;CDH1;PPP3CA;ANXA2;GSN;ANXA4;CASR;SLIT1;S100G;DSPP;COLEC11;DSG2;PLA2G4F;DSG3;S100B;LRP1;ANXA1;PLA2G2C;PLSCR3;CRACR2A;LTBP4;PCLO;AOC3;TRPM4;ANXA3;TKT;MAN1B1;S100A10;CIB1;ANXA7;RCN1;C2CD5
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.5823609287074941,1.1506956123204943,0.3269230769230769,0.7800234184556408,1.0,5/10,26.32%,EXO1;APEX1;DCLRE1A;TATDN1;MGME1
prerank,calcium-release channel activity (GO:0015278),-0.4146072446908307,-1.1496374250845125,0.27722772277227725,0.619593643130155,1.0,2/17,2.87%,ITPR1;RYR2
prerank,cardiolipin binding (GO:1901612),-0.4842617796876709,-1.146032385939472,0.2979274611398964,0.6194393234182918,1.0,2/10,6.15%,MME;GSDMD
prerank,serine-type endopeptidase activity (GO:0004252),0.40563292177246163,1.143375300370989,0.2679814385150812,0.7976479495751505,1.0,3/80,3.42%,F3;PCSK5;PRSS12
prerank,SH3 domain binding (GO:0017124),0.42187600161634936,1.1432628337486275,0.2843601895734597,0.7938970710291761,1.0,8/62,7.03%,AFAP1L1;DPYSL3;ADAM9;ABI1;CBLC;ABL1;RUFY1;SHANK1
prerank,leak channel activity (GO:0022840),0.5125506158033654,1.1427117994739535,0.3172932330827068,0.7914568374954332,1.0,1/18,0.18%,KCNK5
prerank,protein serine/threonine kinase activity (GO:0004674),0.37453006592880694,1.14190275225182,0.16347124117053483,0.7898975756534157,1.0,88/335,18.03%,STK39;EGFR;MAP3K5;MARK1;CIT;GRK5;WNK1;PRKCD;CAMK2D;ULK2;PRKCE;PTK2B;TLK1;BMPR1A;CLK2;CLK1;GSK3B;CDK10;ALPK1;CDK12;HIPK1;TGFBR1;IRAK3;CHEK2;STK16;NEK7;FAM20A;BCR;VRK3;MAPK12;TGFBR2;NRBP2;AURKA;IRAK4;LIMK2;CDK11B;IKBKE;CSNK1A1;NLK;MAST2;TOP1;MAK;GAK;CDK16;RIPK2;CDK13;TTK;AAK1;PLK4;MAP3K7;EIF2AK2;PDK3;CSNK1G3;ULK3;SGK3;CLK4;MAP3K1;RPS6KA3;TRIO;RAF1;MARK2;CDKL2;CSNK1G1;ACVR1;HTATIP2;STK35;PIM2;PRKCA;MARK3;CDK7;PRKDC;CDK2;CDC7;MAP3K10;SIK1;IKBKB;PLK3;CPNE3;ERN2;RPS6KB1;MAP3K14;NEK4;MAP3K4;LRRK2;STK24;STK3;PBK;MAPKAPK2
prerank,protein phosphatase 1 binding (GO:0008157),0.5009495813085112,1.1411051617312225,0.3140376266280753,0.7882913493163267,1.0,3/21,5.50%,PPP1R3B;SHOC2;PPP1R3C
prerank,acetyltransferase activity (GO:0016407),0.45758183297474947,1.1397531861303596,0.30851063829787234,0.7881936531828938,1.0,16/31,29.87%,ELP3;CREBBP;PAFAH1B2;NAA15;ESCO1;NAT10;PAFAH1B3;KAT6B;LCAT;NAA80;KAT6A;GTF2B;KAT8;KAT2B;NAA50;SMARCE1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.5626354834502386,1.139240113118673,0.334384858044164,0.7857272622948225,1.0,8/10,33.99%,SETD2;NSD1;ASH1L;SMYD2;SETD5;SETMAR;PRDM9;NSD3
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.48430062094655757,-1.1391060059213949,0.29891304347826086,0.6272651649839339,1.0,7/10,37.27%,NOX1;NOX4;NCF2;NCF1;NOX3;NCF4;DUOX1
prerank,nuclear localization sequence binding (GO:0008139),0.521588270036802,1.1388456891801206,0.3169705469845722,0.782935334014197,1.0,10/18,28.29%,NUP214;NUP153;TNPO2;KPNA1;KPNA2;KPNA4;BRAP;IPO4;POM121;IPO5
prerank,regulatory RNA binding (GO:0061980),0.4528251789828768,1.1373531457479669,0.3023560209424084,0.783552049349956,1.0,18/38,30.07%,ZC3H7A;AGO2;TUT7;TUT4;ZC3H12A;DDX21;HNRNPA2B1;DHX9;PUM2;PUM1;FMR1;TRIM71;RBM4;ZC3H10;DICER1;AGO1;ELAVL1;PIWIL2
prerank,kinase binding (GO:0019900),0.36736643482145165,1.1337185935220007,0.1576305220883534,0.7908964773377728,1.0,91/435,17.25%,SLC12A7;EGFR;SLC12A2;TCF7L2;PKD1;CIT;CCNA2;WNK1;PRKCD;ANK2;RHOBTB1;GSN;UNC5C;ESR1;TTC28;NBEA;TELO2;DLG2;GSK3B;AP2A2;LIMS1;PLCG2;IRAK3;PTPN2;NR4A3;TAX1BP1;SPRED2;STAT3;CNTLN;SHC1;FOXO3;IBTK;SKI;CHEK2;ACSL3;PER1;TSKS;FAM83E;STRADA;TIAM1;SIKE1;AURKA;IRAK4;BARD1;CEP43;CCND1;BECN1;RND3;CDKN2C;MAVS;LRBA;ATP1A4;CCNB1;ANKRA2;RHOA;PARP1;QARS1;DNAJC3;TOM1L1;CHP1;CAB39;FBXO5;NSF;RB1CC1;MAP3K1;BCAR3;RNF138;CDKN1B;PIP5K1A;TRAF2;DLG1;LYST;NBEAL2;CARD16;CD160;SRCIN1;PPP1R12A;BICD1;NR3C1;DVL1;PTN;TRAF6;PAX6;CDKN1A;LCK;SIK1;IKBKB;CENPJ;IQGAP1;RB1;PTPN23
prerank,lipid phosphatase activity (GO:0042577),0.5301767567695232,1.1319638870892,0.33076923076923076,0.7921072569379463,1.0,2/14,2.48%,PLPP3;PLPPR2
prerank,CCR chemokine receptor binding (GO:0048020),0.4711648017329841,1.1318174133735477,0.31095890410958904,0.7886622833178328,1.0,4/28,9.92%,DEFB130A;CCL3;CCL1;CCL7
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.5553234830433179,1.130931756036282,0.3328125,0.7875011756152502,1.0,2/10,7.15%,CASP6;CASP2
prerank,lipoprotein particle binding (GO:0071813),0.49499664000774146,1.1299813909489773,0.32047477744807124,0.786536249012532,1.0,2/20,3.45%,THBS1;LDLR
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.4262888465633928,1.1292516207860273,0.3150684931506849,0.784963705830749,1.0,16/49,15.83%,TAB3;IKBKG;IKBKE;ZFAND6;UIMC1;WDR81;VCP;TAB2;RAD23B;ZBTB1;ZRANB1;BRCC3;ABRAXAS2;PSMD4;PRPF8;TNIP1
prerank,adenylyltransferase activity (GO:0070566),0.4911968239513718,1.1281937746083972,0.31510791366906477,0.7841439328239571,1.0,6/21,17.28%,NMNAT2;ABL1;NMNAT1;TENT2;FLAD1;TENT4B
prerank,GABA receptor binding (GO:0050811),-0.4639954145002757,-1.1279312406666546,0.3020527859237537,0.6460470730235365,1.0,7/11,33.02%,PLCL2;JAKMIP1;GABARAPL1;GABARAPL2;SHISA7;AKAP5;GABARAP
prerank,store-operated calcium channel activity (GO:0015279),-0.48065698216351627,-1.1275244551901171,0.2966101694915254,0.6385589048057682,1.0,7/10,17.33%,TRPC3;TRPC4;TRPC6;TRPC1;ORAI1;ORAI2;TRPC7
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.4463189423886943,1.1259224945082744,0.3173575129533679,0.7869488086004778,1.0,11/35,23.63%,FOXP1;KLF10;AGO2;TAF4;NR3C1;POU2F1;UBTF;ZBTB17;TBP;TP53;GTF2B
prerank,ribonuclease P RNA binding (GO:0033204),-0.4821153747878265,-1.1252497691807817,0.3232876712328767,0.6358385127244512,1.0,7/10,38.77%,POP4;RPP14;POP7;RPP40;RPP21;POP1;RPP25
prerank,active ion transmembrane transporter activity (GO:0022853),0.4454207480948822,1.1251670745770035,0.31337579617834393,0.7853132967956497,1.0,3/37,1.29%,SLCO3A1;SLCO2A1;SLCO4A1
prerank,pseudouridine synthase activity (GO:0009982),0.5235570584596594,1.1198274874683984,0.35202492211838005,0.7970625206629711,1.0,4/13,17.69%,PUS7L;RPUSD4;RPUSD2;PUSL1
prerank,phospholipase A2 activity (GO:0004623),0.47035751789534463,1.11978645291022,0.3282967032967033,0.7934467556349807,1.0,4/26,8.79%,PLA2G4F;PLA2G15;PLA2G2C;PNPLA3
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.4055242516123555,-1.118750097261777,0.31543624161073824,0.6430759946149203,1.0,9/19,14.49%,GRID2;GRIK2;GABRG3;GABRA2;GABRG1;GABRA5;GABRA1;GABRG2;GRIK1
prerank,exonuclease activity (GO:0004527),0.42544163483830966,1.1187416649888913,0.3074027603513174,0.7928047501612071,1.0,20/46,24.90%,REV3L;EXO1;APEX2;APEX1;WRN;ZC3H12A;RAD50;EXOSC3;REXO2;ERI1;EXOSC1;CPSF3;APLF;EXOG;EXOSC2;REXO1;EXOSC7;EXOSC8;AEN;RAD9A
prerank,GTPase binding (GO:0051020),0.3691078816019817,1.1181607142561563,0.27074688796680496,0.7907055702859187,1.0,53/195,18.27%,PLCE1;CDC42EP5;EXOC4;UNC13B;SGSM2;SRGAP2;AKAP13;ERC1;YBX3;ARHGDIB;NDRG1;HPS4;MLPH;PDE6D;RANGRF;RRAGB;DOCK7;SIKE1;RAB11FIP3;ARFIP2;BECN1;EPRS1;RGP1;CIB1;TNPO3;KIF3B;FGD1;RAF1;AP3M1;OCRL;STRN3;RANBP2;EHD1;FGD3;NUTF2;SORL1;PARD6A;ANKRD27;PIH1D2;EVI5;BICD1;CYFIP1;RNF41;FGD6;RABGAP1;AFDN;CDC42EP2;IQGAP1;ANKFY1;GOLGA4;LRRK2;MTSS2;MYCBP2
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.36179648476680765,-1.1171945761914792,0.2537878787878788,0.6386828414933196,1.0,9/28,14.49%,GRID2;GRIK2;GABRG3;GABRA2;GABRG1;GABRA5;GABRA1;GABRG2;GRIK1
prerank,metallocarboxypeptidase activity (GO:0004181),-0.3617884394460596,-1.1171879542841616,0.30714285714285716,0.6306993059746531,1.0,2/26,0.96%,AEBP1;AGBL4
prerank,sulfuric ester hydrolase activity (GO:0008484),0.5360474675041926,1.1161167456845915,0.3550387596899225,0.7927027127341819,1.0,3/12,7.77%,ARSI;SULF1;ARSB
prerank,RNA polymerase binding (GO:0070063),0.5087563222218497,1.1160093525843853,0.3458755426917511,0.7893310535851692,1.0,8/18,21.38%,NEDD4;STOM;SCAF8;BRCA1;CCNT2;DHX9;CCNT1;TCERG1
prerank,snoRNA binding (GO:0030515),0.4557523134062394,1.1134505590660257,0.3523809523809524,0.7928636187132903,1.0,15/30,29.37%,NUDT5;BMS1;NOP56;NUDT1;DDX21;BYSL;PRKDC;XRCC5;NOP14;NUDT4;IMP4;TBL3;IMP3;NUDT16L1;GAR1
prerank,filamin binding (GO:0031005),0.5415566671814179,1.1128308630877155,0.36019736842105265,0.7909915141651386,1.0,1/11,0.80%,DPYSL3
prerank,ribosome binding (GO:0043022),0.41725503326582797,1.1094606805712994,0.34311224489795916,0.7970431737959873,1.0,16/46,24.00%,RPSA;MTIF3;SEC61A1;ZC3H12A;MRPS27;EIF6;ETF1;EIF2S1;NAA15;SRP19;ERI1;SERBP1;GEMIN5;FMR1;SRP72;SEC61B
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.432176771640225,-1.10764116419937,0.3211009174311927,0.6454659245848141,1.0,7/14,20.38%,NOD1;CTSH;MAL;ATP2A3;RACK1;PYCARD;CASP1
prerank,cholesterol binding (GO:0015485),-0.3275474893470453,-1.1076166250990753,0.23036649214659685,0.6376495871174765,1.0,13/47,13.37%,OSBPL8;APOD;SIDT1;OSBPL10;PROM1;ABCG1;PTCH1;NR1H3;GRAMD1B;OSBPL1A;CD81;SYP;OSBP2
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.5215895792313465,1.1066220408933836,0.3588516746411483,0.8015323625349937,1.0,2/12,3.16%,PGF;VEGFA
prerank,acetylation-dependent protein binding (GO:0140033),0.4922692527602664,1.1057354719567074,0.3589001447178003,0.7970629584289168,1.0,12/20,31.62%,MLLT3;BRD3;THAP7;ZMYND8;BRD4;BRD9;BAZ2A;SMARCA4;BRDT;CARM1;PSME4;PHIP
prerank,lysine-acetylated histone binding (GO:0070577),0.4922692527602664,1.1057354719567074,0.3589001447178003,0.7970629584289168,1.0,12/20,31.62%,MLLT3;BRD3;THAP7;ZMYND8;BRD4;BRD9;BAZ2A;SMARCA4;BRDT;CARM1;PSME4;PHIP
prerank,cadherin binding (GO:0045296),0.360303612481068,1.1042423697976986,0.2408906882591093,0.7977084806659973,1.0,80/315,16.29%,EGFR;CDH11;FXYD5;BAIAP2L1;FMNL2;CDH1;CTNND2;ANXA2;ABI1;EZR;MPP7;AHNAK;SNX2;ERC1;TES;PKP1;PLCB3;GIPC1;CLIC1;NDRG1;KRT18;PHLDB2;EMD;SPTAN1;CAST;PAICS;HDLBP;LYPLA2;CTNNA1;ANXA1;PARVA;PCMT1;CALD1;LIMA1;BAG3;BZW1;ARFIP2;VCL;ITGB1;ARGLU1;PDXDC1;STXBP6;EIF4G2;SHTN1;EIF3E;TXNDC9;RDX;GOLGA3;NOP56;CLINT1;PFKP;KTN1;CD46;JUP;STX5;PLIN3;SH3GLB1;NIBAN2;CTTN;MARK2;FLNB;EHD1;DLG1;DBN1;ACVR1;UNC45A;TNKS1BP1;PLEC;CAPZA1;RAB11B;EPS15L1;AFDN;NCK1;CCS;CHMP2B;KIF5B;RAB1A;ADD1;GAPVD1;SCRIB
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.4568025062414928,1.1041482955475777,0.35894039735099337,0.7944160585867219,1.0,5/28,13.32%,EXO1;DBR1;AGO2;APEX1;RNASEH2A
prerank,methylation-dependent protein binding (GO:0140034),0.41036897985015963,1.1038181303718715,0.3498190591073583,0.7917892153257858,1.0,23/57,27.20%,TDRD3;ZCWPW2;CBX5;MORC4;PYGO1;RRP8;MORC3;MSL3;ATRX;CHD1;THAP7;MBTD1;ZMYND8;CHD8;KMT2E;SUZ12;CBX8;FMR1;PHF8;ING1;ZCWPW1;SGF29;KAT8
prerank,acid-thiol ligase activity (GO:0016878),-0.442090418719163,-1.1033972855708012,0.3176470588235294,0.6402302026452217,1.0,4/13,9.08%,ACSS3;ACSL1;ACSS2;ACSS1
prerank,metal ion binding (GO:0046872),0.35753608779397633,1.1014896897835398,0.21442885771543085,0.7948517953091583,1.0,54/477,10.66%,SLIT3;SLIT2;SMOC2;THBS1;CDH11;EYA2;ACER3;ESYT3;MAP3K5;MARK1;CDH1;PPP3CA;ANXA2;GSN;GCLC;ANXA4;CASR;SLIT1;S100G;DSPP;COLEC11;NUDT5;DSG2;PLA2G4F;DSG3;S100B;ABL1;IRAK3;LRP1;ANXA1;PLA2G2C;MAPK12;PLSCR3;CRACR2A;APEX1;LTBP4;WRN;PCLO;AOC3;TRPM4;ANXA3;NLK;MAST2;NUDT12;TKT;MAN1B1;S100A10;CIB1;YDJC;ANXA7;RCN1;C2CD5;DHX36;CALU
prerank,magnesium ion binding (GO:0000287),0.37541715315716956,1.1013525083277025,0.30686695278969955,0.7916878408170417,1.0,27/135,20.17%,EYA2;MAP3K5;MARK1;GCLC;NUDT5;ABL1;IRAK3;MAPK12;PLSCR3;WRN;NLK;MAST2;NUDT12;TKT;YDJC;DHX36;MARK2;RHEB;PLSCR1;SIK1;ERN2;LRRK2;STK3;SRR;CDC42BPA;NEK6;FOXK2
prerank,protein tyrosine kinase binding (GO:1990782),-0.29593815932094036,-1.1011859904421877,0.2684563758389262,0.6377381670833693,1.0,31/71,24.87%,NRG3;GRM5;PTPN14;NEDD9;CBLB;SIRPA;EPHA4;GRB14;FLT3LG;PITPNM2;SHC4;GAS6;RACK1;SHC3;CDH5;ANGPT2;BLNK;NOX4;SH2B3;SOCS5;HYAL2;DOCK4;TJP2;ARHGEF16;CD247;PCNA;BANK1;TREM2;NRG1;ANGPT4;PHYHIP
prerank,mRNA 5'-UTR binding (GO:0048027),-0.3740066650487516,-1.0993514662373431,0.34868421052631576,0.6344847172423587,1.0,8/24,11.94%,RPS13;RPS14;MYH10;RPL26;RPL41;DDX3X;UTP23;RPS7
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.38394854874148543,-1.0985496433493818,0.3249211356466877,0.6293490617675542,1.0,4/22,6.77%,APOE;PICALM;SYT1;HSPG2
prerank,endopeptidase inhibitor activity (GO:0004866),-0.2939772282471713,-1.0983957662937414,0.21621621621621623,0.6225938026762117,1.0,16/82,11.47%,COL4A3;SPOCK3;SPOCK2;SPOCK1;APP;TIMP3;PROS1;SERPINI1;CST3;ITIH2;SERPIND1;BST2;BIN1;GAPDH;TFPI;A2M
prerank,carboxy-lyase activity (GO:0016831),0.4666629513244779,1.096692812446755,0.35966149506346967,0.801023237686757,1.0,10/23,28.25%,CSAD;ECHDC1;ODC1;AZIN1;GGCX;PPCDC;UMPS;MVD;GAD1;PISD
prerank,estrogen receptor binding (GO:0030331),-0.3443661892496526,-1.0965125771267354,0.32432432432432434,0.6199525429308169,1.0,4/32,2.48%,TACC1;LEF1;NCOA1;PPARGC1B
prerank,growth factor activity (GO:0008083),0.3927827624212071,1.0961999841880998,0.3275862068965517,0.7988902555346573,1.0,13/74,16.35%,OSGIN2;PGF;FGF2;NGF;VEGFA;CLCF1;INHBA;ANGPTL3;JAG1;CLEC11A;CNTF;PTN;GDNF
prerank,single-stranded telomeric DNA binding (GO:0043047),0.5307546374841976,1.0961738680593442,0.37094281298299847,0.7954900911594012,1.0,3/11,17.73%,STN1;RAD50;HNRNPA2B1
prerank,transcription coregulator binding (GO:0001221),0.41654345214399663,1.0924689872409123,0.3406451612903226,0.8022485949437077,1.0,18/50,20.09%,CIT;ESR1;ZBTB16;PER1;LCOR;EHMT1;RORA;EED;PER3;NR1D1;FAM89B;THAP7;CCNT2;SMAD4;MED25;SUZ12;ZBTB7A;NEK6
prerank,actinin binding (GO:0042805),0.46540584408064234,1.08919514559746,0.3640226628895184,0.8080342060975769,1.0,3/21,4.07%,CACNA1C;CSRP3;RARA
prerank,myosin II binding (GO:0045159),0.5414691922724989,1.0888487950991745,0.36577708006279436,0.8056379705288723,1.0,2/10,4.63%,GSN;SHROOM4
prerank,neurexin family protein binding (GO:0042043),0.5418405654314898,1.0883483408763612,0.3836477987421384,0.8036232045125499,1.0,4/10,16.98%,SYTL4;SYTL5;NLGN1;CEL
prerank,GABA receptor activity (GO:0016917),-0.38428540818020557,-1.0853810042995327,0.3333333333333333,0.6386999654173985,1.0,10/21,14.14%,GABRG3;GABRB3;GABRB1;GABRA2;GABRB2;GABBR2;GABRG1;GABRA5;GABRA1;GABRG2
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.4375837373382928,-1.084718388275505,0.34464751958224543,0.6330718165359083,1.0,5/12,11.59%,CDK19;CDK8;CDK6;MAPK1;CDK4
prerank,voltage-gated potassium channel activity (GO:0005249),0.3894056827701856,1.083951770493396,0.3459335624284078,0.812341739699306,1.0,5/80,3.07%,KCNJ2;KCNB2;KCNJ15;KCNB1;KCNS3
prerank,protein homodimerization activity (GO:0042803),0.3478946681230502,1.08339385561109,0.23823823823823823,0.8104161127510685,1.0,101/590,14.42%,SLIT2;FOXP2;AOX1;EXT1;LRP6;ABCD3;MAP3K5;MGLL;HES1;PRPS2;CAMK2D;ABCG2;CASR;CPQ;SRGAP2;ADRB2;SNX2;CLTRN;MMACHC;VEGFA;SRM;BMPR1A;GRHL1;NPR3;MID1;NECTIN3;NUDT5;HPS4;S100B;IRAK3;ERCC5;PNPO;NOG;SCARB2;NR4A3;HSPB8;PDGFC;FGFR1;STAT3;CISD2;ACP3;EEA1;CHEK2;ZBTB16;CEACAM5;ECE1;BHLHE40;XPNPEP3;XPNPEP1;PRMT8;CRYL1;SPPL2A;NRF1;RAB11FIP3;TENM1;BARD1;DGCR8;ZDHHC2;IKBKG;WRN;ABCD1;SLC51A;PAFAH1B2;KNSTRN;SLC39A13;CEP43;MLX;MLXIPL;PHETA2;TKT;EPRS1;S100A10;PTPA;ARNT;TYW5;RIPK2;XDH;CDADC1;IDE;EIF2AK1;ODC1;MCL1;MAD2L1;ZBTB1;JUP;SH3GLB1;UBA5;GLCE;SLC8B1;PAFAH1B3;RPE;PDCD6IP;PDLIM4;ACVR1;PIP4K2A;DNTTIP1;ACOX1;GTF2A2;RNF8;COMMD1;TIMM9
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.44664173128917406,1.0820352880556685,0.3758300132802125,0.8106197284460106,1.0,10/28,21.71%,EDA;FEM1B;MYD88;TRAF2;PIDD1;TRAF6;TRAF5;TRAF4;TRAF3;TMBIM1
prerank,translation elongation factor activity (GO:0003746),-0.41633778743578354,-1.0817183166303375,0.35428571428571426,0.6328397010352351,1.0,7/14,23.72%,EEF1A1;EEF1B2;EEF2;GTPBP1;EIF5AL1;EIF5A;EEFSEC
prerank,"DNA binding, bending (GO:0008301)",0.5134048099797571,1.0804071564855453,0.40683229813664595,0.8117352006248235,1.0,3/14,9.03%,FOXD1;FOXL1;FOXC1
prerank,zinc ion binding (GO:0008270),0.35309405139834515,1.0801596694877518,0.3161094224924012,0.8091678686468178,1.0,67/293,16.08%,ZFPM2;ACER3;HDAC4;ADH7;TES;CBLC;TNP2;ADAMTS3;KLF4;ADA;LIMS1;TIMP1;S100B;PLA2G15;KLF7;CLIP1;SKI;EEA1;TAB3;ECE1;GLI2;MNAT1;SIRT6;MBD1;NPEPPS;ZFYVE1;SEC24B;SMPDL3A;ZMYM2;ZDHHC20;TIMP2;CHD3;PHEX;SEC23A;EGR1;MMP16;RXRA;NUDT12;ARIH1;EPRS1;ALKBH8;IFIH1;SEC24D;NSD1;SORD;CDADC1;TAB2;IDE;TK1;CHORDC1;ESCO1;ZBTB32;UBA5;MDM4;ZDHHC15;DPEP1;SIRT3;PRDM2;ADH5;RNF8;PRIMPOL;TIMM9;PLSCR1;ZMYND8;KDM5B;DPP3;HHIP
prerank,histone acetyltransferase binding (GO:0035035),0.46279572084009973,1.0783124799436132,0.39046199701937406,0.8107738881153043,1.0,10/21,25.53%,BCAS3;GLI3;MEF2A;EGR1;PAX6;ZBTB7A;KANSL1;TP53;TAF7;TRIM68
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.427170880073336,-1.0770559766227177,0.3333333333333333,0.6368830521371782,1.0,3/13,1.51%,PDGFD;PDGFRB;IL1R1
prerank,adrenergic receptor binding (GO:0031690),0.49708878740782025,1.074286930105156,0.3901734104046243,0.8187079374398335,1.0,2/16,2.20%,NEDD4;GNAS
prerank,voltage-gated calcium channel activity (GO:0005245),0.4206778310054625,1.0709776296379765,0.38311688311688313,0.8242047572790302,1.0,5/37,2.89%,CACNA1C;CACNA1G;CACHD1;CACNG6;CACNA1F
prerank,phosphatase activator activity (GO:0019211),-0.3998346620164843,-1.0692822641498354,0.3450479233226837,0.647585025405416,1.0,5/14,15.30%,FRS2;CALM1;BMP2;PPP2R5E;PPP2R5A
prerank,poly-purine tract binding (GO:0070717),-0.34720822383738903,-1.0690845309540484,0.3269230769230769,0.6410714056420858,1.0,6/27,10.58%,RBPMS;ATXN1;RBMS1;KHDRBS2;ELAVL4;DDX3X
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.518824153455188,1.0681253376939919,0.38639876352395675,0.8285878024971216,1.0,2/11,7.15%,CASP6;CASP2
prerank,phosphatidylinositol binding (GO:0035091),0.3750483299987408,1.0668395813767302,0.3717217787913341,0.8288254686460748,1.0,25/91,18.12%,TNFAIP8L3;ESYT3;PITPNC1;SNX2;PITPNA;BCAS3;EEA1;CEACAM5;ZFYVE1;FCHO2;PLEKHF1;SNX22;PIGU;PHF12;SNX24;PARD3;DPEP1;RUBCN;SNX8;GRAMD2A;SNX12;ANKFY1;PIGK;ITPR2;MYO1E
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.5143531065501696,1.0665600801577957,0.4169139465875371,0.8261671525257919,1.0,7/12,25.37%,JMJD1C;KDM1A;HR;KDM3B;PHF8;KDM3A;KDM4D
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.42519624344724105,1.0662176453442067,0.37632978723404253,0.8236979387453244,1.0,11/34,17.21%,CYTH3;ARAP1;GAB2;GBF1;KIF16B;ZFYVE1;PARD3;COMMD1;ANXA8;FCHSD2;IQGAP1
prerank,NADP binding (GO:0050661),0.4274388204423891,1.0653785095584758,0.3654891304347826,0.82257133472165,1.0,8/32,19.14%,ME1;CBR3;GMDS;DECR1;LBR;CAT;HMGCR;CRYZL1
prerank,damaged DNA binding (GO:0003684),0.4040231289576709,1.0613649484183143,0.3935897435897436,0.8301019739721505,1.0,7/44,9.58%,MPG;ERCC5;CREBBP;CRY2;APEX1;SMC6;NEIL3
prerank,protein kinase binding (GO:0019901),0.3418473545837186,1.0610714400640486,0.3346693386773547,0.8275100590404737,1.0,97/480,17.25%,SLC12A7;SLC12A2;TCF7L2;PKD1;CIT;ADAM9;GRK5;CCNA2;WNK1;PRKCD;ANK2;RHOBTB1;EZR;HDAC9;UNC5C;IRS1;NELL1;ESR1;NBEA;DSP;TELO2;GSK3B;RARA;AP2A2;LIMS1;PLCG2;ABL1;IRAK3;PTPN2;NR4A3;SPRED2;STAT3;CNTLN;SHC1;FOXO3;IBTK;SKI;CHEK2;ACSL3;DACT1;TSKS;FAM83E;SIKE1;AURKA;IRAK4;ITGB1;CEP43;CCND1;BECN1;RND3;CDKN2C;MAVS;LRBA;ITGAV;ATF7;CCNB1;ANKRA2;RHOA;DUSP19;PARP1;QARS1;DNAJC3;TOM1L1;FBXO5;NSF;RB1CC1;MAP3K1;RNF138;DUSP5;CDKN1B;TRAF2;DLG1;LYST;TIRAP;NBEAL2;ACVR1;PARD6A;SRCIN1;PPP1R12A;BICD1;NBR1;KHDRBS1;SOX9;NR3C1;DVL1;PTN;TRAF6;TNIP1;PAX6;CDKN1A;LCK;PIN1;SIK1;IKBKB;CENPJ;IQGAP1;PTPN23
prerank,chloride channel inhibitor activity (GO:0019869),0.5271008373097644,1.0602842688150842,0.40549273021001614,0.8263446286084116,1.0,1/10,1.59%,WNK1
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.45406482353916405,1.0586683990891053,0.3878954607977992,0.8273935382727942,1.0,7/23,14.28%,PLEKHA4;GBF1;KIF16B;WDR45B;SNX14;WIPI2;COMMD1
prerank,double-stranded RNA binding (GO:0003725),0.38442491964133974,1.057618534974595,0.39651162790697675,0.8269453657429366,1.0,12/70,11.45%,STRBP;MBNL1;SIDT2;AGO2;DGCR8;ZFR;ILF2;IFIH1;DHX36;EIF2AK2;TLR8;ZFR2
prerank,peptide hormone receptor binding (GO:0051428),0.5063919029089317,1.056328295499568,0.43759630200308164,0.8270588575105636,1.0,2/11,12.09%,PTHLH;GNRH1
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.4502595704171574,-1.0548020106763465,0.41133004926108374,0.667150525680526,1.0,2/10,5.08%,MECOM;PRDM16
prerank,microtubule plus-end binding (GO:0051010),0.4675760379540137,1.0535077383258384,0.41424418604651164,0.8315581619893315,1.0,4/20,8.06%,CLIP4;CLIP1;PAFAH1B1;KNSTRN
prerank,sterol binding (GO:0032934),-0.2962706038989878,-1.0533498439497193,0.3103448275862069,0.6633316988533494,1.0,14/56,13.37%,OSBPL8;APOD;SIDT1;OSBPL10;PROM1;ABCG1;PTCH1;INSIG2;NR1H3;GRAMD1B;OSBPL1A;CD81;SYP;OSBP2
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.4733295981966841,1.0511314899767983,0.4217791411042945,0.8344337495622418,1.0,5/17,17.04%,BDH2;DECR1;TECR;LBR;PECR
prerank,platelet-derived growth factor binding (GO:0048407),0.5092552978766646,1.048098918782965,0.43243243243243246,0.8390102687840949,1.0,2/11,2.53%,COL6A1;COL3A1
prerank,transaminase activity (GO:0008483),-0.4404448405519349,-1.0478151009120051,0.4087193460490463,0.6693067212512989,1.0,9/11,46.51%,GOT2;GOT1;AGXT;GOT1L1;AADAT;BCAT1;BCAT2;PSAT1;AGXT2
prerank,poly(A) binding (GO:0008143),-0.36623082856596606,-1.0459435597796913,0.3715277777777778,0.6667446701070289,1.0,6/21,14.00%,RBPMS;RBMS1;KHDRBS2;ELAVL4;DDX3X;PABPC4L
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.49587387123086946,1.0456999326048009,0.4266263237518911,0.84191088639485,1.0,5/13,25.44%,PNPLA3;LPCAT1;LPCAT2;AGPAT2;LCLAT1
prerank,methylated histone binding (GO:0035064),0.38522685373885374,1.0446342179378012,0.431980906921241,0.8413291473859402,1.0,24/62,27.20%,TDRD3;ZCWPW2;CBX5;MORC4;PYGO1;RRP8;MORC3;MSL3;ATRX;CHD1;THAP7;MBTD1;ZMYND8;CHD8;KMT2E;SUZ12;CBX8;FMR1;PHF8;TAF7;ING1;ZCWPW1;SGF29;KAT8
prerank,sulfotransferase activity (GO:0008146),0.41686371189918064,1.0445238584048626,0.41655716162943496,0.8384236032222048,1.0,9/33,16.84%,UST;CHST13;HS3ST1;CHST11;GAL3ST4;CHST5;SULT1A1;HS2ST1;CHST12
prerank,actin binding (GO:0003779),0.3492936712438314,1.043905399125481,0.3939393939393939,0.8367733507580751,1.0,28/170,9.42%,MICAL2;FXYD5;COBL;PRKCE;GSN;EZR;PAWR;GIPC1;PDLIM7;MYOZ3;PHACTR1;MLPH;ABL1;EMD;PARVA;CALD1;MRTFA;LIMA1;ALKBH4;FLII;VCL;ITGB1;DMTN;PHACTR2;GC;SLC6A2;RDX;MAP1B
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.3736455837807394,-1.0436358605935208,0.3561643835616438,0.6651487719683254,1.0,3/18,1.78%,LTBP1;ENG;TGFBR3
prerank,ubiquitin protein ligase activity (GO:0061630),0.34667936807702754,1.0377926366232513,0.4247967479674797,0.8496899145705625,1.0,57/228,19.40%,WWP1;NEDD4;RNF144A;MKRN3;CBLC;SH3RF3;WWP2;RNF126;UBE4B;TRIM55;TRAF3IP2;RNF114;HERC2;UBR5;FANCL;RNFT2;RNF115;TRIM39;RNF185;ARIH1;CUL3;UBE4A;ANAPC11;ANKIB1;DTX2;UBR4;FBXO27;NSMCE1;UBE3C;TRIM44;TRIM41;RNF138;RNF130;UBE2K;UBR3;TRIP12;COP1;RNF122;RNF8;RNF41;KCMF1;NHLRC1;UBE2D3;MKRN2;RNF111;TRAF6;UBE2O;RNF11;FBXO17;TMEM129;AREL1;RNF14;SMURF1;MYCBP2;TRIM35;NFX1;LRSAM1
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.3836670673255504,1.0362586925360961,0.4030732860520095,0.8505471696364448,1.0,11/60,7.12%,EGFR;CRIM1;MET;NTRK3;DDR2;NRP1;IGF2R;EPHB3;FGFR1;ERBB2;ROR1
prerank,myosin binding (GO:0017022),0.3874725308346417,1.0353424160104145,0.42206235011990406,0.849716394739455,1.0,8/55,6.16%,GSN;GIPC1;RAB25;MLPH;SHROOM4;CALD1;RAB6A;MYOC
prerank,ribonuclease P activity (GO:0004526),-0.4249169917908263,-1.0326613918135557,0.425,0.6836632468316234,1.0,7/11,38.77%,POP4;RPP14;POP7;RPP40;RPP21;POP1;RPP25
prerank,C-C chemokine receptor activity (GO:0016493),-0.3672644989507839,-1.0313309518323992,0.38198757763975155,0.6801030133188334,1.0,12/21,40.10%,CCR9;CCR5;GPR75;CCRL2;CXCR6;CCR1;CCR2;ACKR3;CCR10;ACKR4;CCR6;CXCR2
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.35435757699266507,1.0282563478342754,0.4444444444444444,0.8648901513895819,1.0,26/100,17.34%,CYTH3;ARAP1;PLCZ1;GAB2;PLEKHA4;GBF1;KIF16B;RLBP1;ARFIP2;ZFYVE1;WDR45B;PLEKHF1;SNX22;SNX24;TTPAL;PARD3;WIPI2;COMMD1;RUBCN;ANXA8;FCHSD2;GOLPH3;ZFYVE19;SNX12;IQGAP1;ANKFY1
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.4093801697758001,1.0264451522122036,0.41959798994974873,0.8662213311425674,1.0,16/37,27.32%,WARS2;NARS2;EPRS1;EARS2;QARS1;CARS2;YARS1;VARS1;VARS2;FARSA;RARS2;LARS1;YARS2;CARS1;NARS1;FARS2
prerank,adenyl nucleotide binding (GO:0030554),0.4938763415291013,1.025785154263556,0.4610492845786963,0.8615524327056487,1.0,7/11,30.37%,BAG3;BAG5;BAG2;HSPH1;GRPEL2;GRPEL1;SIL1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.4938763415291013,1.025785154263556,0.4610492845786963,0.8615524327056487,1.0,7/11,30.37%,BAG3;BAG5;BAG2;HSPH1;GRPEL2;GRPEL1;SIL1
prerank,phosphoric diester hydrolase activity (GO:0008081),0.4086955380893957,1.0249476488620604,0.44543147208121825,0.8604384518788395,1.0,6/35,7.45%,PLCE1;MPPED2;PLCB3;APEX2;APEX1;SMPDL3A
prerank,deoxyribonuclease activity (GO:0004536),0.4806667028127376,1.0247011663063272,0.4333843797856049,0.8578763500430009,1.0,5/14,20.11%,ERCC5;APEX1;MAP1S;APLF;ERCC4
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.4087944736576285,1.0244848404027747,0.42782152230971127,0.8552262410178118,1.0,21/34,35.73%,SETD2;EHMT1;ETFBKMT;EEF1AKMT4;EEF2KMT;KMT5B;KMT5A;SMYD3;KMT2E;SETD6;SMYD2;SETD7;DOT1L;SETDB1;MEN1;EHMT2;EEF1AKMT3;PRDM9;NSD3;EEF1AKMT1;METTL21A
prerank,calcium channel activity (GO:0005262),0.3685900433539989,1.0204098199195206,0.46048109965635736,0.8626962448638699,1.0,14/84,11.52%,SLC24A3;CACNA1C;PKD1;ANXA2;CACHD1;CACNG6;CACNA1F;ORAI3;TRPM7;SEC61A1;TRPM4;ITGAV;TRPM8;MCU
prerank,E-box binding (GO:0070888),-0.3152552111780622,-1.0200634260388635,0.4369369369369369,0.6988533494266748,1.0,4/34,5.11%,TCF4;ZEB1;MITF;AHR
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.4918689744054465,1.019448740139585,0.4578696343402226,0.8619241649181342,1.0,3/12,11.61%,B3GNT2;B4GAT1;B3GNT9
prerank,PDZ domain binding (GO:0030165),0.37192510386566346,1.0178729541189875,0.44047619047619047,0.8629553869565163,1.0,9/61,6.12%,CRIM1;CIT;SLC26A6;ERC1;FZD1;FZD7;KIDINS220;ATP2B4;SNTG2
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.4957051121481331,1.0159074451581893,0.4588045234248788,0.8648069421121323,1.0,4/10,19.69%,CDKN2C;CDKN1B;CDKN1A;HEXIM1
prerank,kinase activity (GO:0016301),0.34940210948728123,1.015612649478134,0.4496124031007752,0.8624196830368235,1.0,19/109,12.48%,STK39;PIK3C2B;PAPSS2;GSK3B;CCL3;RFK;ABL1;CHKB;IP6K1;NADK;DGKA;IP6K2;PPIP5K1;ETNK1;HYKK;PI4KB;CKB;ADPGK;AGK
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.39058502204059165,1.0149483298314232,0.4568854568854569,0.8608341591891077,1.0,10/38,17.03%,PLCZ1;PLEKHA4;KIF16B;ZFYVE1;WDR45B;PLEKHF1;PARD3;WIPI2;ZFYVE19;SNX12
prerank,chemokine activity (GO:0008009),0.41144852197800474,1.014788054055599,0.44474761255115963,0.8581917504127662,1.0,4/31,9.92%,CXCL2;CCL3;CCL1;CCL7
prerank,endoribonuclease activity (GO:0004521),0.40554582342526785,1.0142702704665294,0.46254927726675427,0.8564361729800152,1.0,14/32,30.07%,SMG6;AGO2;ZC3H12C;ZC3H12A;ZC3H12B;CPSF3;ERN2;EXOG;YBEY;DICER1;AGO1;SND1;TSNAX;PIWIL2
prerank,hexosyltransferase activity (GO:0016758),0.35377124860403153,1.0121642126555903,0.4707865168539326,0.8587177337932657,1.0,15/101,12.67%,EXT1;TMTC1;B3GNT2;MGAT4C;HEXA;LARGE1;HAS1;B4GALNT3;B4GALT1;DPY19L3;ALG12;B4GAT1;POGLUT3;B3GNT9;POFUT1
prerank,protein heterodimerization activity (GO:0046982),0.3409697077025359,1.0113429109930487,0.4648478488982162,0.8576835081824284,1.0,35/178,13.29%,KCNB2;EXT1;ADRA1B;ATP1B1;SNX2;KCNB1;HEXA;IRAK3;KATNB1;MEF2A;BMP6;BHLHE40;ERBB2;NR4A2;AURKA;SAE1;TENM1;BARD1;PAFAH1B1;IKBKG;SLC51A;ITGB1;PAFAH1B2;AOC3;MLX;MLXIPL;TLR4;ARNT;ATP1A1;ATF6;MCL1;ZBTB1;PAFAH1B3;NR4A1;PRMT5
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.4795904917840742,1.0080224152279575,0.4706766917293233,0.8627552801949987,1.0,4/12,10.89%,GAB2;IRS1;SHC1;TRAT1
prerank,ubiquitin protein ligase binding (GO:0031625),0.3296424197402987,1.0066435047924298,0.48314606741573035,0.8632278900532472,1.0,53/254,18.45%,EGFR;SNCAIP;TANK;SMAD6;USP2;FHIT;MID1;GSK3B;HERC2;SKI;CHEK2;USP25;FANCL;USP13;PER1;UBE2A;VCL;IKBKG;IKBKE;SMAD2;HSPA1L;BECN1;GPI;NLK;ARIH1;CUL3;VCP;SMC6;CUL1;ANKRA2;SLC22A18;CKB;DET1;CLU;TRAF2;BRCA1;UBE2K;PATZ1;SPOPL;RNF8;PSMD1;UBE2B;TRAF6;CDKN1A;TRAF5;GLMN;RB1;SMAD7;RNF20;TRAF4;BAG5;RALB;SPOP
prerank,lysophospholipase activity (GO:0004622),0.43358454386244893,1.0057307572925005,0.4648876404494382,0.8624000391143417,1.0,3/20,10.37%,MGLL;LYPLA2;LYPLAL1
prerank,high voltage-gated calcium channel activity (GO:0008331),0.5054267218982922,1.0056625441600835,0.47768595041322315,0.8595483546782653,1.0,2/10,2.89%,CACNA1C;CACNA1F
prerank,chemokine receptor binding (GO:0042379),0.3971377151084769,1.0050831524024337,0.4553805774278215,0.8579793467371225,1.0,4/35,9.92%,CXCL2;CCL3;CCL1;CCL7
prerank,cytochrome-c oxidase activity (GO:0004129),-0.37529233617889024,-1.0008192398485674,0.4831081081081081,0.7374011987976867,1.0,6/15,25.07%,NDUFA4;COX4I1;COX5B;NDUFA4L2;COX6B1;COX4I2
prerank,N-acyltransferase activity (GO:0016410),-0.3110694899437867,-1.0001498730569032,0.47280334728033474,0.7318949909474954,1.0,7/32,15.09%,CERS4;TGM2;PLAAT3;NMT2;CERS2;CERS1;SAT2
prerank,calcium-dependent phospholipid binding (GO:0005544),0.37797305783282303,1.0001082949445053,0.4645962732919255,0.8674578429862365,1.0,10/49,12.85%,ESYT3;ANXA2;ANXA4;PLA2G4F;ANXA1;PCLO;ANXA3;C2CD5;CPNE8;CPNE1
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.4086037371399024,-0.9995261923937622,0.3866279069767442,0.7264333132166566,1.0,3/12,1.78%,LTBP1;ENG;TGFBR3
prerank,phosphatidate phosphatase activity (GO:0008195),0.4715384355853098,0.9992798881455774,0.4728434504792332,0.8664363723260751,1.0,3/13,10.75%,PLPP3;PLPPR2;LPIN2
prerank,C-C chemokine binding (GO:0019957),-0.3477184073391488,-0.9983954847200137,0.459375,0.7222873800116145,1.0,12/22,40.10%,CCR9;CCR5;ZFP36;CCRL2;CXCR6;CCR1;CCR2;ACKR3;CCR10;ACKR4;CCR6;CXCR2
prerank,tau-protein kinase activity (GO:0050321),0.44092269392508365,0.9974107361954049,0.4801178203240059,0.868128898361187,1.0,4/20,14.90%,MARK1;GSK3B;MARK2;MARK3
prerank,pyridoxal phosphate binding (GO:0030170),0.43643869618128045,0.9964995760463806,0.46771879483500717,0.8673904814770544,1.0,2/20,4.72%,PYGB;PNPO
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.4079564774120707,0.9960389131605855,0.4768392370572207,0.8656259044640141,1.0,9/29,21.74%,ACER3;GANAB;IDUA;GBA2;GALC;LCT;NEU3;ENGASE;GANC
prerank,lipase activity (GO:0016298),0.3870372315872127,0.9949577517880999,0.4748743718592965,0.8654574945559561,1.0,9/43,17.98%,MGLL;PLA2G15;PNPLA3;ABHD6;SEC23IP;PNPLA2;LCAT;CEL;DAGLB
prerank,RNA binding (GO:0003723),0.3216155978347205,0.9946642196306192,0.516,0.8631994616565917,1.0,356/1321,23.29%,STRBP;MSI2;SLTM;RNMT;MBNL1;SPATS2L;RPSA;FNDC3A;DDX5;ZCCHC24;ANXA2;RBFOX2;SAMD4A;TCF20;EZR;AHNAK;MKRN3;HOXB6;PURG;SIDT2;GPATCH8;TES;YBX3;EIF4G3;DDX17;DSP;ERI3;NUDT5;CELF3;PRR3;SREK1;SRSF11;KRT18;ZCCHC7;U2AF2;FASTKD1;SON;LUC7L2;RBM14;ABCF1;TDRD3;FNDC3B;SMG6;POLR1G;CAST;C1D;LRP1;HDLBP;G3BP2;RBM27;ZC3H18;DDX18;SNTB2;THOC2;KMT2C;STAT3;CISD2;CTNNA1;ZC3H7A;DDX49;EWSR1;STAU1;DBR1;ALG13;LARP1B;ANKHD1;PNISR;DIAPH1;SRSF5;AGO2;TRMT10A;BZW1;TUT7;GOLGB1;MRPL40;PCDH20;RBM39;NQO1;BARD1;DGCR8;SRSF6;ZC3H14;TDRD7;CDK11B;APEX1;DDX24;URB1;MEX3A;DDX43;BMS1;GLRX3;RBM33;NUFIP2;TUT4;SRRM2;CHD3;DAZAP1;ZC3H12C;ZC3H12A;CKAP4;MRPL42;ZFR;DUSP11;THRAP3;NOA1;EIF4G2;EIF3E;KDM1A;HELB;MRPS27;RDX;EPRS1;PSMC1;VCP;TOP1;PPRC1;MRPL11;ILF2;NOL6;ATXN2;ALKBH8;IFIH1;NOP56;GSPT1;TYW5;ANXA7;SCAF8;MTO1;RPUSD4;SUCLG1;CDK13;PABPC1;RRBP1;EIF3A;SEC23IP;PARP1;DHX36;WDR43;EIF2AK2;ETF1;KIN;PARP12;ANKRD17;MECP2;TLR8;NPM3;ZFR2;EIF2S1;RBM3;KTN1;NAA15;UBAP2L;RRP36;FAM133B;YARS1;EXOSC3;CDC40;NAT10;SRSF2;EIF5B;RBM47;CELF4;KPNA2;FYTTD1;GANAB;EBNA1BP2;RBM25;BRCA1;MARK2;CELF1;TIA1;MTHFSD;FUS;RPL22L1;HNRNPH1;FLNB;RPUSD2;NUDT1;SNRNP35;RRP1B;KIF1C;ELP5;U2SURP;RRP8;MTDH;RBMX;DDX11;NELFE;AATF;DCP1A;SCAF11;SRBD1;SPATS2;DDX56;DDX21;ARCN1;GDI2;KHDRBS1;SRSF1;CHERP;ZC3H12B;PLEC;WBP4;NGDN;NMD3;FAM120C;NKAP;DIDO1;BYSL;MRPL15;PSTK;EIF3L;YLPM1;SRP19;HNRNPM;SNRNP70;LSM8;CIRBP;MKRN2;PRKDC;ERI1;RNPS1;PSMD4;PRPF8;SMC1A;MEX3D;KNOP1;MRM3;RBMS3;UBE2O;ADD1;MOV10;EXOSC1;KRI1;FASTKD5;NCOA5;PCDHGA9;LBR;MBNL2;SSB;CNOT4;CPSF3;CPNE3;CHTOP;CS;SYF2;STXBP1;TENT4B;NAF1;UBTF;PABPC4;LARP4;PCID2;PCBP4;PSMA6;EIF4B;GPKOW;HNRNPA2B1;APEH;OTUD4;DDX19B;DEK;VIRMA;DHX9;MRPL23;PUM2;ZNF106;CCDC9;NONO;EIF2S2;TASOR;SERBP1;FARSA;ESF1;SYNCRIP;IGF2BP3;RBM6;NFX1;CSTF3;SARNP;HDAC2;EIF4G1;MRPL44;FBRSL1;GEMIN5;SNRNP40;RSRC2;HEXIM1;XRCC5;FASTKD3;THUMPD1;PDCD11;IREB2;USP10;LGALS3;LARP4B;EXOSC2;SPTBN1;MRPS21;DHX8;UTP4;PPP1CC;SLPI;PUM3;CAPRIN1;PNN;LSM4;DHX30;IBA57;YY1;EXOSC7;SAMD4B;TCERG1;ZC3H15;DDX51;LUC7L3;NAP1L1;PUM1;MRPS30;PES1;RARS2;HNRNPH2;GTPBP4;PKM;FMR1;TARDBP;DHX38;SRSF3;NOP14;TPD52L2;METAP2;USP36;KCTD12;NUDT4;SRRM1;PTCD1;SUGP1;RPL15;RPL10;DDX59;IMP4;PPHLN1;MTIF2;CCAR1;SRPK2;SRP72;JMJD6;KHDC4;TSFM;YWHAE;MAZ;ALKBH1;CNOT1;LARP7;ZC3H11A;YARS2
prerank,phosphatidic acid binding (GO:0070300),0.43929931149942375,0.9944380724924142,0.4678624813153961,0.8607913637303855,1.0,2/19,1.42%,MARK1;PITPNC1
prerank,nuclear import signal receptor activity (GO:0061608),0.46902314679601864,0.9926739647540238,0.49045521292217326,0.862072223505497,1.0,5/15,15.61%,TNPO2;KPNA1;TNPO3;KPNA2;KPNA4
prerank,single-stranded DNA binding (GO:0003697),0.3508762068101614,0.9916384938634843,0.49,0.8616524054682919,1.0,28/93,23.71%,ERCC5;NABP1;CDC45;MCM2;RAD51;CRY2;STN1;TOP1;SMC6;NEIL3;POU4F1;DHX36;RAD23B;WDR48;RNF138;DDX11;MCM7;FAM111A;NUP35;MCM9;BRCA2;DHX9;ERCC4;TDP2;SPRTN;RAD52;RAD51D;RBBP8
prerank,voltage-gated cation channel activity (GO:0022843),0.35190857952002286,0.9916253797398275,0.4908883826879271,0.8587756079347165,1.0,8/97,3.07%,KCNB2;CACNA1C;PTK2B;CACHD1;CACNG6;CACNA1F;KCNB1;KCNS3
prerank,ubiquitin binding (GO:0043130),0.3559642453175231,0.9904397470017128,0.48424737456242706,0.8588662307867753,1.0,20/73,23.91%,NEDD4;USP25;USP13;MVB12B;IKBKG;ADRM1;RNF185;RAD23B;TOM1L1;WDR48;DDI2;NBR1;ASCC2;RBCK1;UBXN2B;USP16;DNAJB2;BUB3;SPRTN;USP33
prerank,phosphatidylinositol kinase activity (GO:0052742),0.4531723906277371,0.9876544565170366,0.47293447293447294,0.8627285630015538,1.0,3/15,10.87%,PIK3C2B;PIK3R3;PI4KB
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.3947946302481943,-0.9874009772647308,0.45786516853932585,0.7413239781386246,1.0,6/12,20.38%,NOD1;CTSH;ATP2A3;RACK1;PYCARD;CASP1
prerank,poly-pyrimidine tract binding (GO:0008187),0.4239622098387719,0.9867352093731064,0.4832869080779944,0.8620293118276166,1.0,15/23,29.36%,U2AF2;DAZAP1;PABPC1;HNRNPH1;KHDRBS1;RBMS3;SSB;PABPC4;FMR1;RBM11;PABPC1L;PATL1;MCRS1;PTBP1;HNRNPC
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.41845794075139353,-0.9843132117404872,0.5026737967914439,0.7419114195668208,1.0,2/11,6.84%,LEF1;GATA2
prerank,exoribonuclease activity (GO:0004532),0.47893013959076686,0.9830561164418566,0.5046583850931677,0.8682310225603046,1.0,6/12,24.31%,ZC3H12A;EXOSC3;EXOSC1;EXOSC2;EXOSC7;EXOSC8
prerank,sodium channel activity (GO:0005272),-0.3028469627729571,-0.9827207694670705,0.4698275862068966,0.7388504703426664,1.0,14/37,22.14%,SHROOM2;GRIK2;SCN7A;HCN1;SCN1A;SCN9A;HCN2;GRIK1;SCN3A;PKD2L1;SCN2A;CACNA1I;SCN5A;CACNA1H
prerank,mRNA 3'-UTR binding (GO:0003730),0.35082553586016896,0.9819690122856892,0.5129107981220657,0.8679190780302204,1.0,34/79,26.22%,DDX5;YBX3;AUH;DAZAP1;ZC3H12A;PABPC1;DHX36;ANGEL2;CELF1;CIRBP;RNPS1;MEX3D;CCT5;RBMS3;RNF20;PABPC4;LARP4;PCBP4;HNRNPA2B1;PUM2;SERBP1;IGF2BP3;GEMIN5;LARP4B;PUM1;FMR1;TARDBP;TP53;RSL1D1;EXOSC8;RBM4;PARN;PABPC1L;SECISBP2
prerank,carboxylic acid binding (GO:0031406),-0.3001892360806138,-0.9814991118882432,0.5188679245283019,0.7348000219454656,1.0,7/38,10.12%,GRM7;NOS3;GRIN2B;GRIN1;MAG;GLRA3;GLRA1
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.39330856367836214,0.9806815745389373,0.49870466321243523,0.8681931835806688,1.0,15/34,25.80%,FAM20A;STRADA;CCNB1;CAB39;CCNT2;MLST8;IQGAP1;STK3;CCNT1;MAP2K2;IGF2;TAOK1;CALM2;MTCP1;CAB39L
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.32724888386404827,0.9799210763461152,0.5386965376782077,0.867141361613112,1.0,55/232,19.40%,WWP1;NEDD4;RNF144A;MKRN3;CBLC;SH3RF3;WWP2;RNF126;TRIM55;TRAF3IP2;RNF114;HERC2;UBR5;FANCL;RNFT2;RNF115;TRIM39;RNF185;ARIH1;CUL3;ANAPC11;ANKIB1;DTX2;UBR4;FBXO27;NSMCE1;UBE3C;TRIM44;TRIM41;RNF138;RNF130;UBR3;TRIP12;COP1;RNF122;RNF8;RNF41;KCMF1;NHLRC1;UBE2D3;MKRN2;RNF111;TRAF6;UBE2O;RNF11;FBXO17;TMEM129;AREL1;RNF14;SMURF1;MYCBP2;PIAS2;TRIM35;NFX1;LRSAM1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.4207908542680888,-0.9788398305911645,0.4918032786885246,0.734639286238562,1.0,7/10,18.96%,GABRG3;GABRA2;GABRG1;GABRA5;GABRA1;GABRG2;GABRA4
prerank,epidermal growth factor receptor binding (GO:0005154),0.41137426756916257,0.9778612407488172,0.49929676511954996,0.8692686654226986,1.0,10/25,21.00%,SNX2;CBLC;SHC1;AGR2;ATXN2;ARF4;PLSCR1;EFEMP1;FER;EGF
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.3832412021819723,-0.9771728609366276,0.48466257668711654,0.7318707431675144,1.0,7/14,38.77%,POP4;RPP14;POP7;RPP40;RPP21;POP1;RPP25
prerank,ion channel activity (GO:0005216),0.3495341095823551,0.9761250677983476,0.5195852534562212,0.8705332660154617,1.0,11/80,11.25%,PIEZO2;TMC6;TMEM120A;GRIK4;TRPM7;TRPM6;CALHM5;TRPM4;TMC8;TRPM8;NALCN
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.3182694159814952,0.9758371986038326,0.5676767676767677,0.868284146773614,1.0,54/269,18.45%,EGFR;SNCAIP;TANK;SMAD6;USP2;FHIT;MID1;GSK3B;HERC2;SKI;CHEK2;USP25;FANCL;USP13;PER1;UBE2A;VCL;IKBKG;IKBKE;SMAD2;HSPA1L;BECN1;GPI;NLK;ARIH1;CUL3;VCP;SMC6;CUL1;CCNB1;ANKRA2;SLC22A18;CKB;DET1;CLU;TRAF2;BRCA1;UBE2K;PATZ1;SPOPL;RNF8;PSMD1;UBE2B;TRAF6;CDKN1A;TRAF5;GLMN;RB1;SMAD7;RNF20;TRAF4;BAG5;RALB;SPOP
prerank,Hsp90 protein binding (GO:0051879),0.39635651995178983,0.9743998718812207,0.5013192612137203,0.8688314733250985,1.0,7/33,16.31%,SLC12A2;TELO2;HDAC8;CHORDC1;UNC45A;NR3C1;PPP5C
prerank,hydro-lyase activity (GO:0016836),0.3782918860882626,0.9721157246456027,0.5032938076416338,0.871411351208115,1.0,8/41,11.33%,EHHADH;UROC1;CYP2S1;GMDS;AUH;ECHDC1;UROS;ACO2
prerank,alpha-actinin binding (GO:0051393),0.41157396073512964,0.972103423613232,0.5118881118881119,0.8686170370290944,1.0,3/24,4.07%,CACNA1C;PDLIM7;RARA
prerank,protein kinase activator activity (GO:0030295),0.36153409442985984,0.9718676125593164,0.5132530120481927,0.86634644272787,1.0,21/60,24.27%,WNK1;WNT11;ABI1;FGF13;FAM20A;STRADA;DUSP19;CAB39;MARK2;MLST8;CDKN1A;IQGAP1;STK3;NCKAP1L;MAP2K2;IGF2;SPDYA;TAOK1;CALM2;MTCP1;PAK2
prerank,potassium channel regulator activity (GO:0015459),0.3680670462531785,0.97151911878665,0.5080745341614907,0.8643789510483975,1.0,5/49,3.07%,KCNMB3;KCNMB2;WNK1;ADRB2;KCNS3
prerank,cholesterol transfer activity (GO:0120020),-0.37215261561320107,-0.971429394917449,0.4884488448844885,0.7386843693421846,1.0,3/16,10.96%,PLTP;ABCG1;GRAMD1B
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.3777312919149684,-0.971370352779826,0.48214285714285715,0.732339675380364,1.0,4/15,16.91%,PIK3R1;PIK3R6;PIK3R5;SOCS5
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.39242865376153113,0.9706894448848248,0.5195822454308094,0.8635745338126805,1.0,13/32,24.36%,EGLN3;TMLHE;ALKBH4;TYW5;JMJD4;FTO;KDM2A;RIOX2;HIF1AN;PHYHD1;PHF8;ALKBH1;HSPBAP1
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.30637572724850043,-0.9698010361311081,0.4743083003952569,0.7294665582115399,1.0,8/28,12.82%,PRKAA2;PAK3;SGK1;MAP2K6;RPS6KA1;TNK2;MAP2K1;MAPK10
prerank,1-phosphatidylinositol binding (GO:0005545),-0.3701925702032902,-0.969439855150294,0.4849315068493151,0.7239740494870247,1.0,3/15,6.04%,EPB41;PICALM;SNAP91
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.47525540985686854,0.9688531441116575,0.4891640866873065,0.864864595617469,1.0,4/10,18.07%,DSP;DSG2;JUP;CXADR
prerank,solute:proton symporter activity (GO:0015295),0.4497875593221597,0.9685373922124759,0.5116618075801749,0.8628154245906752,1.0,1/16,1.45%,SLC2A13
prerank,phosphatase inhibitor activity (GO:0019212),0.4186154735887103,0.9680066283737598,0.5130057803468208,0.8613293651270703,1.0,9/20,23.24%,STYXL1;URI1;MGAT5;PTN;ARPP19;LGALS3;CABIN1;BOD1L1;STYX
prerank,cytokine receptor activity (GO:0004896),0.3374626541143916,0.9675918552444213,0.5091743119266054,0.8595164559198235,1.0,8/83,7.90%,F3;IL22RA1;CMKLR1;IL20RB;IL17RE;IL17RA;CD44;IL17RD
prerank,ubiquitin-protein transferase activity (GO:0004842),0.3179158924923885,0.9629976932845927,0.5961732124874118,0.8673664911987813,1.0,85/346,20.07%,WWP1;NEDD4;RNF144A;MKRN3;FBXO10;CBLC;SH3RF3;WWP2;RNF126;TRIM55;TRAF3IP2;RNF114;HERC2;UBR5;FANCL;RNFT2;TRIM47;UBE2A;RNF115;BARD1;TRIM39;RNF214;TSPAN17;RNF185;ARIH1;CUL3;CUL1;ANAPC11;ANKIB1;FBXW8;DTX2;UBR4;BCOR;FBXO27;NSMCE1;UBE3C;TRIM44;TRIM41;RNF138;RNF130;RNF146;TRAF2;BRCA1;UBE2K;RNF123;UBE2M;UBR3;TRIP12;COP1;MIB1;RNF122;RNF8;RNF41;SEL1L;UBE2B;KCMF1;NHLRC1;UBE2D3;MKRN2;RNF111;TRAF6;RNF141;UBE2O;TRAF5;RNF11;FBXO17;CNOT4;TMEM129;RNF20;AREL1;RNF14;UBE2S;DTL;RBCK1;SMURF1;MYCBP2;CHFR;RMND5A;TRIM35;NFX1;FBXL6;LRSAM1;TRAF7;UBE2Z;BRAP
prerank,nucleotide diphosphatase activity (GO:0004551),0.44896093408520976,0.9602906602804521,0.5152439024390244,0.8707816120733196,1.0,3/14,8.85%,FHIT;NUDT17;NUDT12
prerank,glycine binding (GO:0016594),-0.40454639206622744,-0.9600331098012308,0.4943181818181818,0.7380576574903672,1.0,4/11,10.12%,GRIN2B;GRIN1;GLRA3;GLRA1
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.3654104547084184,0.9590935882664879,0.5317848410757946,0.8705633206111402,1.0,7/55,7.28%,SLC24A3;PKD1;ATP2C2;ANXA2;TRPM7;ATP2B4;SEC61A1
prerank,snRNA binding (GO:0017069),0.3684995785453125,0.9547074964262277,0.5336721728081322,0.8776737420756805,1.0,14/42,23.25%,LSM11;SNRNP35;DDX21;CCNT2;SNRNP70;LSM8;PRPF8;RNPC3;GEMIN5;HEXIM1;CCNT1;SF3B3;LSM4;LARP7
prerank,phosphatidylglycerol binding (GO:1901611),0.4533727739788002,0.9542783281602562,0.5236593059936908,0.8758800019800429,1.0,2/13,3.78%,PITPNC1;PITPNA
prerank,metalloaminopeptidase activity (GO:0070006),0.44386755654939675,0.9541954450262677,0.5442477876106194,0.8733957610175863,1.0,4/16,8.49%,XPNPEP3;XPNPEP1;NPEPPS;MMP16
prerank,exopeptidase activity (GO:0008238),-0.2767152903910627,-0.9531620796872922,0.5157894736842106,0.7468162801878012,1.0,13/50,12.38%,DPP10;DPP4;CTSH;ACE;MME;CTSA;LTA4H;PRCP;ENPEP;DPP6;ACE2;ZMPSTE24;RNPEP
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.3833663237903209,-0.9524718221723671,0.5429447852760736,0.7419402281129711,1.0,8/13,14.14%,GABRG3;GABRA2;GLRA3;GLRA1;GABRG1;GABRA5;GABRA1;GABRG2
prerank,ATPase regulator activity (GO:0060590),0.37399130896256333,0.9510089845720309,0.5294117647058824,0.8779244702860101,1.0,13/38,22.61%,ATP1B1;KATNB1;BAG3;DNAJC1;DNAJA2;FXYD2;BAG5;ATP5IF1;BAG2;TOR1AIP1;DNAJB2;HSPH1;GRPEL2
prerank,P-type ion transporter activity (GO:0015662),0.4642298710414301,0.9456841161442255,0.5605095541401274,0.8866249706258728,1.0,2/12,5.90%,ATP2C2;ATP2B4
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.43202089337679594,0.9446180206238586,0.5263157894736842,0.8863208328611475,1.0,3/15,3.66%,HS3ST4;HS6ST2;HS3ST1
prerank,fatty acid synthase activity (GO:0004312),-0.4035031304398945,-0.9445365553420713,0.5444444444444444,0.7535304767652384,1.0,6/10,29.63%,ELOVL7;ELOVL6;CBR4;ELOVL4;OXSM;ELOVL1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.4438785539760944,0.9442551686691688,0.5410071942446043,0.8843065613579518,1.0,3/15,17.23%,KMT2C;WDR82;KMT2D
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.4313756209146118,0.9440177454560642,0.5385779122541604,0.8821562939990124,1.0,2/15,10.45%,PLCZ1;PLEKHF1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.4618271651191147,0.9432797532627482,0.5364667747163695,0.8809878388180686,1.0,6/11,26.52%,APEX2;APEX1;NEIL3;APLF;ALKBH1;NEIL1
prerank,ligand-gated cation channel activity (GO:0099094),0.3377420157191693,0.943161838610024,0.5465909090909091,0.8786098016587356,1.0,4/75,3.63%,KCNJ2;KCNJ15;PTK2B;GRIK4
prerank,sterol transfer activity (GO:0120015),-0.3519332972568666,-0.9426307762297995,0.5324675324675324,0.7515374294877231,1.0,3/17,10.96%,PLTP;ABCG1;GRAMD1B
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.465602505950775,0.9414667698368023,0.5370370370370371,0.879697521283296,1.0,4/11,17.13%,SGMS2;DPAGT1;PIGO;GNPTAB
prerank,acetylcholine receptor activity (GO:0015464),-0.32551610823243843,-0.9369084229016118,0.5538461538461539,0.7579320715889867,1.0,13/22,43.85%,CHRM2;CHRM3;ANXA9;CHRNA4;CHRM1;CHRNB2;CHRM5;CHRNA5;CHRNA3;CHRNE;CHRNB4;CHRNB3;HRH4
prerank,steroid hydroxylase activity (GO:0008395),0.4340418620079034,0.93642163193951,0.555886736214605,0.8879193706303442,1.0,2/16,4.90%,CYP1B1;CYP2S1
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.36650117404224813,0.9348072992420983,0.556687898089172,0.8887923668480676,1.0,11/40,19.65%,PCMT1;NNMT;PRMT8;DNMT3A;RRP8;METTL2A;METTL2B;LRTOMT;TARBP1;TPMT;ASMT
prerank,semaphorin receptor binding (GO:0030215),-0.32021868446056645,-0.9339211684101452,0.5329153605015674,0.7579669399590798,1.0,13/23,20.81%,SEMA6A;SEMA7A;RIT2;SEMA6D;SEMA3B;SEMA5A;SEMA3G;SEMA5B;SEMA6B;SEMA4G;SEMA3A;SEMA3F;SEMA4D
prerank,pyrophosphatase activity (GO:0016462),0.35689325399191774,0.9331017350667044,0.5709090909090909,0.8897406881474241,1.0,15/50,22.62%,ALPL;ENTPD6;NUDT5;ENTPD2;ENTPD5;NUDT15;ENTPD7;NUDT1;DHX9;FITM2;LHPP;RNGTT;NUDT4;PLPP1;TRPM2
prerank,DNA replication origin binding (GO:0003688),0.4085406697415843,0.932492342511544,0.5650349650349651,0.8884129851714881,1.0,7/23,18.46%,CDC45;MCM2;ORC3;DDX11;MCM7;MCM9;DHX9
prerank,GTPase activity (GO:0003924),0.3095306499663891,0.9313592429342977,0.616580310880829,0.8881649331583149,1.0,32/192,16.15%,RHOJ;RHOBTB1;GNAS;ATL3;NRAS;KRAS;ARHGDIB;ATL2;MRAS;RRAGB;RAB43;RAB6A;RAB24;GNG8;BMS1;RHOQ;RND3;GSPT1;RAB35;RHOA;RAP1A;GPN1;ENTPD7;DRG1;RAB21;RAP2C;GNA13;RAB11B;ATL1;RHEB;RAB28;RAB1A
prerank,peptidase inhibitor activity (GO:0030414),0.379566522689531,0.9296086207168425,0.5507246376811594,0.8893523219982632,1.0,5/33,7.88%,GPC3;TIMP1;CAST;RENBP;TIMP2
prerank,hexosaminidase activity (GO:0015929),0.44192581834983113,0.9258664022097473,0.5579598145285936,0.8943718212370935,1.0,2/12,3.41%,SPAM1;HEXA
prerank,bHLH transcription factor binding (GO:0043425),0.4140270742891553,0.9232549302381609,0.6054131054131054,0.8973195969576134,1.0,4/19,8.63%,TWIST1;BHLHE40;CREBBP;KDM1A
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.38914156304264913,0.921300083162683,0.578167115902965,0.8987282811410332,1.0,9/27,17.58%,RNF144A;DCUN1D5;ZMYM2;ARIH1;ANKIB1;DCUN1D2;TRAF6;DCUN1D1;RNF14
prerank,tRNA methyltransferase activity (GO:0008175),0.4232620514331806,0.9207893882066034,0.5570776255707762,0.8971669549922048,1.0,8/16,28.89%,ALKBH8;METTL2A;METTL2B;TARBP1;TRDMT1;FTSJ1;TRMT44;THUMPD2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.3911207966575161,-0.9203404412156736,0.585635359116022,0.78108513247805,1.0,4/10,10.30%,APOBEC1;ADARB2;LACC1;GDA
prerank,sequence-specific mRNA binding (GO:1990825),0.4585059512116384,0.9192662795535581,0.5774647887323944,0.8978749611113009,1.0,4/10,22.06%,ETF1;SSB;DHX9;FMR1
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.458229292162519,0.919114414388353,0.5825242718446602,0.8929645935689725,1.0,6/10,32.17%,DUSP5;DUSP7;DUSP10;DUSP16;DUSP4;DUSP1
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.458229292162519,0.919114414388353,0.5825242718446602,0.8929645935689725,1.0,6/10,32.17%,DUSP5;DUSP7;DUSP10;DUSP16;DUSP4;DUSP1
prerank,amyloid-beta binding (GO:0001540),0.33004878729632825,0.9184138096272314,0.5983510011778563,0.89181300042003,1.0,12/79,13.58%,COL25A1;ADRB2;LDLR;ITM2C;LRP1;TLR4;ATP1A3;NLGN1;EPHB2;CLU;APBB3;SORL1
prerank,lipoprotein particle receptor binding (GO:0070325),-0.3041652526788381,-0.9169265764791725,0.6020761245674741,0.7827592033796017,1.0,4/27,6.77%,APOE;PICALM;SYT1;HSPG2
prerank,ribonuclease activity (GO:0004540),0.3440241970472407,0.9140037911683239,0.6044226044226044,0.8983632014778921,1.0,22/56,30.07%,SMG6;AGO2;ZC3H12C;ZC3H12A;EXOSC3;RNASE3;RNASEH2A;ZC3H12B;EXOSC1;CPSF3;ERN2;EXOG;EXOSC2;YBEY;EXOSC7;EXOSC8;DICER1;RNASE12;AGO1;SND1;TSNAX;PIWIL2
prerank,chloride channel regulator activity (GO:0017081),0.43044877372776863,0.9125285623716726,0.5674846625766872,0.8987504013585362,1.0,4/14,21.86%,WNK1;SGK3;VTI1B;STX8
prerank,voltage-gated chloride channel activity (GO:0005247),0.44682038480713626,0.9125233655629658,0.5920634920634921,0.8961707588004436,1.0,2/10,8.61%,ANO6;CLCN5
prerank,signaling receptor complex adaptor activity (GO:0030159),0.36400762727135716,0.9120869299234751,0.5982028241335045,0.8944865095214142,1.0,11/38,17.95%,GAB2;IRS1;G3BP2;SHC1;NCK2;SHANK1;TRAT1;NCK1;DLG5;LRRK2;LAT
prerank,N-acetyltransferase activity (GO:0008080),0.40255424219925123,0.9116774496874152,0.5812220566318927,0.8927616232399221,1.0,8/19,29.87%,NAT1;ESCO1;NAT10;ATAT1;NAA80;KAT2B;NAA50;SMARCE1
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.25044617042910855,-0.9095562921661773,0.6871165644171779,0.7919360864442337,1.0,23/57,28.61%,NDUFB9;NDUFA4;UQCRH;NDUFA13;COX4I1;COX5B;NDUFC1;NDUFV3;UQCR10;UQCRC1;CYB561A3;NDUFA7;NDUFA4L2;COX6B1;NDUFB6;NDUFB8;NDUFA3;COX4I2;CYB561D2;NDUFA1;UQCRQ;NDUFB10;NDUFA2
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.4103028349329633,0.9095298348507417,0.5751533742331288,0.8944575435802463,1.0,1/15,2.28%,CMKLR1
prerank,hormone receptor binding (GO:0051427),0.42928297642207486,0.9094472429566257,0.5632530120481928,0.8920987353621931,1.0,5/14,27.99%,PTHLH;NCOA6;JAK2;CCK;SOCS2
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.37828485417756996,0.9058391905884846,0.5951704545454546,0.8969235440014051,1.0,7/25,15.86%,GAB2;PLEKHA4;KIF16B;ZFYVE1;COMMD1;ANXA8;FCHSD2
prerank,CXCR chemokine receptor binding (GO:0045236),0.4284074738605257,0.9050796439510014,0.5591054313099042,0.8960706664953249,1.0,2/11,11.96%,CXCL2;YARS1
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.4504821895189294,0.9046361726797832,0.5950920245398773,0.8945055273948646,1.0,2/10,9.82%,PIK3C2B;PIK3R3
prerank,mRNA binding (GO:0003729),0.2981908218999725,0.9021566474090752,0.7065439672801636,0.8970476517463954,1.0,70/249,22.06%,DDX5;RBFOX2;SAMD4A;YBX3;EIF4G3;CELF3;LUC7L2;RBM14;HDLBP;G3BP2;THOC2;AUH;SRSF5;AGO2;SRSF6;TDRD7;SRRM2;DAZAP1;ZC3H12C;ZC3H12A;EIF4G2;SCAF8;PABPC1;EIF3A;DHX36;ANGEL2;ETF1;RBM47;CELF4;FYTTD1;RBM25;CELF1;SNRNP35;RBMX;DCP1A;SRBD1;KHDRBS1;SRSF1;ZC3H12B;HNRNPM;SNRNP70;CIRBP;RNPS1;CCT5;RBMS3;SSB;RNF20;PABPC4;LARP4;PCBP4;HNRNPA2B1;DHX9;PUM2;EIF2S2;SERBP1;SYNCRIP;IGF2BP3;CSTF3;EIF4G1;GEMIN5;IREB2;LARP4B;SLPI;PUM3;SAMD4B;LUC7L3;PUM1;PKM;FMR1;TARDBP
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.44334614304217296,0.9020873642858195,0.5816164817749604,0.8947001319799172,1.0,6/11,29.31%,PRMT8;PRMT5;PRMT6;NDUFAF7;FBXO11;CARM1
prerank,protein kinase C activity (GO:0004697),0.4267457277618565,0.9009398305553132,0.5705705705705706,0.8942560994945211,1.0,3/14,4.13%,PRKCD;PRKCE;CCL3
prerank,transcription coactivator binding (GO:0001223),0.3993901741373423,0.9005912541889813,0.6116071428571429,0.8924482705286201,1.0,6/20,19.08%,CIT;ESR1;RORA;CCNT2;SMAD4;MED25
prerank,voltage-gated anion channel activity (GO:0008308),0.4098580410523929,0.9002642113310276,0.5978755690440061,0.89053550826338,1.0,2/15,8.61%,ANO6;CLCN5
prerank,mannosyltransferase activity (GO:0000030),0.39464523969531856,0.8941757766791448,0.5857142857142857,0.900119238053296,1.0,9/21,24.43%,TMTC1;DPY19L3;ALG12;TMTC3;DPM1;ALG8;POMT2;POMT1;PIGB
prerank,histone demethylase activity (GO:0032452),0.3670604462045908,0.8925719412885745,0.6042496679946879,0.9007142259356048,1.0,11/27,25.37%,JMJD1C;KDM1A;HR;KDM5B;KDM3B;KDM2A;RIOX2;PHF8;JMJD6;KDM3A;KDM4D
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.3941887095178146,0.8898429096187109,0.6086330935251798,0.9036605843628537,1.0,6/20,19.11%,PLA2G15;PNPLA3;LPCAT1;MOGAT1;LPCAT2;AGPAT2
prerank,SH2 domain binding (GO:0042169),0.36206316869851435,0.8890091532459047,0.6020942408376964,0.9028495860313611,1.0,10/31,19.42%,IRS1;ABL1;RUFY1;ARHGAP5;NLK;INPPL1;KHDRBS1;LCK;JAK2;AFAP1
prerank,nucleoside-triphosphatase activity (GO:0017111),0.29387194939656897,0.888706311426133,0.7282051282051282,0.9010422609147035,1.0,47/248,18.46%,RHOJ;RHOBTB1;GNAS;ATL3;NRAS;KRAS;ARHGDIB;ATL2;MRAS;RRAGB;RAB43;RAB6A;VWA8;RAB24;GNG8;ABCD1;BMS1;RHOQ;CHD3;CHD1L;RND3;VCP;GSPT1;RAB35;RHOA;RAP1A;GPN1;ENTPD7;CLU;DRG1;KIF1C;RAB21;RAP2C;TOR1B;GNA13;RAB11B;ATL1;RHEB;KLC1;RAB28;RAB1A;PIN1;RAB5B;LRRK2;MYO1E;RALB;DHX9
prerank,AMP binding (GO:0016208),0.4482974831566081,0.8882263987741039,0.6235864297253635,0.899536023606502,1.0,2/11,10.28%,MPPED2;PFKP
prerank,GDP binding (GO:0019003),0.334768331414402,0.8881438494350582,0.6275449101796408,0.8972372298683009,1.0,15/63,19.41%,NRAS;KRAS;MRAS;RAB35;MIEF1;ARL3;RAP1A;RAB21;RAP2C;RAB11B;RHEB;RAB28;RAB5B;RALB;RAP2B
prerank,calcium:sodium antiporter activity (GO:0005432),0.43829375768491813,0.887056556818991,0.6107784431137725,0.8968039930602153,1.0,1/10,0.76%,SLC24A3
prerank,endopeptidase regulator activity (GO:0061135),-0.26044893861995716,-0.8868979529057182,0.6757990867579908,0.8329872314542457,1.0,15/40,26.00%,PROS1;CST3;ITIH2;SERPIND1;TFPI;A2M;APH1B;ABCA2;UCHL5;PSME2;ITIH3;VSIR;HRG;NLRC4;AHSG
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.4247790051915921,0.8865712785600987,0.6071964017991005,0.895245770979482,1.0,6/13,27.41%,ARHGDIB;ITGB1BP1;GDI2;GPSM1;GPSM2;GDI1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.3734515004486049,0.8858953899203,0.6206896551724138,0.894163026101271,1.0,3/24,5.36%,CAMK2D;PTK2B;PHKA2
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.34279339128808295,0.8846751786282715,0.6571428571428571,0.8941236984594729,1.0,12/44,18.46%,KMT2C;SETD2;EHMT1;EED;WDR82;NSD1;KMT5B;KMT5A;SMYD3;KMT2D;ASH1L;KMT2E
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.35632612858371104,0.8820759010082533,0.6246851385390428,0.8965352569781332,1.0,13/34,25.90%,ERI3;CNOT8;ANGEL2;EXOSC3;REXO2;ERI1;DIS3;EXOSC2;EXOSC7;CNOT1;PAN3;ANGEL1;PARN
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.3599255417772771,0.8808687282319395,0.6256544502617801,0.8963732623026306,1.0,10/33,17.58%,RNF144A;DCUN1D5;ZMYM2;RNF185;ARIH1;ANKIB1;DCUN1D2;TRAF6;DCUN1D1;RNF14
prerank,peptidase activator activity (GO:0016504),0.38007702353953354,0.8800406545957716,0.6395511921458625,0.8954872267449258,1.0,3/22,9.11%,TANK;ADRM1;VCP
prerank,tRNA binding (GO:0000049),0.3419432103613646,0.8778833347529406,0.6426767676767676,0.8970176699326233,1.0,16/43,27.32%,TRMT10A;MRPS27;ALKBH8;TYW5;RPUSD4;NAT10;ELP5;PSTK;SSB;PTCD1;ALKBH1;YARS2;CARS1;DALRD3;TRNAU1AP;FARS2
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.404233667489643,0.8776140392331501,0.6143497757847534,0.895171397044238,1.0,5/15,25.44%,PNPLA3;LPCAT1;LPCAT2;AGPAT2;LCLAT1
prerank,poly(U) RNA binding (GO:0008266),0.38368363695295804,0.8771818982749148,0.637660485021398,0.8936450815692798,1.0,12/20,26.69%,DAZAP1;PABPC1;HNRNPH1;KHDRBS1;RBMS3;SSB;PABPC4;FMR1;RBM11;PABPC1L;PATL1;MCRS1
prerank,phosphatidylcholine transporter activity (GO:0008525),0.39380925912624587,0.8770346671777389,0.6203288490284006,0.8915765957539467,1.0,5/17,15.78%,PITPNC1;PITPNA;ABCA7;ATP10A;PCTP
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.36490902913986145,-0.8764128750026773,0.6395663956639567,0.8482126018406759,1.0,4/11,28.11%,HCN1;HCN2;CNGB3;AQP1
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.43195604895909845,0.8747349155794018,0.6282245827010622,0.8934397644294835,1.0,3/10,17.87%,DESI2;OTUD5;OTUD4
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.2947514389640405,0.8744824330874448,0.720510095642933,0.8916060027258421,1.0,21/147,11.72%,ARHGEF28;PLCE1;DOCK5;CYTH3;VAV2;AKAP13;HPS4;RANGRF;HERC2;DNMBP;BCR;WDR41;TIAM1;RASGEF1B;FARP1;RGP1;SERGEF;DENND4A;RAP1A;SBF1;FGD1
prerank,Toll-like receptor binding (GO:0035325),0.4246573235445119,0.8723481775968436,0.6398104265402843,0.8929975959721878,1.0,3/11,13.32%,TLR1;MYD88;TIRAP
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.31158494704832923,0.8722909821307872,0.6655011655011654,0.8907709699011511,1.0,13/74,12.48%,PIK3C2B;PAPSS2;RFK;CHKB;FAM20A;NADK;DGKA;ETNK1;HYKK;PI4KB;GALK2;ADPGK;AGK
prerank,ATPase activator activity (GO:0001671),0.3817547431034255,0.8720697771768886,0.6008403361344538,0.8888207479661249,1.0,6/20,20.86%,ATP1B1;DNAJC1;DNAJA2;FXYD2;TOR1AIP1;DNAJB2
prerank,3'-5' DNA helicase activity (GO:0043138),0.4000107110851429,0.8696208183525145,0.6631736526946108,0.8910548799981929,1.0,5/16,18.46%,MCM2;WRN;MCM7;RECQL5;DHX9
prerank,galactosyltransferase activity (GO:0008378),0.41835037921130125,0.8673644349117999,0.632,0.8927559789246003,1.0,3/11,15.85%,B4GALT1;B3GALT6;A3GALT2
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.4083303798801904,0.8666993655173861,0.6261682242990654,0.891609290240652,1.0,6/13,30.55%,TRMT10A;TARBP1;TRMT11;FTSJ1;THUMPD2;WDR4
prerank,signal sequence binding (GO:0005048),0.3459109483451966,0.862669730066386,0.6429495472186287,0.8965275372309265,1.0,17/35,28.29%,SEC61A1;NUP214;NUP153;TNPO2;KPNA1;KPNA2;KPNA4;AP2B1;KDELR2;CAT;BRAP;KDELR3;IPO4;KCNIP2;TOMM20;POM121;IPO5
prerank,titin binding (GO:0031432),0.40678690388165034,0.8626039393191437,0.6466973886328725,0.8943635835597876,1.0,1/13,1.67%,CAMK2D
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.3856709167732575,0.8592465286264118,0.6375545851528385,0.8979007768316322,1.0,4/18,12.95%,SERPINB9;PRDX5;RPS6KA3;DPEP1
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.33099313278236225,-0.8570273051007452,0.6465256797583081,0.8813279813616651,1.0,3/15,10.41%,P2RY14;P2RY1;P2RX7
prerank,guanyl ribonucleotide binding (GO:0032561),0.28479360204665516,0.8569901664394052,0.7731529656607701,0.8994669940334501,1.0,31/196,16.10%,RHOJ;RHOBTB1;ATL3;MPPED2;NRAS;KRAS;PDE5A;ATL2;MRAS;RRAGB;RAB6A;ARFIP2;BMS1;RHOQ;NOA1;RND3;RAB35;MIEF1;ARL3;RHOA;RAP1A;ARF4;NMUR2;DRG1;RAB21;RAP2C;RAB11B;ATL1;RHEB;TUBE1;RAB28
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.3437347166098351,0.8532056889760522,0.6621803499327052,0.9035923288149922,1.0,5/35,5.73%,PTK2B;SRMS;CLK1;ABL1;FRK
prerank,DNA secondary structure binding (GO:0000217),0.3502932470606166,0.8523922069883428,0.6662234042553191,0.9028051160038544,1.0,5/31,9.60%,ABL1;ERCC5;WRN;NEIL3;CLSPN
prerank,rRNA binding (GO:0019843),-0.2509653511770449,-0.8522404832069758,0.7836538461538461,0.8840397381737152,1.0,7/42,10.65%,RPS13;RPS9;RPS3;RPS14;RPL11;RPS5;UTP23
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.3510626257723468,0.8518386689251437,0.6554054054054054,0.9014847658710466,1.0,7/29,16.26%,CIT;SPRED2;CDKN2C;CIB1;CDKN1B;PKIG;CDKN1A
prerank,5'-3' exonuclease activity (GO:0008409),0.3967419592347374,0.8507243134286455,0.661993769470405,0.901177019057488,1.0,5/14,27.80%,EXO1;CPSF3;EXOG;DCLRE1A;DXO
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.3882068369317893,0.849740340783673,0.6536231884057971,0.9006586327783525,1.0,4/17,19.70%,AK4;AK3;AK1;CLP1
prerank,dynactin binding (GO:0034452),0.4058734711467413,0.8468978246327309,0.6557911908646004,0.9032237200582681,1.0,4/12,14.35%,GSK3B;PAFAH1B1;HOOK3;BICD1
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.2945252838573915,-0.8466486753740307,0.6524822695035462,0.8883754785388843,1.0,8/22,21.42%,CPEB2;CPEB3;ELAVL4;HNRNPA0;EXOSC9;ZFP36;RBM24;ZFP36L1
prerank,GTP binding (GO:0005525),0.2824761775608025,0.8456445042513991,0.7757894736842105,0.9030155730956038,1.0,28/172,16.10%,RHOJ;RHOBTB1;ATL3;NRAS;KRAS;ATL2;MRAS;RRAGB;RAB6A;ARFIP2;BMS1;RHOQ;NOA1;RND3;RAB35;ARL3;RHOA;RAP1A;ARF4;NMUR2;DRG1;RAB21;RAP2C;RAB11B;ATL1;RHEB;TUBE1;RAB28
prerank,insulin-like growth factor receptor binding (GO:0005159),0.4076075643792566,0.8448870699943033,0.6592356687898089,0.9020986781733031,1.0,3/12,5.33%,GNAS;IRS1;SHC1
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.4025712775981465,0.8419345597657087,0.6572769953051644,0.9046668045614615,1.0,2/11,12.06%,RDH12;DHRS13
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.3427245282376968,-0.8418199045648426,0.6685393258426966,0.8908761727108137,1.0,5/12,19.16%,STAT1;TBPL1;H3-3A;GTF2A1;TAF1
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.3035912757264824,0.8394080903365291,0.7050970873786407,0.9066555421672444,1.0,18/60,22.26%,PPP3CA;PPM1H;PHLPP2;PPP1R3C;CDC14A;CTDSPL2;PPTC7;ILKAP;CDKN3;UBLCP1;SSU72;PPP5C;LCK;LRRK2;PPM1L;PPP1CC;PPEF1;PPP6C
prerank,G protein-coupled peptide receptor activity (GO:0008528),-0.22573017117616623,-0.8391087072011127,0.8231292517006803,0.8894528112677591,1.0,10/73,12.08%,LGR4;SORCS3;NPR1;CALCRL;BDKRB2;LGR5;HCRTR2;CYSLTR2;SORCS1;CYSLTR1
prerank,voltage-gated sodium channel activity (GO:0005248),-0.29598966355614187,-0.8383509740006964,0.7012987012987013,0.884206757401886,1.0,11/22,22.14%,SCN7A;HCN1;SCN1A;SCN9A;HCN2;SCN3A;SCN2B;SCN2A;CACNA1I;SCN5A;CACNA1H
prerank,serotonin receptor activity (GO:0099589),-0.29174480158926586,-0.8340853056217664,0.7077922077922078,0.8727341206736298,1.0,10/22,34.47%,HTR2C;CHRM2;CHRM3;HTR2A;HTR1F;CHRM1;HRH1;HTR1A;CHRM5;HTR1D
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.29174480158926586,-0.8340853056217664,0.7077922077922078,0.8727341206736298,1.0,10/22,34.47%,HTR2C;CHRM2;CHRM3;HTR2A;HTR1F;CHRM1;HRH1;HTR1A;CHRM5;HTR1D
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.29174480158926586,-0.8340853056217664,0.7077922077922078,0.8727341206736298,1.0,10/22,34.47%,HTR2C;CHRM2;CHRM3;HTR2A;HTR1F;CHRM1;HRH1;HTR1A;CHRM5;HTR1D
prerank,MHC class II protein complex binding (GO:0023026),0.40563196460252654,0.8331091303949502,0.6549079754601227,0.9152895388276385,1.0,1/11,1.98%,ATP1B1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.35885989017076053,0.832419315380974,0.6782729805013927,0.9141864921164001,1.0,3/22,7.52%,ATP2C2;TCIRG1;ATP6V0A4
prerank,vinculin binding (GO:0017166),0.4059517734534629,0.829711491406645,0.6779661016949152,0.916432090965353,1.0,2/11,5.31%,SORBS3;CTNNA1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.2714902094170712,-0.8284326558692211,0.7330960854092526,0.8767022644380887,1.0,4/26,7.63%,CHSY3;CSGALNACT1;CHSY1;B3GALT1
prerank,MAP kinase phosphatase activity (GO:0033549),0.4009071071895095,0.828189460411307,0.6888544891640866,0.9166072361604839,1.0,6/12,32.17%,DUSP5;DUSP7;DUSP10;DUSP16;DUSP4;DUSP1
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.3393311550405621,0.8270933919742591,0.7013157894736842,0.9162040774332431,1.0,10/30,21.06%,CAST;SERPINB9;PRDX5;RPS6KA3;DPEP1;CARD16;UBE2O;CST7;UBE2Z;BIRC6
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.3778090340068311,0.8243425476440921,0.6762048192771084,0.9162401807114282,1.0,2/16,3.59%,ANO9;ANO6
prerank,intracellular chloride channel activity (GO:0061778),0.3778090340068311,0.8243425476440921,0.6762048192771084,0.9162401807114282,1.0,2/16,3.59%,ANO9;ANO6
prerank,microtubule binding (GO:0008017),0.274903961865205,0.8240751507074002,0.8386108273748724,0.914402830694777,1.0,46/222,17.77%,EZR;FGF13;MAP7D3;MTUS1;MID1;CLIP4;NDRG1;KIF13A;KATNB1;FMN1;NDEL1;CLIP1;FAM161A;KIF16B;KIF1B;MACO1;PAFAH1B1;KIF9;KNSTRN;TOGARAM1;MAST2;KRIT1;HOOK3;MAP1B;HDGFL3;ARL3;EML6;GAS2L1;CHP1;KIF3B;TUBGCP6;KIF7;DRG1;KIF1C;MAP6;MAP1S;ABRAXAS2;KIF5B;RMDN3;CCDC66;TUBGCP2;CAMSAP3;CRIPT;POLB;CEP57L1;LRRK2
prerank,tumor necrosis factor receptor binding (GO:0005164),0.39540627547222174,0.8227180478283511,0.6858877086494689,0.9142518895470958,1.0,5/12,21.02%,TRAF2;TRAF6;TRAF5;TRAF4;TRAF3
prerank,phospholipase binding (GO:0043274),-0.3291589417300897,-0.8218102329844521,0.6931818181818182,0.8822154105321657,1.0,1/13,0.88%,ARHGAP6
prerank,NAD+ binding (GO:0070403),0.3990381397445556,0.8215320263822201,0.6911076443057722,0.9139376324434216,1.0,3/12,13.62%,SIRT6;CRYL1;SIRT3
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.2864813704017861,-0.8208897656868848,0.7395833333333334,0.8774721958789551,1.0,5/21,11.34%,AKAP6;RYR2;WASF3;AKAP1;KCNQ1
prerank,ionotropic glutamate receptor binding (GO:0035255),0.4072467644192315,0.8194790797587785,0.6998368678629691,0.9150423921946094,1.0,3/10,11.82%,GNAS;SHANK1;NSF
prerank,adenyl ribonucleotide binding (GO:0032559),0.26918864650886287,0.8162722982566967,0.8752535496957403,0.9179175107276812,1.0,32/291,10.80%,ME1;ABCD3;MAP3K5;MARK1;SMC4;WNK1;PRPS2;GCLC;N4BP2;MPPED2;TLK1;BMPR1A;TGFBR1;ABL1;IRAK3;ABCF1;RAD51;CDK11B;ABCD1;PPIP5K1;HSPA1L;NLK;MAST2;TOP1;PTPA;ATP1A3;ATP1A1;MIEF1;PFKP;DHX36;IDE;PDK3
prerank,proton transmembrane transporter activity (GO:0015078),-0.2434382546816062,-0.8125959827645015,0.8238095238095238,0.8863750176555939,1.0,8/39,14.21%,NDUFA4;UQCRH;COX4I1;CLCN3;COX5B;UQCR10;UQCRC1;SLC33A1
prerank,hyaluronic acid binding (GO:0005540),-0.3444272625664113,-0.8102164160315839,0.7007672634271099,0.884353192176596,1.0,2/10,5.23%,CEMIP;LAYN
prerank,heme binding (GO:0020037),0.3007742040030005,0.8097240441975134,0.7710280373831776,0.926406165988703,1.0,11/65,12.71%,CYP1B1;PTGIS;CYP2S1;PTGES2;DGCR8;RSAD1;COX15;TDO2;EIF2AK1;HMOX2;NR1D1
prerank,ankyrin binding (GO:0030506),-0.2925617255037332,-0.8087083848352914,0.740506329113924,0.8806314385674675,1.0,6/19,12.37%,CACNA1D;SLC8A1;FLNC;SPTB;SPTBN4;KCNQ2
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.3909060385166108,0.8084313025103498,0.6988727858293076,0.9262680461664372,1.0,4/11,19.23%,NAA15;NAA40;NAA80;NAA60
prerank,protein tyrosine kinase activator activity (GO:0030296),0.3558021971167744,0.8080758926989733,0.7113997113997114,0.9246020932583557,1.0,2/19,2.18%,ABI1;EFNA5
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.29327297229865457,0.8048342779109505,0.7652694610778443,0.9274489736786513,1.0,15/69,15.52%,SOAT1;ELP3;PLA2G15;CREBBP;ZDHHC2;HHAT;ZDHHC20;ZDHHC12;SOAT2;NAA15;ESCO1;ZDHHC15;ZDHHC13;MOGAT1;KAT6B
prerank,NADPH binding (GO:0070402),0.38234804113151044,0.8047572894814732,0.6828125,0.9253613586646234,1.0,4/13,18.62%,CBR3;DECR1;LBR;HMGCR
prerank,myosin V binding (GO:0031489),0.3790174917628612,0.8038907260041366,0.7047477744807121,0.9244744847259462,1.0,4/15,20.16%,RAB25;RAB6A;RAB11B;RAB11A
prerank,pentosyltransferase activity (GO:0016763),0.3162099847342302,0.8026543023183123,0.7289836888331243,0.9242092612251301,1.0,12/36,22.84%,LARGE1;SIRT6;PARP3;PARP1;UPP2;SIRT3;PARP6;PARP2;PARP4;LARGE2;UMPS;TNKS2
prerank,cAMP response element binding (GO:0035497),0.39480857466641883,0.8009922844307844,0.7209302325581395,0.9245661753787734,1.0,6/10,21.01%,NR4A3;ATF7;CREB3L1;E4F1;ATF2;CREB1
prerank,ephrin receptor binding (GO:0046875),0.3470057404339669,0.8008209037349321,0.7138728323699421,0.9226256815626813,1.0,3/21,5.33%,EFNA5;ABL1;SHC1
prerank,G protein-coupled receptor binding (GO:0001664),0.2744693076847696,0.8005635958631069,0.821505376344086,0.920851319549296,1.0,8/132,6.16%,WNT9A;LRP6;WNT11;GNAS;FZD1;FZD7;PROK2;MYOC
prerank,MHC protein binding (GO:0042287),-0.2884240477642802,-0.7996780490186142,0.7473684210526316,0.8892576946288473,1.0,9/20,20.56%,CD81;TAP2;ATP5F1A;ABCB9;CD74;ATP5F1B;TUBB4B;DERL1;TAPBP
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.26432626940256204,-0.7986984482684656,0.7542087542087542,0.8846357147316504,1.0,4/24,7.17%,ZDHHC14;ZDHHC1;ZDHHC17;ZDHHC9
prerank,LRR domain binding (GO:0030275),0.3744064747136242,0.7982557010413275,0.7140672782874617,0.9221946130109668,1.0,3/14,5.73%,ERC1;PAWR;MRTFA
prerank,MAP kinase kinase activity (GO:0004708),-0.3056886044048934,-0.7956647761979826,0.7576687116564417,0.8832888286307157,1.0,4/15,12.82%,PAK3;MAP2K6;MAP2K1;MAPK10
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.25779778317985524,0.7948872507826958,0.9259259259259259,0.9250422676287435,1.0,83/431,20.31%,ABCD3;RHOJ;MAP3K5;MARK1;SMC4;WNK1;PRPS2;RHOBTB1;N4BP2;ATL3;NRAS;KRAS;TLK1;BMPR1A;ATL2;MRAS;TGFBR1;ABL1;IRAK3;ABCF1;RRAGB;RAD51;RAB6A;ARFIP2;CDK11B;ABCD1;BMS1;RHOQ;PPIP5K1;NOA1;HSPA1L;RND3;NLK;MAST2;TOP1;PTPA;ATP1A3;ATP1A1;RAB35;PFKP;ARL3;RHOA;DHX36;IDE;PDK3;RAP1A;CARS2;ARF4;NMUR2;MARK2;DRG1;ACVR1;RAB21;RAP2C;RAB11B;ATL1;RHEB;TUBE1;RAB28;SMARCA5;P2RX5;PPP5C;SIK1;CHD8;ERN2;PSMA6;P2RX4;LRRK2;STK3;RALB;DHX9;SRR;DAPK1;PEX1;TLK2;RAP2B;EIF4G1;CLP1;ANXA6;CDC42BPA;NEK6;ADSS2;OLA1
prerank,alkali metal ion binding (GO:0031420),0.37760897683092925,0.7943219111524314,0.6864535768645358,0.923715443725332,1.0,4/13,12.82%,HDAC4;SLC34A2;ATP1A1;DRG1
prerank,ribosomal small subunit binding (GO:0043024),-0.3006898149063569,-0.7937255652001601,0.7484472049689441,0.880266771766039,1.0,5/17,16.30%,CPEB2;NPM1;DDX3X;NME1;PIM1
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.3226968509431892,0.7927854571554477,0.7422279792746114,0.923825581396213,1.0,9/33,21.10%,ERI3;CNOT8;ANGEL2;EXOSC3;REXO2;ERI1;DIS3;EXOSC2;EXOSC7
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.2532232865246103,-0.7924669015992385,0.8068181818181818,0.8764047692834657,1.0,8/30,15.46%,SLC30A10;SLC39A10;SLC39A8;SLC40A1;SLC30A1;SLC39A12;SLC39A1;SLC31A1
prerank,ribosomal large subunit binding (GO:0043023),0.3907292465178582,0.7904248011719113,0.7231726283048211,0.9251517492266161,1.0,6/11,25.13%,EIF6;RBM3;NMD3;MRRF;MALSU1;LTN1
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.3788322571204632,0.7903908542104086,0.7232142857142857,0.9230457876542969,1.0,2/12,9.82%,PIK3C2B;PIK3R3
prerank,thioesterase binding (GO:0031996),0.3960569773316817,0.7898263516980639,0.7297709923664122,0.921685334756943,1.0,5/11,21.02%,TRAF2;TRAF6;TRAF5;TRAF4;TRAF3
prerank,phosphatase activity (GO:0016791),0.2835420422245998,0.7892246367552452,0.7757225433526012,0.9204274691886324,1.0,11/73,12.75%,ALPL;PLPP3;PLPPR2;ACP3;ACP4;DUSP11;LPIN2;SBF1;DUSP28;DUSP5;OCRL
prerank,channel activity (GO:0015267),-0.23257054051233234,-0.7873824009037304,0.8263157894736842,0.8786518856346677,1.0,9/41,18.29%,BCL2;AQP11;TRPV2;PDPN;AQP4;KCNK3;TRPV4;SLC14A1;TRPA1
prerank,general transcription initiation factor binding (GO:0140296),0.3279145401757534,0.7872350718724875,0.7350543478260869,0.9211273783995887,1.0,9/25,23.63%,ESR1;PSMC1;GTF2A2;THAP7;TBP;TAF12;YEATS2;TAF13;GTF2B
prerank,cell-cell adhesion mediator activity (GO:0098632),0.3096717817204987,0.7870821545557416,0.7595419847328244,0.9192011391862603,1.0,6/42,8.63%,BAIAP2L1;ANXA2;KRT18;ANXA1;STXBP6;EMB
prerank,amino acid binding (GO:0016597),0.32254960378356234,0.7855971808773526,0.7554980595084088,0.9193103627145861,1.0,3/31,4.12%,GCLC;CASR;GLRB
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.2919773293399516,-0.785364094761346,0.7660256410256411,0.876077248038624,1.0,5/18,20.01%,PIK3R1;PIK3R6;PIK3R5;SOCS5;AGAP2
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.2382943908209525,-0.7837060542854,0.8516746411483254,0.8727513618723697,1.0,6/38,11.47%,SPOCK1;APP;SERPINI1;SERPIND1;TFPI;A2M
prerank,histone methyltransferase binding (GO:1990226),-0.3226384601304974,-0.7834045920270369,0.7622950819672131,0.8674205126576248,1.0,5/11,15.16%,CBX3;HSP90AB1;LCORL;WIZ;CTNNB1
prerank,anion transmembrane transporter activity (GO:0008509),0.3755858464288886,0.7804145306676047,0.7365079365079366,0.9248171638908724,1.0,2/12,4.18%,ABCG2;SLC4A2
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.38106912875221705,0.7783487015643133,0.7297297297297297,0.9256860946594305,1.0,2/11,13.09%,NUDT5;NUDT1
prerank,U6 snRNA binding (GO:0017070),0.3613286960566173,0.7775165037017318,0.7349768875192604,0.9247852491173407,1.0,8/14,35.88%,LSM8;PRPF8;LSM4;LARP7;METTL16;DDX39B;LSM2;LSM3
prerank,protein phosphatase activator activity (GO:0072542),-0.3093759938497507,-0.7755743939307381,0.7739938080495357,0.8730282698474683,1.0,4/13,15.30%,IGFBP3;CALM1;PPP2R5E;PPP2R5A
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.3306184910514917,0.7728594571566278,0.7471910112359551,0.9291098410122242,1.0,10/22,32.17%,DUSP19;SBF1;DUSP5;CDKN3;DUSP7;DUSP10;DUSP16;DUSP4;DUSP12;DUSP1
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.3645794917255156,0.7726906463039143,0.7388059701492538,0.9272508272583161,1.0,2/13,3.75%,EZR;GSK3B
prerank,methyltransferase activity (GO:0008168),0.2917475298369714,0.7696952851353829,0.7936117936117936,0.9292565887581345,1.0,8/46,15.93%,NNMT;PRMT8;EHMT1;EEF1AKMT4;PRMT5;RRP8;LRTOMT;TRMT11
prerank,growth factor receptor binding (GO:0070851),0.2666538268210962,0.7658826007993916,0.8635321100917431,0.9324126695992644,1.0,22/95,22.09%,PGF;FGF2;SNX2;CBLC;VEGFA;PDGFC;SHC1;AGR2;ATXN2;ARF4;ITGB3;CNTF;PLSCR1;EFEMP1;GLMN;ITGA5;JAK2;PIBF1;FER;EGF;ERAP1;IL27RA
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.3330295952878337,0.7620620967208391,0.7748538011695907,0.9356107523128071,1.0,4/20,8.44%,SLC39A14;SLC39A13;SLC39A11;SLC30A3
prerank,chemokine binding (GO:0019956),0.3076300391383684,0.7611828724482044,0.7710027100271003,0.934645834868738,1.0,5/30,16.87%,FGF2;ITGB1;ITGAV;ITGB3;CXCR5
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.3625503557896321,0.7608116911093857,0.7567567567567568,0.9330802829529319,1.0,3/12,21.90%,NQO1;CRYZL1;DHRS4
prerank,Tat protein binding (GO:0030957),-0.32025752502303456,-0.759831835241695,0.7673130193905817,0.8889970922258189,1.0,3/10,13.42%,ACTB;NPM1;GABARAPL1
prerank,phosphate ion binding (GO:0042301),0.37297638612423234,0.7569603566875999,0.7472698907956318,0.9360921106181446,1.0,1/10,2.82%,SLC34A2
prerank,microtubule minus-end binding (GO:0051011),0.35675329355084096,0.7520142203962069,0.7614533965244866,0.9406251483926112,1.0,6/13,27.90%,TUBGCP6;TUBGCP2;CAMSAP3;CEP290;TUBGCP5;TUBGCP3
prerank,receptor tyrosine kinase binding (GO:0030971),0.2803719944404423,0.7484470748517792,0.8446833930704899,0.9434209406045553,1.0,13/56,17.96%,GAB2;CBLC;IRS1;PTPN2;SHC1;ACP4;MAP3K7;TRAT1;ALKAL2;RNF41;NCK1;CPNE3;TOB1
prerank,carboxylic ester hydrolase activity (GO:0052689),0.2638530045651739,0.7481333033077373,0.851063829787234,0.9416992940079325,1.0,14/85,19.06%,MGLL;PLA2G4F;PLA2G15;LYPLA2;PAFAH1B2;PNPLA3;ABHD6;LYPLAL1;PAFAH1B3;PNPLA2;LCAT;CEL;DAGLB;PON2
prerank,UDP-galactosyltransferase activity (GO:0035250),0.36447035904316,0.7474837633942375,0.7637540453074434,0.940408027036851,1.0,3/10,15.85%,B4GALT1;B3GALT6;A3GALT2
prerank,ATP binding (GO:0005524),0.24611178750841675,0.7457923808500255,0.9298780487804879,0.9406735461965962,1.0,28/266,10.80%,ABCD3;MAP3K5;MARK1;SMC4;WNK1;PRPS2;N4BP2;TLK1;BMPR1A;TGFBR1;ABL1;IRAK3;ABCF1;RAD51;CDK11B;ABCD1;PPIP5K1;HSPA1L;NLK;MAST2;TOP1;PTPA;ATP1A3;ATP1A1;PFKP;DHX36;IDE;PDK3
prerank,lipase activator activity (GO:0060229),-0.32657347212012944,-0.7407542416810364,0.8027027027027027,0.9078785991005898,1.0,1/10,0.88%,ARHGAP6
prerank,mitogen-activated protein kinase binding (GO:0051019),0.3063689123561367,0.7399858271260419,0.8097222222222222,0.9462843061733085,1.0,13/29,28.98%,ABL1;ATF7;DUSP5;NFATC1;NBR1;TNIP1;MAPKAPK2;MAPKAPK5;PPM1D;DUSP7;DUSP10;DUSP16;DUSP4
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.26157722141137596,-0.7396946070691032,0.8803986710963455,0.9031788217817185,1.0,3/21,7.09%,KL;FGF1;FRS2
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.31624675432123456,0.7388812382248989,0.7727930535455861,0.9434776921168663,1.0,7/21,16.12%,CDK10;CDK12;CDK11B;CDK13;CDKL2;CDK7;CDK2
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.31624675432123456,0.7388812382248989,0.7727930535455861,0.9434776921168663,1.0,7/21,16.12%,CDK10;CDK12;CDK11B;CDK13;CDKL2;CDK7;CDK2
prerank,cytokine receptor binding (GO:0005126),0.2601847846414532,0.738185724647265,0.8617511520737328,0.9423315258392614,1.0,7/83,7.92%,PGF;VEGFA;CLCF1;USP15;SPRED2;KITLG;SMAD2
prerank,aminopeptidase activity (GO:0004177),0.3105041894173196,0.7375078329327495,0.7956403269754768,0.9410650485918906,1.0,4/26,8.49%,XPNPEP3;XPNPEP1;NPEPPS;MMP16
prerank,gamma-tubulin binding (GO:0043015),-0.2513600031929937,-0.7342703649668827,0.8528428093645485,0.9041491606733064,1.0,7/22,19.43%,PAK1;DIXDC1;CDK5RAP2;DDX3X;BRSK1;ARHGEF7;B9D2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.33748115353661345,0.7330410518771378,0.8224852071005917,0.9426516143797057,1.0,6/16,27.01%,TCIRG1;ATP6V0A4;ATP6V1A;ATP6V0D1;ATP6V0A2;ATP6V0B
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.33748115353661345,0.7330410518771378,0.8224852071005917,0.9426516143797057,1.0,6/16,27.01%,TCIRG1;ATP6V0A4;ATP6V1A;ATP6V0D1;ATP6V0A2;ATP6V0B
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.28875233501537123,-0.7303514174616508,0.8253012048192772,0.9030675385590857,1.0,8/14,37.27%,NOX1;NOX4;NCF2;NCF1;MICAL1;NOX3;NCF4;DUOX1
prerank,DNA polymerase binding (GO:0070182),0.32515682759503967,0.7272571419156835,0.8301886792452831,0.9478754793286993,1.0,4/18,17.11%,SMG6;RAD51;NAT10;POLG2
prerank,tau protein binding (GO:0048156),0.28668990617381035,0.7268894578274596,0.8463508322663252,0.9462735716586926,1.0,9/40,16.61%,MARK1;GSK3B;S100B;SMAD2;CLU;MARK2;MARK3;PPP5C;PIN1
prerank,tubulin binding (GO:0015631),0.2388328036320921,0.7267492976059788,0.9575757575757575,0.9444058558996143,1.0,56/296,17.77%,EZR;FGF13;NLRP5;MAP7D3;UNC5C;MTUS1;MID1;NDRG1;BCAS3;KIF13A;EMD;KATNB1;FMN1;NDEL1;CLIP1;FAM161A;KIF16B;KIF1B;SETD2;MACO1;PAFAH1B1;KIF9;TOGARAM1;MAST2;KRIT1;TTLL2;HOOK3;MAP1B;HDGFL3;ARL3;EML6;GAS2L1;CHP1;KIF3B;TUBGCP6;KIF7;BRCA1;DRG1;KIF1C;MAP6;MAP1S;AGBL5;RABGAP1;TRAPPC14;OFD1;ABRAXAS2;CCT5;KIF5B;RMDN3;CCDC66;TUBGCP2;CRIPT;POLB;CENPJ;CEP57L1;LRRK2
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.30911218249268957,-0.7197122645914584,0.8166666666666667,0.9096229831133784,1.0,1/10,2.66%,KDM7A
prerank,phospholipase activator activity (GO:0016004),-0.31670253337410725,-0.7180061389763688,0.8042328042328042,0.9057992607121305,1.0,1/10,0.88%,ARHGAP6
prerank,four-way junction DNA binding (GO:0000400),0.325328108926244,0.7177835779300327,0.8002936857562408,0.9532923417025047,1.0,2/17,7.50%,ABL1;WRN
prerank,syntaxin-1 binding (GO:0017075),0.2993492560789657,0.715091241682089,0.8285302593659942,0.9546071744786716,1.0,9/22,22.61%,UNC13B;NSF;VAMP2;STXBP1;LRRK2;DAPK1;STXBP5;CPLX2;PRRT2
prerank,chemokine receptor activity (GO:0004950),0.3032052996407761,0.7149720391839125,0.8189655172413793,0.9526887524893127,1.0,1/24,2.28%,CMKLR1
prerank,nuclear receptor coactivator activity (GO:0030374),0.2722449947559775,0.7148136781288729,0.8771084337349397,0.9508210818513217,1.0,11/52,15.51%,FGF2;DCAF6;RBM14;MED13;MED24;THRAP3;KDM1A;PPRC1;NCOA6;SRA1;SLC30A9
prerank,protein phosphatase regulator activity (GO:0019888),0.26978559193471946,0.7125143877228202,0.8814180929095354,0.9514124000209045,1.0,21/53,24.02%,SHOC2;STYXL1;PTPA;PPP2R5C;RCAN1;PPP6R3;EIF2AK2;PPP2R2D;IGBP1;MGAT5;PTN;PPP4R2;ARPP19;PPP1R16A;LGALS3;PPP6R1;CABIN1;PPP6R2;PPP4R1;BOD1L1;CALM2
prerank,glutathione transferase activity (GO:0004364),0.29866072222967255,0.7124246154883082,0.8423295454545454,0.9494575914979267,1.0,7/23,22.92%,GSTT1;GSTA2;GSTT2;GSTM4;LANCL1;GSTO1;PTGES
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.2952756443087099,0.7095190716068444,0.8355978260869565,0.9509131041061081,1.0,8/25,22.84%,SIRT6;PARP3;PARP1;SIRT3;PARP6;PARP2;PARP4;TNKS2
prerank,retinoid X receptor binding (GO:0046965),0.34733950997967766,0.7083901639824159,0.7932692307692307,0.9501310456103089,1.0,8/11,29.72%,NR4A2;NSD1;NCOA6;PPARG;MED25;HMGA1;RARG;NRIP1
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.3387825014061783,0.708180165766947,0.8107692307692308,0.9483396490243324,1.0,3/12,23.87%,TENT2;TENT4B;PAPOLG
prerank,methyl-CpG binding (GO:0008327),0.3072401788923092,0.7074380649207506,0.8268156424581006,0.9472089794560671,1.0,5/22,17.18%,MBD1;MECP2;MBD3;PRMT5;CHTOP
prerank,ubiquitin-dependent protein binding (GO:0140036),0.35343650697366064,0.7070189835008858,0.7973640856672158,0.9456736081572913,1.0,2/10,10.55%,USP15;IDE
prerank,semaphorin receptor activity (GO:0017154),0.33348855288323087,0.7011174063430871,0.8249211356466877,0.950221682808254,1.0,3/11,20.23%,NRP1;PLXNB1;PLXNA4
prerank,G protein-coupled receptor activity (GO:0004930),0.23002087617892314,0.6984363719123545,0.9610655737704918,0.9511725640405501,1.0,15/239,8.88%,ADGRL2;GPR156;ADRA1B;PDGFRL;CMKLR1;CASR;ADRB2;TAS1R3;NPR3;NTSR1;C5AR2;GPR65;GPR27;MRGPRF;GPR4
prerank,neuropeptide binding (GO:0042923),0.3074992109917485,0.695472174960284,0.8415697674418605,0.9525525930185542,1.0,3/18,19.53%,NMUR2;SORL1;SSTR2
prerank,palmitoyltransferase activity (GO:0016409),0.29088066292372233,0.6953852778019027,0.841248303934871,0.9506150308132352,1.0,10/28,22.44%,ZDHHC2;HHAT;ZDHHC20;ZDHHC12;ZDHHC15;ZDHHC13;ZDHHC24;GOLGA7;ZDHHC3;ZDHHC19
prerank,ubiquitin-specific protease binding (GO:1990381),0.3027816389598734,0.6900765926437673,0.8530670470756063,0.9545087777613939,1.0,2/19,9.11%,LCOR;VCP
prerank,O-methyltransferase activity (GO:0008171),0.3509470315037365,0.6863851895192498,0.8407960199004975,0.9564883226902994,1.0,5/10,27.92%,LRTOMT;ASMT;FTSJ3;CMTR2;CMTR1
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.29988067575205646,0.682850437023935,0.8417910447761194,0.9581623634758941,1.0,18/18,70.05%,HSD17B2;RDH5;HSD3B7;DHRS11;HSD11B1;HSD3B1;HSD17B10;HSD17B3;HSD17B6;RDH16;DHRS9;AKR1C1;HSD17B14;HSD3B2;SRD5A2;HSD17B8;HSD17B1;HSD17B7
prerank,beta-tubulin binding (GO:0048487),0.2759612633971167,0.6812694299959042,0.8918205804749341,0.957699202241322,1.0,3/31,4.58%,FGF13;BCAS3;EMD
prerank,cGMP binding (GO:0030553),0.32866079730652653,0.6812064109721893,0.8402457757296466,0.9557754412553947,1.0,1/11,3.67%,PDE5A
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.321843177698619,0.6811049853419182,0.8375184638109305,0.9538769424592811,1.0,3/13,13.81%,PIK3C2B;PIP5K1A;PIP4K2A
prerank,ATP hydrolysis activity (GO:0140603),0.2680907616911691,0.677580145721841,0.8803088803088803,0.9553660816719366,1.0,9/41,18.46%,VWA8;ABCD1;CHD3;CHD1L;VCP;CLU;TOR1B;MYO1E;DHX9
prerank,glutamate receptor binding (GO:0035254),0.30678384485902627,0.6774580284489232,0.856093979441997,0.9534999253234195,1.0,5/17,17.48%,GNAS;SHANK1;NSF;HOMER2;HOMER1
prerank,endopeptidase activator activity (GO:0061133),0.3407470489133635,0.6746406018322594,0.8317307692307693,0.9544395030216954,1.0,3/10,21.13%,ADRM1;PSMD14;PSME3
prerank,RNA methyltransferase activity (GO:0008173),-0.23778951974767482,-0.6722089277123354,0.889589905362776,0.9449240376794101,1.0,7/19,26.45%,TRMT9B;METTL4;FBL;TRMT5;MRM2;TYW3;METTL8
prerank,phosphoric ester hydrolase activity (GO:0042578),0.2540943669632931,0.6720847016701821,0.9114391143911439,0.9549882204882334,1.0,9/49,12.23%,MPPED2;ACP3;ACP4;APEX1;SMPDL3A;DUSP11;SBF1;DUSP28;DUSP5
prerank,MAP-kinase scaffold activity (GO:0005078),0.32899563862084524,0.6719829746599781,0.8476923076923077,0.9531279857001334,1.0,4/11,20.87%,AKAP13;DUSP19;IQGAP1;MAP2K2
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.3314978339822741,0.6710381922213167,0.8451816745655608,0.9522484505450133,1.0,3/11,21.36%,SLC25A45;SLC25A20;SLC22A5
prerank,ion gated channel activity (GO:0022839),0.2858550805293478,0.6659456491689048,0.8653576437587658,0.9549634864389183,1.0,4/24,12.30%,ANO9;ANO6;TRPM4;NMUR2
prerank,TBP-class protein binding (GO:0017025),0.2830488502581856,0.6612308097151964,0.8713286713286713,0.9573366012467703,1.0,7/21,23.63%,ESR1;PSMC1;GTF2A2;TAF12;YEATS2;TAF13;GTF2B
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.3025977690496141,0.6598288029303214,0.881559220389805,0.9567353016987071,1.0,3/16,9.58%,SMUG1;DNPH1;NEIL3
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.2669935487447278,0.6569262999218586,0.900131406044678,0.957517585836747,1.0,13/34,29.04%,UBE2A;UBE2K;UBE2B;UBE2D3;UBE2O;UBE2S;UBE2F;UBE2Z;BIRC6;UBE2R2;UBE2I;UBE2Q2;UBE2N
prerank,death domain binding (GO:0070513),0.31510004148717685,0.6497369090223472,0.8494623655913979,0.9621450106217275,1.0,6/11,27.92%,CRADD;MCL1;DAP;TRADD;DAPL1;BAX
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.31099786482678976,0.6427164848090787,0.8819875776397516,0.9664696881429141,1.0,1/11,8.23%,ARG1
prerank,syntaxin binding (GO:0019905),0.235109098559814,0.6427041445255025,0.9464720194647201,0.9645135013156154,1.0,17/61,23.88%,UNC13B;ABL1;PTPN2;NSF;SCFD2;VAMP2;STXBP1;SNAP23;LRRK2;DAPK1;STXBP5;VPS52;RAB11A;STX8;CPLX2;PRRT2;VPS54
prerank,RNA stem-loop binding (GO:0035613),0.31083426022321015,0.6421791289423759,0.8748019017432647,0.9630135041201319,1.0,5/12,26.48%,ZC3H12A;EPRS1;DHX9;FMR1;METTL16
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.30114711417473256,0.6367458024055246,0.8923303834808259,0.9656796369603246,1.0,2/14,13.65%,AK4;AK1
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.2625935410155605,-0.6362608185189953,0.9002932551319648,0.9662151590335055,1.0,5/13,25.54%,SLC38A5;SLC7A7;SLC7A1;SLC3A1;SLC66A1
prerank,peptide N-acetyltransferase activity (GO:0034212),0.31659242634956336,0.6359014208445447,0.8945634266886326,0.9644670701158597,1.0,3/10,19.23%,NAA15;NAA80;NAA60
prerank,muscle alpha-actinin binding (GO:0051371),0.2933110738302557,0.6317310065827315,0.898176291793313,0.9659098639512654,1.0,4/15,21.30%,PDLIM7;PDLIM4;PDLIM5;PDLIM2
prerank,disordered domain specific binding (GO:0097718),-0.21288592468772022,-0.6216739549857342,0.9615384615384616,0.9696565231718198,1.0,8/23,23.71%,TEAD2;CALM1;HSP90AB1;GAPDH;HSPA1A;KCNA1;BCL2L2;HSPA2
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.2540662937879234,0.6170500615205416,0.9218543046357616,0.9749914349453468,1.0,8/31,21.06%,UBE2A;UBE2K;UBE2B;UBE2D3;UBE2O;UBE2S;UBE2Z;BIRC6
prerank,WW domain binding (GO:0050699),-0.20215275340451264,-0.6102649495127503,0.9634146341463414,0.9705002428720726,1.0,4/26,10.25%,RAPGEF2;LITAF;ENAH;TNK2
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.25241502884123435,-0.607477594314453,0.9312977099236641,0.9661710649037143,1.0,7/11,45.93%,CHRNA4;CHRNB2;CHRNA9;CHRNA5;CHRNA3;CHRNB4;CHRNA1
prerank,metalloexopeptidase activity (GO:0008235),0.2279940973420716,0.6035533010549382,0.9640287769784173,0.982458498521966,1.0,8/51,14.04%,CPQ;XPNPEP3;XPNPEP1;AGBL3;NPEPPS;MMP16;DPEP1;AGBL5
prerank,retinoic acid receptor binding (GO:0042974),0.27081802911937364,0.5967900445719696,0.9309838472834068,0.9847610601959574,1.0,11/17,31.68%,NR4A2;NSD1;NCOA6;PPARG;MED25;CNOT1;HMGA1;RARG;ASXL1;NRIP1;SNW1
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.26050274855577793,0.5826476452085746,0.9375907111756169,0.991253492666439,1.0,7/16,28.75%,MTMR12;SYNJ1;MTMR1;SACM1L;MTMR9;MTM1;MTMR11
prerank,ferrous iron binding (GO:0008198),0.25381767795312943,0.5820051560085432,0.9445214979195562,0.989567471286483,1.0,6/21,25.32%,EGLN3;FXN;FTO;HIF1AN;ALKBH1;HEPH
prerank,nucleosomal DNA binding (GO:0031492),0.2521516067582287,0.5748293699917493,0.9509803921568627,0.9917166752716681,1.0,6/21,29.87%,SMARCC1;MBD3;HDAC2;SMARCA4;HNRNPC;SMARCE1
prerank,telomerase RNA binding (GO:0070034),0.24441496211498281,0.5714330446773859,0.9572039942938659,0.9914797948306484,1.0,8/22,29.37%,SMG6;DHX36;TENT4B;NAF1;PARN;SNRPB;HNRNPC;GAR1
prerank,neuropeptide receptor activity (GO:0008188),0.22500808020657892,0.5476447050857813,0.9763888888888889,1.0,1.0,7/29,26.87%,NTSR1;NMUR2;NPSR1;SSTR2;GRPR;NPY2R;GALR1
prerank,protein phosphatase inhibitor activity (GO:0004864),0.22848209803588798,0.5456694279008494,0.9605442176870749,0.9997841170997026,1.0,7/26,23.19%,STYXL1;MGAT5;PTN;ARPP19;LGALS3;CABIN1;BOD1L1
prerank,alpha-tubulin binding (GO:0043014),-0.17007994647097835,-0.5421323088586141,0.9881889763779528,0.9882281085718856,1.0,8/31,22.46%,TTLL7;EML4;TBCEL;TRPV4;EFHC1;TRIM36;SNCA;DLEC1
prerank,carbohydrate kinase activity (GO:0019200),0.25914788128206045,0.5387704511491336,0.9592169657422512,1.0,1.0,3/11,28.42%,GALK2;GALK1;HK1
prerank,neuropeptide receptor binding (GO:0071855),0.2528137560589626,0.5386481021505476,0.947129909365559,0.9987506705320721,1.0,1/14,7.03%,SHANK1
prerank,antiporter activity (GO:0015297),0.22776232500012875,0.5294592268359654,0.9741750358680057,1.0,1.0,5/20,26.40%,SLC35D2;ATP1A3;SLC35D1;SLC35E2B;SLC35E2A
prerank,motor activity (GO:0003774),0.19725573293474113,0.528047630377209,0.991812865497076,0.998904179729096,1.0,22/60,28.95%,KIF13A;KIF16B;KIF1B;KIF9;KIF3B;KIF7;KIF1C;KLC1;KIF5B;PIN1;MYO1E;DNAH17;DYNC2H1;KIF23;KIF15;APPBP2;SMC3;KIF13B;KIF22;KIF20B;DNAH8;CENPE
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.2590033019662652,0.5255486126975242,0.9442622950819672,0.9977755899176441,1.0,3/10,20.90%,IDE;DNAJB2;PML
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.23901790276871,0.519879017585226,0.9716417910447761,0.9977892747014341,1.0,6/14,28.75%,MTMR12;SYNJ1;MTMR1;MTMR9;MTM1;MTMR11
prerank,Hsp70 protein binding (GO:0030544),-0.16669762527794338,-0.5168467273325814,0.9960159362549801,0.9898995009377743,1.0,7/31,21.82%,RPS3;SACS;HIKESHI;ERN1;NOD2;SNCA;DNAJC2
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.22473269328553047,0.5165456143198742,0.978448275862069,0.9968669546906506,1.0,4/21,20.53%,GLRB;P2RX5;P2RX4;CHRNB1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.1556645291085125,-0.5140613601352957,1.0,0.98476700577636,1.0,35/35,84.47%,QTRT2;TRMT9B;TARS2;TRMT5;AARS1;AARS2;GATB;TYW3;DTWD1;BCDIN3D;MRPL58;DUS2;PTRH2;PTRH1;LCMT2;NT5C3A;ELAC2;TRMT12;DTWD2;TRIT1;QRSL1;DUS1L;TRPT1;ELAC1;TRMT13;QTRT1;PUS10;DUS3L;GATC;ALKBH1;FTSJ1;TRDMT1;MTFMT;FTO;DUS4L
prerank,neuropeptide hormone activity (GO:0005184),0.2205540549029461,0.5123129060382449,0.9820193637621023,0.9961757164680122,1.0,22/22,77.98%,HCRT;SPX;GRP;AGRP;CCK;NMB;NPFF;OXT;CORT;QRFP;GHRH;NPPA;UCN;CALCB;GAL;CRH;VIP;PPY;PNOC;ADCYAP1;NPY;PENK
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.24900627171668752,0.5105775412918419,0.9607250755287009,0.9947778786399314,1.0,4/12,25.90%,CNOT8;CNOT1;PAN3;PARN
prerank,microtubule motor activity (GO:0003777),0.1919557488292607,0.5060898967757834,0.9963898916967509,0.9941234493700668,1.0,18/51,28.95%,KIF13A;KIF16B;KIF1B;KIF9;KIF3B;KIF7;KIF1C;KIF5B;DNAH17;KIF23;KIF15;APPBP2;SMC3;KIF13B;KIF22;KIF20B;DNAH8;CENPE
prerank,kinesin binding (GO:0019894),0.2097458601889736,0.4937090651601837,0.9852744310575636,0.9954090330292752,1.0,5/27,24.22%,KIF1B;PLEKHM2;TOR1B;NEK6;KIFAP3
prerank,alanine transmembrane transporter activity (GO:0022858),0.22607473939775885,0.46841698639619966,0.9768211920529801,0.9989150533009454,1.0,2/12,20.17%,SLC38A3;SLC36A4
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.20921679227575576,0.45872651538137615,0.9807407407407407,0.9986053534396725,1.0,3/16,18.32%,TDO2;ALOX5;IDO2
prerank,hormone activity (GO:0005179),0.16964254917891172,0.4554089000436818,0.9940546967895363,0.9972501136915698,1.0,9/54,22.48%,PTHLH;INHBA;GNRH1;INHBB;HCRT;EDN3;SPX;GRP;AGRP
prerank,tropomyosin binding (GO:0005523),0.2033639630157939,0.43942117033322586,0.9915134370579916,0.9976141354316455,1.0,1/16,5.55%,CALD1
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.17612715352442504,0.4340299441191659,0.9986842105263158,0.9944164806812605,1.0,8/34,26.55%,NDUFS3;NDUFC2;NDUFB4;NDUFA12;NDUFA9;NDUFB2;NDUFS2;NDUFV1
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.17612715352442504,0.4340299441191659,0.9986842105263158,0.9944164806812605,1.0,8/34,26.55%,NDUFS3;NDUFC2;NDUFB4;NDUFA12;NDUFA9;NDUFB2;NDUFS2;NDUFV1
